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The purpose of this thesis was to assess whether heavy social drinking cannabis and 
smoking polydrug use results in more significant working memory task impairment when 
compared to heavy social drinkers. Analysis of the academic literature indicated that both 
binge drinking and cannabis consumption acts as a depressant on the central nervous 
system. Resulting in impaired Neurotransmission and disruption to Long Term 
Potentiation, the process through which memories are formed and maintained. Both binge 
drinking and cannabis consumption result in structural alterations to the brain, specifically 
the prefrontal cortex and dorsolateral prefrontal cortex, which is associated with 
impairments to working memory and attendant executive functions.  
 
The study began with a scoping search in the; The PsycInfo, Pubmed, cinall and Web of 
Science databases in which either 'binge drinking', cannabis, and the polydrug was paired, 
working memory, memory, executive functions, and the corresponding synonyms. 
Results identified nine papers on visuospatial working memory and nine on verbal 
working memory that were suitable for analysis. No statically significant effect for 
visuospatial working memory reported. However, there was a large and statistically 
significant mean weighted effect size showing lower task performance by the polydrug 
users for verbal working memory  
 
A 3-participant group design with a control group consisting of (N= 28)  non-binging 
alcohol users (CO) and two experimental groups of (N=20) binge drinkers (HSD) and 
(N=22) binge drinking-cannabis smoking polydrug users (HSDCC). The study recruited 
participants via opportunity sampling from Edge Hill University.  Participants completed 
a battery of assessments, including a background and drugs history questionnaire. The 
study also employed a series of computerised working-memory and Executive Functions 
tests. The study measured the Haematological response via fNIRS. Results found 
significant between groups effects for IC, IR, VSWM and ESS (2 and 3 Back conditions) 
With the HSDCC group reporting quicker reaction times for IC. The study found no other 
significant between groups effects. Results reported no between-groups effects for fNIRS 
through a multivariate impact on the left hemisphere for the N-Back.  The study did report 
a  significant negative correlation between the use of cannabis and Oxy-Hb changes in 
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 The Psychobiological consequences of Binge Drinking and Cannabis smoking 
polydrug use 
  
Importance as a research topic 
Evidence from several countries indicates that heavy social drinking cannabis smoking 
polydrug use is the most common form of poly drug-taking behaviour worldwide. Reports 
from the United Kingdom in the 2015-16 Crime Survey for England and Wales estimated 
that over  9.6 million people aged 16 to 59 years had used cannabis whilst engaged in 
heavy social drinking at some time in their lives. The corresponding estimates for use in 
the last year and last month, respectively, were approximately 2.1 million and 1.1 million 
people. In each case, these were the most extensive estimates of consumption for any 
combination of drugs. In the United States, 8.3% of the population aged 12 years or older 
reported the use of cannabis whilst binge drinking in the past month in 2015. (Lader, 
2016).   
 
According to the European Monitoring Centre for Drugs and Drug Addiction 
[EMCDDA] (2017) frequent or heavy alcohol users were, in general, between two and 
six times more likely to report the use of cannabis compared to the general population 
and between two and nine times more likely to use cocaine. The strongest associations 
between intense alcohol and illicit drug use were in Cyprus, France, Italy, Portugal, and 
the weakest associations in those countries where frequent or heavy alcohol use is more 
widespread, such as Ireland and the United Kingdom (England and Wales). In France, the 
prevalence of cocaine use among frequent or heavy alcohol drinkers was 8 %, compared 
with just over 1 % in the general population, and in Italy, the corresponding figures were 
27 % and 3 %. 
 
The NIAAA (2016) reported that young people experience a dynamic and expanding 
drugs market, with an increasing range of (licit and illicit) psychoactive substances, or 
products made quickly and cheaply available. The expansion of the leisure and alcohol 
industry into areas of youth culture has also meant that, in many European countries, there 
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is now a critical mass of potential polydrug users who regularly gather in large numbers 
at music clubs and other nightlife settings (De Bellis et al., 2002). New technologies 
facilitate communication about drugs, their effects, where and how to get them, within 
and between social networks.  
 
HSD cannabis smoking polydrug use dramatically increases the likelihood of adverse side 
effects occurring either physically (greening out) or psychologically (panic, anxiety and 
paranoia). Calafat et al. (2017) reported that over 35% of all road traffic accidents in 2009 
were the result of individuals driving whilst under the influence of both alcohol and 
cannabis. While the negative effect that alcohol has on driving demonstrate that, cannabis 
use also affects a person’s ability to concentrate and react in driving situations. Even at 
low doses, the combination of alcohol and cannabis is dangerous and places the drivers, 
their passengers and others on the road at serious risk (Louis-Martin (2017).  
 
The importance of heavy social drinking and cannabis smoking as a topic for research 
lies in the combination of their relatively high prevalence amongst the general population.  
Reviews of scientific evidence highlight an association with impairments in 
neurocognitive performance (Broyd et al.,  2016; Ganzer et al., 2016; Volkow et al., 
2016). Changes in brain structures  (Lorenzetti et al., 2013, 2016; Malchow et al., 2013; 
Rochetti et al., 2013), and changes in neurotransmission (Colizzi et al., 2016; Sami et al., 
2015; Szabo, 2014).  This evidence suggests that the relationship between alcohol and 
cannabis use to such impairments indicates that this form of drug-taking behaviour may 
serve as a significant public health issue.  Decriminalising cannabis and the widespread 
coverage of this issue in the public domain only adds to the importance and relevance of 
research into the psychobiological implications of this form of polydrug use. 
 
What is Alcohol? 
Alcohol is the common term given for ethanol or ethyl alcohol, a chemical compound, 
ethanol is a volatile, flammable, colourless liquid with a slight characteristic odour. It is 
a psychoactive substance and is the primary type of alcohol found in alcoholic drinks. 
The natural fermentation of sugars produces ethanol, or through petrochemical processes. 
Ethanol is a popular recreational drug. As a central nervous system depressant, ethanol is 
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one of the most commonly consumed psychoactive drugs (Reusch 2015). It can lift mood, 
cause feelings of euphoria, decrease anxiety, and increase sociability and talkativeness. 
Alcoholic drinks, like wine, beer, cider and spirits, typically contain 1% to 50% of ethanol 
by volume. Alcoholic beverages sometimes feel like a stimulant (or even hallucinogen in 
some cases), but alcohol is a depressant. It inhibits the release of neurotransmitters in the 
brain, which slows down normal bodily responses (Robinson 2007). 
 
The office for national statistics (2017) reported that 7% of adults in England regularly 
drink excessive amounts of alcohol, some 2.5 million people, who reported drinking over 
Chief Medical Officer’s low-risk guidelines (less than 14 alcoholic units per week). In 
2016, 79% of the population reported drinking regularly. In the UK, in 2015 there were 
8,758 alcohol-related deaths (around 14 per 100,000 people). The mortality rates are 
highest among people aged 55-64. In England, there are an estimated 595,131 dependent 
drinkers, of whom only 108,696 are currently accessing treatment. Alcohol misuse is the 
most significant risk factor for death, ill-health and disability among 15-49-year-olds in 
the UK, and the fifth-biggest risk factor across all ages. Alcohol harms are estimated to 
cost the NHS around £3.5 billion annually. While the price of alcohol has increased by 
36% since 2005, it remains 60% more affordable than it was in 1980. 
 
Burton et al. (2016) reported that alcohol is a causal factor in more than 60 medical 
conditions, including mouth, throat, stomach, liver and breast cancers; high blood 
pressure, cirrhosis of the liver; and depression in the UK in 2014-5. There were an 
estimated 1.1 million hospital admissions related to alcohol consumption, where an 
alcohol-related disease, injury or condition was the primary reason for hospital admission 
or a secondary diagnosis. In the same period, there were 339,000 admissions for problems 
directly caused by alcohol (Public Health England 2017). Males accounted for 
approximately 65% of all alcohol-related deaths in the UK in 2014. The alcohol-related 
mortality rate of men in the most disadvantaged socio-economic class is 3.5 times higher 
than for men in the least impoverished class. At the same time, for women, the figure is 
5.7 times higher (Siegler et al. 2011). In England and Wales, an alcohol-induced liver 
disease caused 63% of all alcohol-related deaths in 2014. Liver disease is one of the few 
major causes of premature mortality that is increasing, and deaths have increased by 
around 40% in a decade (Williams et al., 2017). Between the ages of 60 and 74 admitted 
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to hospitals in England with mental and behavioural disorders associated with alcohol.  
Use has risen by over 150% in the past ten years, while the figure for 15-59 years old has 
increased by 94% 
 
What is binge drinking? 
Binge drinking or heavy social drinking (HSD) is heavy episodic consumption of alcohol 
within a short period followed by a period of abstinence, precisely four or more drinks 
for a woman and five or more for a man (Squeglia et al. 2012). Other, less common 
definitions are blood alcohol concentration (BAC). For example, the National Institute on 
Alcohol Abuse and Alcoholism (NIAAA 2013) defines the term “binge drinking” as a 
pattern of drinking that brings a person’s blood alcohol concentration (BAC) to 0.08%. 
In the United States, the term “extreme drinking” or “industrial-strength bingeing” is 
sometimes used to describe a more severe form of (single-evening) binge drinking;  is 
defined as ten or more standard American drinks on a single occasion (sometimes as eight 
glasses for women). If done over 2 to 3 hours, a typical adult would have a peak BAC of 
at least 0.20 % (White 2006). 
 
In summary, therefore, whilst the precise numerical definition used is open to debate, 
binge drinking consists of massive or rapid alcohol consumption over a short period with 
the explicit intention of becoming intoxicated. Notably, four or five drinks consumed over 
a whole day as an accompaniment to meals will not have the same effect as the same 
amount consumed over a couple of hours on an empty stomach (British Medical 
Association 2013 ). 
 
The Office for National Statistics (2014) reported that of the 28.9 million people who said 
that they drank alcohol, 12.9 million (45%) engaged in binge drinking behaviour, 
drinking more than 4.67 units (around 2 pints of 4% beer or two medium (175 millilitres) 
glasses of 13% wine) on their most intense drinking day. Of these, 2.5 million (9%) drank 
more units in one day than the weekly recommended amount of 14 units (6 pints of beer 
or 1.4 bottles of 13% wine). Young people were less likely to have consumed alcohol; 
less than half (48%) of those aged 16 to 24 reported drinking alcohol in the previous 
week, compared with 66% of those aged 45 to 64.  While overall being less likely to drink 
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alcohol, young drinkers were more likely than any other age group to consume more than 
the weekly recommended limit in one day. Among 16 to 24-year-old drinkers, 17% 
finished more than 14 units compared with 2% of those aged 65 and over. 
  
What is cannabis? 
Three varieties of cannabis belonging to the genus’ cannabis’, specifically Sativa, Indica, 
and Ruderalis have are known. Whether these different strains represent specific 
taxonomic categories or a single species is far from equivocal (de Meijer, 2014; Gloss, 
2015; Hilig & Mahlberg, 2004). Cannabis is the common term given to the recreationally 
used drug derived from the plant (Both buds and leaves). In North America, the label 
‘marijuana’ is the drug, rather than cannabis (NIDA, 2016). Recreational use of cannabis 
takes the form of smoke inhalation via cannabis “joints”, although oral administration in 
the form of ‘cakes’ or ‘tea’ is also standard (Heustis & Smith, 2014). Traditionally, 
cannabis is processed through sieving the plant into a powder and then compressed and 
heated, a concrete block which referred to as cannabis resin, which is then self-
administered through smoke inhalation (Advisory Council on the Misuse of Drugs, 2008; 
NIDA, 2016). The inhalation of vapour from the heating of an oil extract from the leaves 
of the cannabis plant sometimes referred to as dabbing, has developed as a means of self-
administration in recent years, partly because the process of producing the oil leads to a 
relatively potent form of cannabis (Krauss et al., 2015; Loflin & Earleywine, 2014). The 
commonly self-reported desired effects of cannabis consumption include increased 
feelings of relaxation, an elevated mood level, and enhancements in sensory perception 
(Grinspoon et al., 2005; Winstock et al., 2010). The clinical administration of cannabis-
based medications may include oral ingestion, sublingual, rectal, dermal, eye drops, and 
intravenous routes (Heustis & Smith, 2014; Scuderi et al., 2009). 
 
The number of separately identified compounds isolated from the Cannabis Sativa plant 
has grown steadily since the 1980s, with 545 identified compounds (Elsohly & Gul, 
2014). This total of 545 included 104 identified as being cannabinoids by their structure. 
This group of cannabinoids consists of those compounds considered to be psychoactive, 
most notably Δ9-tetrahydrocannabinol (Δ9-THC) (Pertwee, 1988). As this cannabinoid 
is chiefly responsible for the psychoactive effects of cannabis, descriptions of the potency 
of cannabis are generally related to the Δ9-THC concentration of a given supply (Freeman 
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et al., 2014; Hardwick & King, 2008). It is the high Δ9-THC concentration of the oil 
extracted from cannabis plant products for vapour inhalation, which makes it a potent 
form of the drug (Loflin & Earleywine, 2014). The breeding of cannabis plants and the 
use of cuttings from the flowering tops produce cannabis with elevated levels of Δ9-THC. 
Sometimes referred to as sinsemilla, or colloquially by users as ‘skunk’, this has become 
increasingly prevalent for consumption by smoking since the 1990s in the United 
Kingdom (Freeman et al., 2014; Hardwick & King, 2008), the United States (ElSohley et 
al., 2016), and Australia (Swift et al., 2013). Δ9-THC activates dopaminergic activity in 
the ventral tegmental and substantia nigra, which are both implicated in neural substrates 
relevant to substance addiction generally (French et al., 1997). The bioavailability level 
of THC consumed through cannabis smoking is approximately 25%, although much 
variability in this measure can be found both within and between individuals (Heustis & 
Smith, 2014). 
 
There is evidence for a relationship between cannabis consumption and deleterious 
effects concerning neurotransmission and the integrity of neural structures, and cognitive 
performance. However, there is also evidence that cannabinoids can also be 
neuroprotective in some instances. Indeed, the existence of an endogenous cannabinoid 
system (ECS) may reasonably imply some benefits for human functioning and wellbeing 
through the activation of neuronal receptors for cannabinoid compounds. Capasso (2017) 
provides a brief background to the development of knowledge concerning the ECS and 
presents evidence that CBD, in particular, may have neuroprotective effects which protect 
against epilepsy. The mediation of glutamatergic activation is the likely basis for this 
neuroprotective effect. However, concomitant cannabis use by human users of ecstasy 
(MDMA) has not shown any neuroprotective effects such as may be implied by 
reductions in impaired cognitive performance compared to ecstasy users without 
concomitant cannabis use (Fisk et al., 2006). In this context, it is worth noting that low 
dose administrations of Δ9-THC have is a potential treatment for age-related cognitive 







What is polydrug use? 
The term polydrug use is a blanket term for different types of specific drug-taking 
behaviour, several precise definitions of what polydrug use is, must, therefore, be 
considered. At one extreme is the notion of planned use, which is where the combined 
effects of multiple drugs elicit the desired result. According to the European Monitoring 
Centre for Drugs and Drug Addiction (2002) (EMCDDA) the term planned polydrug use, 
also referred to as CDI or combined drug intoxication, refers to the act of ingesting two 
or more psychoactive substances to achieve a combined effect. It is often the case that 
one drug is a base or primary narcotic, with the additional used to heighten the 
psychotropic effect. These drugs also act in a compensatory capacity for the side effects 
of the primary narcotic, thus making the experience more enjoyable with 
pharmacologically synergistic effects. The EMCDDA (2009) describe the behaviour as 
chaotic. The use of several substances simultaneously or consecutively. Boyes et al. 
(1999) were able to catalogue some of the different polydrug combinations; Ecstasy, 
combined with GBL, heroin with methadone, and alcohol with cannabis.  Ives and Gehoni 
(2006) note an increase in the range and availability of drugs; this has increased the 
prevalence of illicit polydrug use worldwide. Coupled with a societal shift towards 
increased acceptability of polydrug use, means that this is becoming an area of increased 
interest for research.  
 
Polydrug use often takes place in the context of recreational activities, with population 
surveys confirming that drug use is associated with visiting bars and nightclubs. Studies 
conducted in targeted nightlife settings during the past decade in several European 
countries have found comparatively high levels of polydrug use. Studies conducted in 
recreational settings indicates that lifetime prevalence estimates range from 15 % to 71 
% for alcohol and ecstasy use and from 17 % to 68 % for amphetamine use. Tobacco (48 
%), alcohol (11 %) and cannabis (9 %) were overall the substances most commonly used 
together regularly (five or more days a week); fewer than 1 % of respondents reported 
regular use of other substances. However, the study identified the existence of a tiny 
group of drug users who consumed drugs in a too intensive manner. It found that 
concomitant alcohol use was expected, with 34 % of those interviewed reported having 
been drunk more than twice during the four weeks before the interview. Drunkenness is 
likely to increase the risk of making ill-considered decisions about drug-taking and 
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engaged in by more males than females: 42 % and 27 % respectively (European 
Commission, 2007). 
 
 In the context of recreational drug-taking, polydrug use can be limited and linked to a 
specific social situation or location. For example, surveys conducted among 868 tourists 
at Ibiza airport reported that those who were already using drugs in the United Kingdom 
had a significantly higher frequency of polydrug use during the holiday period. Some 6.7 
% reported using ecstasy for five nights or more while in the United Kingdom, compared 
with 36.9 % while in Ibiza; on average consumers used at least two illicit drugs during 
the holiday (for example, 46 % of ecstasy users also used cocaine) as well as alcohol 
(Bellis et al., 2008). Furthermore, some individuals who had never used illicit drugs at 
home started using while on holiday. An EMCDDA’ Selected issue’ on recreational drug 
use reported that 23 % of the young people surveyed had tried illicit drugs for the first 
time while abroad (EMCDDA, 2006). Evidence suggests that during short holiday 
periods and weekends, young people are particularly liable to indulge in poly drug-related 
activities. This pattern highlights the need for specifically targeted prevention and harm-
reduction responses that take into account the context in which polydrug use occurs (De 
Bellis et al., 2003). 
 
Polydrug use, proposed implications for neurotransmission 
Evidence from within the psychobiological literature has demonstrated that the 
psychoactive agents in cannabis (THC) and alcohol (ethanol) can exert their effects upon 
psychological functions and attendant behaviours by disruption to neural communication. 
(Murphy et al., 2018; Marinkovic et al., 2019). It is important to note that ethanol is purely 
an exogenous substance entering the body via the consumption of alcoholic drinks alone 
(Schleur et al. 2019). Pharmacological research has demonstrated that ethanol has an 
affinity for both NMDA and Glutamate receptor sites (Lu et al. 2019, De Ternay, et al. 
(2019).  Therefore alcohols influence upon neurotransmission can be seen as a function 
of ethanol’s ability to serve as both an agonist and antagonist to these structures (Ranson 
et al. 2019). However, to appreciate THC’s effects, Endogenous cannabinoids are 
compounds that are created within the central nervous system (CNS) and play a central 
role in the modulation of the CNS’s monoamine functioning (Van Bockstale, 2013). Like 
ethanol, exogenous cannabinoids such as THC enter the body via external means, 
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predominantly through the smoking of cannabis cigarettes. Psychopharmacological 
research has been able to demonstrate that both exogenous and endogenous cannabinoids 
have an affinity for the cannabinoid receptors found within the brain. Exogenous 
cannabinoids, including THC, exert their influence on psychological functioning by 
disrupting neurotransmission at these cannabinoid receptors cites (Pertwee and Cascio, 
2014). 
 
Neuroanatomical research has identified two receptor sites of particular interest for an 
investigation into disruption to neural communication and HSD, specifically The N-
methyl-D-aspartate receptor (NMDR) and the GABAA receptor (GABAAR). Both 
GABBAR and NMDR receptors are prominent throughout the brain. NMDRs ubiquity is 
a function of its role as a  receptor for the minds primary excitatory neurotransmitter, 
glutamate whilst GBBAAR’s ubiquity is a function of its role as a receptor for the primary 
inhibitory neurotransmitter GABA (Brassai et al. 2015). Alcohols influence upon neural 
communication is a function of decreased excitatory and increase inhibitory 
neurotransmission. (Petroff et al., 2002). To date, two cannabinoid receptors have been 
identified, referred to as cannabinoid receptor 1 and 2 or CB1 and CB2.  These two 
primary G-protein receptors located within the endocannabinoid system (ECS). Whilst 
the role of the CB2 receptor is still largely to be elucidated upon, CB1’s position is 
understood more clearly. CB1 receptors are on presynaptic axon terminals; the CB1 
receptor-mediated synaptic inhibition. Since THC exerts an influence over the CB1 
receptor, it is logical to conclude, therefore that THC’s effect over neurotransmission is 
one of influencing neuronal inhibition (Murphy, 2018). It is also worth noting that while 
pharmacological research has almost exclusively focused on THC related activity at CB1 
and CB2 receptor sites, there are other receptors throughout the body that are cannabinoid 
receptors (Russo et al., 2013). In a recent review examining THC’s affinity for the CB1 
and CB2 binding, Pertwee and Cascio (2014) reported that THC could be a partial agonist 
on both receptor sites. The authors note the more significant agonistic effects being for 
the synthetic THC, Nabilone, used in the treatment of multiple sclerosis (Wright and Guy, 
2014).   
 
While the receptors associated with alcohol consumption within all regions of the brain, 
it is logical to assume that in consideration of the effects of HSD cannabis smoking 
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polydrug research use should focus on those regions of the brain with a high density of 
CB1 receptors. Neuroanatomical research emphasises the importance of consideration of 
the pharmacological effects in the Prefrontal Cortex (PFC), Amygdala, Hippocampus, 
Nucleus-Accumbens, Ventral Tegmental Area (VTA), Cerebellum, and Basal Ganglia 
(Lopez-Moreno et al., 2015). Further research has identified the Cerebral Cortex, 
Hippocampus, Globus Pallidus, Cerebellum as being the cortical structures where the 
majority of CB2 receptors are (Pertwee et al., 2010). Functionally NMDR GABBAR and 
CB1 receptors modulate neurotransmitter production; specifically, the secretion of 
glutamate, GABA, Serotonin, Dopamine and Acetylcholine within the PFC and 
Hippocampus, whilst also modulating GABA, Dopamine, and Glutamate in the 
Amygdala (Huizenga et al. 2019; Ceccarini et al., 2018). Given the range of 
neurotransmitter systems reliant upon NMDR GABBAR and CB1 functioning, the 
receptors is a critical component in neuro-pharmacological processes as well as 
psychological and behavioural functioning  (Laaris et al., 2010, Cass et al., 2014). It is 
logical to conclude, therefore that ethanol and THC from HSD cannabis smoking 
polydrug exposure would result in deficits to those Psychological and behavioural 
functions networked through those cortical structures. However, any conclusion made 
regarding this relationship is tenuous at best as the findings are from rodent and primate 
studies, as such, it isn’t easy to relate these findings to psychological and functional 
effects of THC upon CB1 functioning in humans (Murphy 2018)   
 
In terms of psychological functioning HSD and cannabis smoking have both been shown 
to disrupt Long Term Potentiation and Long Term Depression, the neurological process 
that underpins memory and learning. Psychopharmacological research has shown that the 
receptor cites affected by ethanol and THC exposure  (GABAa, glutamate and CB1 
receptors) play a central role in the effective neural communication, which in turn 
facilitates LTP ad LTD (Bliss and Collingridge, 1993). In this capacity, ethanol can 
disrupt this process through simultaneous binding to the GABAA receptor of the 
endogenous inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and 
inhibition of the function of the excitatory neurotransmitter receiver (NMDR) for 
glutamate, the primary neurotransmitters necessary for neural communication. By 
binding to both inhibitory and excitatory receptor cites on pre and postsynaptic neurons. 
It is reasonable to conclude that ethanol can cause disruption LTP and LTD through 
suppression of neurological excitation and stimulation of neurological inhibition.  (Davis 
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et al., 2003). The CB1 receptors facilitate LTP and LTD via retrograde signalling of 
endocannabinoid neurotransmitters from postsynaptic neuron (Xu and He, 2015). 
Exogenous CB1 agonists such as THC disrupt LTP and LTD induction through binding 
to the CB1 receptor. This binding action prevents endogenous cannabinoid from 
functioning correctly. Consequently, suppressing the excitatory neurotransmitter 
Glutamate and GABA-ergic transmission potentiated (Hu et al., 2013). It is logical to 
conclude therefor that ethanol and THC induced disruption to LTP potentially affects 
multiple psychological and behavioural processes. 
 
Upon analysis of the available data on both ethanol and THC’s effects on 
neurotransmission and disruption to LTP and LTD, demographic variables play a 
significant role in the expression of psychological and behavioural impairment (Broyd et 
al., 2016, Harvey et al. 2019). Broyd and colleagues were able to demonstrate that age 
the onset of cannabis misuse is a particularly salient area to consider. This observation 
was echoed by Broyd, who also noted that the early start of HSD resulted in more 
significant cognitive impairment when compared to those individuals who began to 
engage this behaviour later in life. Indeed there seems to be a consensus across cannabis 
and alcohol literature with regards to the early onset of both drug-taking types and an 
increase in the severity of cognitive disruption (Connor et al. 2019). The severity of 
cognitive impairment in both populations is related to the impairment of neurogenesis in 
the hippocampus and increased stress reactivity (Lee et al., 2014) as well as an 
impairment to GABA expression in the PFC (Cass et al., 2014). Early exposure to alcohol 
and THC produces a neuro-inflammatory effect within the PFC (Gao et al. 2019). 
 
It is also important to note that the increase in the availability of affordable alcohol with 
increased ethanol levels and use of potent strains of cannabis with significantly elevated 
levels of THC. Combined with the increased prevalence of synthetic cannabinoids such 
as spice which has a much higher affinity to CB1 receptors raises the possibility of 
alterations to neurotransmission and alterations to psychological performance (El Sohly 
et al., 2016, and Thomas et al., 2014). Furthermore, THC’s high lipid solubility, its effects 
on neurotransmission occur within a particular pharmacokinetic context (Ashton, 2001). 
The body metabolises over 80 to 90% of THC within five days; it can, however, remain 
in the body of chronic cannabis user up to twenty-four days post-consumption (Lowe et 
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al., 2009). It recommended that the effects of THC on neurotransmission and attendant 
psychological functioning are observable within the first five days post-exposure, with a 
more extended time frame for chronic users. 
 
Polydrug use proposed structural alteration to the brain. 
The concerns surrounding toxicity levels raised in the discussion on neurotransmission 
presented earlier in this chapter are also related to issues of structural alteration—the 
availability of alcohol with high ethanol content. Strains of cannabis with increased THC 
levels, as well as synthetic cannabinoids such as spice, which have a higher affinity to the 
CB1 receptor all, serve to increase potential neurotoxic effects impacting on attendant 
psychological functioning (Centre for Disease Control, 2011).    
 
Neuroanatomical research has identified discrete regions in the brain that are vulnerable 
to the effects of both alcohol and cannabis. Referred to as the mesolimbic dopamine 
system (MLDS) this area includes; the ventral tegmental area, nucleus accumbens, and 
prefrontal cortex, amygdala, striatum, and Hippocampus (Kalivas and O’Brien 2008 and 
Spiga et al. 2010). It is logical, therefore, to consider the neuroplastic and attendant 
neurocognitive changes to these regions. 
 
Research studies conducted by Chanraud et al., (2009) and Campanella et al .,(2013) have 
noted volumetric reductions to the Fornix and Hippocampus in HSD populations, 
observed behavioural deficits and damage to hippocampal networked episodic memory. 
In a recent review examining the effects of cannabis on cortical structural stability, THC, 
as well as other CB1 agonists, were also associated with structural alterations to the 
hippocampus. Rodent studies reported that the administration of the synthetic CB1 
agonist WIN, 55212-2 was associated with increased cell death and decreased synaptic 
connections within the PFC when compared to controls. The observed volumetric 
reductions to these areas result in deficits to psychological and behavioural functions 
networked through these areas (Bologov et al., 2011). However, it is worth noting that 
rodent studies have also reported neuroprotective effects in instances of ultra-low doses 
of THC exposure (Assaf et al., 2011; Fishbein-Kaminietsky et al., 2014). In an attempt to 
explain this differential in effect, mechanisms reflecting the internal state of the cell and 
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its innate viability have been proposed, with weaker natural states serving to enhance 
vulnerability to neurotoxicity (Bologov et al. 2011). 
 
Studies conducted in groups with uncomplicated alcoholism have identified 
compromised white matter in the temporal lobe (Gazdzinski et al., 2005) and 
microstructural grey matter abnormalities in the hippocampal formation (Chanraud et al., 
2009). Volumetric reductions in Grey Matter concentrations within the Hippocampus of 
Cannabis users have observed in recent neuroimaging reviews by Lorrenzetti et al. (2016) 
and Rocchetti et al. (2013). In both studies, exclusion criteria included a diagnosis of 
Psychosis, thus removing any potential methodological confounds as a result of 
neuroanatomical alterations typified by these conditions.  Results from the Meta-Analytic 
review conducted by Rocchettie and colleagues found statistically significant volumetric 
reductions to overall hippocampal volume. The author concluded that since the 
hippocampus is a critical cortical structure implicated in memory task performance, 
volumetric reductions to this structure serves to highlight the potential role of exogenous 
cannabinoids in declines in memory and learning. 
 
Battistella et al. (2014) were able to validate the notion that there does indeed exist a 
relationship between cannabis use Hippocampal volume reductions. Results from 
Battistella and colleagues indicated that cannabis use from under eighteen years of age 
was associated with a significant reduction in grey matter in the left Para Hippocampal 
Gyrus between the ages of nineteen and twenty-nine when compared to the onset of 
cannabis use after the age of eighteen. Misuse levels also were associated with 
Hippocampus changes. Persistent cannabis misuse resulted in statistically significant 
reductions in grey matter concentrations when compared to recreational users. However, 
the study failed to find the duration of use to be a reliable moderator for this effect. 
However, this result may be due to the insensitive nature of the analysis of cannabis 
consumption by the participants. It is also worth noting that insufficient data reporting on 
consumption meant that this as a viable moderation in the Meta-Regression. There were 
also conflicting reports for the primary studies cited in this review, Ashtari et al., (2011) 
reported a negative correlation between Hippocampal volume in the gyrus and estimates 





Evidence from within the literature also suggests that exogenous cannabinoids play a 
significant role in the impairment of emotion and memory with reported reductions to the 
functional connections between the hippocampus, amygdala, and cortical structures 
implicated in emotion processing (Lorenzetti et al., 2016). Lorenzetti and colleagues 
reported reductions in amygdala volume in cannabis users when compared to controls, 
with additional studies highlighting an increased grey matter density and alterations to 
amygdala morphology. 
 
Research investigating the PFC have reported cortical density alterations related to the 
age of cannabis use onset. Studies have demonstrated that cannabis consumption 
negatively correlates with the age of onset use and density to the right superior frontal 
lobe. Urine analysis reported a negative correlation to cannabis consumption levels and 
the thickness of the cadual middle of the right frontal lobe, right lingual and left superior 
gyrus. The author concluded that there seems to be a relationship between structural 
alterations to those areas of the brain and cannabis users compared to controls. Synaptic 
connectivity in these regions also plays a potential role in the development of structural 
changes related to cannabis consumption (Lorenzetti et al., 2016). In a review by 
Chanraud et al. (2009), HSD resulted in grey matter shrinkage of the frontal lobes, pons, 
thalamus and cerebellum. Moreover, through the use of tractography, research has shown 
decreased white matter density between the PFC midbrain and the pons in HSD 
populations. 
 
The potential impact of nicotine on polydrug use 
Evidence from within the broader academic literature has noted that nicotine consumption 
in the form of cigarette smoking is prevalent in HSD and Cannabis consumption research, 
(Herschberger et al. 2020). The EMCDDA (2019) notes that nicotine usage in both binge 
drinking and cannabis consuming populations is considerably higher than the rest of the 
community. Statistics notes that nicotine use amongst the general population is 
approximately 15%, but that this rises to 40% in binge drinkers and 75% in cannabis 
users. Neuropsychological research has demonstrated that nicotine consumption results 
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in deficits to WM and EF. It is logical, therefore, to consider the impact of nicotine use 
with regards to binge drinking and cannabis smoking polydrug use. 
 
While the neurotoxic properties of nicotine are yet to be clarified, the existing studies 
report similar patterns of cortical damage as that observed in HSD and cannabis 
consumption. Specifically, lower grey matter density in the prefrontal cortex, cingulate 
gyrus, parietal lobe, cerebellum, thalamus, striatum and medial temporal lobe. HSD 
cannabis and nicotine misuse have also resulted in deficits in working memory and 
executive functions.  (Jacobsen et al. 2007, Musso, et al. 2007).  
 
Research conducted by Nardone et al. (2020) reported that nicotine use was positively 
correlated with deficits to WM and EF in cannabis smokers. Results indicated that 
participants displayed deficits to spatial working memory on the delayed response task. 
The researchers concluded that damage to delayed response is indicative of impairment 
in the DLPFC. Otto et al. (2020) reported that combinations of ethanol and nicotine 
resulted in decreased visuospatial working memory task performance. The research 
assessed participants with regards to the Corsi block tapping test, those individuals who 
reported co-usage of nicotine had visible deficits to the total number of blocks remembers 
and overall reaction time. 
 
Neuropsychological research has observed that nicotine, ethanol, and THC alter nicotinic-
acetyl cholinergic receptor response. Studies reported similar withdrawal responses in 
HSD, cannabis and nicotine misuse. The authors suggested that this is indicative of 
similar functional and biochemical interactions taking place between the three substances. 
From the evidence within the broader academic literature, there does appear to be 
convergent evidence to suggest that nicotine has additional consequences for WM and 
EF impairment (Valjent et al. 2002). However, to date, the precise neuroanatomical 
effects of nicotine use are not precisely known, nor are the interactions between HSD and 




Given the evidence presented it logical to conclude that any investigation into binge 
drinking and cannabis consumption must factor in the potential effect that nicotine 




In conclusion, from the evidence presented, both heavy social drinking and cannabis 
consumption properties neurotoxic properties. Both substances act as a depressant on the 
CNS and disrupt regular neural communication and long-term potentiation. The act of 
binge drinking cannabis smoking polydrug could potentially have a cumulative effect on 




















Heavy Social Drinking cannabis smoking polydrug use. Bio-Psychological 
implications for memory, learning and behaviour 
 
Verbal Learning and Memory 
Reviews into the constructs Verbal Learning and Memory have demonstrated that these 
are cognitive domains in which primary studies have been able to establish impaired 
functioning in both HSD and cannabis smoking populations when compared to controls. 
In addition to this, research has also been able to demonstrate a correlational relationship 
between the estimates of lifetime substance misuse and task performance (Broyd et al. 
2016 & Jones et al.,2019). 
 
Research findings from Solowji et al. (2011) based on a sample of adolescent cannabis 
users, assessed using the Rey Auditory Verbal-Learning Test (RAVALT) demonstrate 
deficits in word recall, verbal learning, retention and retrieval when compared to non-
cannabis smoking controls. Upon a more detailed consideration of the findings, the results 
indicated that cannabis consumption resulted in measurable deficits to a total of eight out 
of eleven key performance indicators. In HSD research, Parada et al. (2011) reported that 
HSD displayed significant reductions in word recall and greater interference to word 
recall when compared to controls. In both of these studies, the researchers were able to 
observe a correlational relationship between deficits in task performance and estimated 
lifetime substance misuse, whereby higher quantities and frequency of use resulted in 
increased impairment. Results also indicated that in both the HSD and cannabis studies, 
the average age of onset was a significant factor in verbal learning memory task 
performance. With intoxication as a potential methodological confound, both studies 
made use of a washout period, twelve hours for Solowji and colleagues. 
In comparison, Parada employed a washout period of twenty-four hours. Also, there was 
a median abstinence period for participation in Solowji and colleagues research, with the 
cannabis users having to display abstinence of twenty point three hours. However, no 
additional abstinence criteria, other than the one day washout period, was recorded in the 
HSD group. In Solowji’s research, a urinary analysis employed to control for the presence 
of cannabinoid metabolites. However, there was no observable relationship from the other 
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four measures. With no indication of toxicological screening in Parada’s research, it is 
impossible to comment on the impact that alcohol’s presence may have played on task 
performance.   
 
Bolla et al. (2002) were able to demonstrate, that when comparing neuropsychological 
performance to cannabis consumption, a negative correlation existed between 
consumption level and deficits to delayed recall on the RAVALT following twenty-eight-
day abstinence. However, it is worth noting that Bolla and colleagues did not use a control 
group to compare their results. Similarly, concerning HSD Cabria et al. (2017) also 
reported a negative correlation between two of the conditions on the RAVALT decreases 
in immediate recall and delayed recall of stores and length of time engaged in HSD. 
 
In a study conducted by Medina et al. (2007) cannabis users performed significantly 
worse than non-cannabis smoking controls on verbal story memory when analysed using 
the Wechsler’s Memory Scale version three (WMS III). Groth et al. (2018), in direct 
response to the research conducted by Cabria et al. (2017) noted that the observed deficits 
verbal learning where validated on a more extended battery of tests, with participant’s 
performing worse on recognition ability, on the California Verbal Learning Test (CVLT). 
The study failed to find a significant gender difference, although years of alcohol misuse 
and task performance were weakly correlated. Similarly, Medina and colleagues were 
unable to find a connection between cannabis consumption and verbal list learning when 
using the California Verbal List Test (CVLT). Cannabis consumption was, however, 
associated with deficits to intricate attention when within a non-verbal learning task. 
Correlational analysis indicated that scores of verbal story memory and detailed attention 
is related to increased estimates of lifetime use.  
 
Therefore, there does appear to be a relationship between HSD, cannabis consumption 
and deficits to learning ability and memory. Correlational analysis indicates that increased 
levels of either alcohol or cannabis are related to decreases in task performance, and age 
of onset also appears to play a significant role, with the highest levels of deficits being 
present in those who have engaged in the behaviours for an extended period. Given the 
array of evidence from primary studies presented within this review, these observations 
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appear to be the accepted consensus within the academic literature. It is logical to assume 
therefore that any investigation into HSD Cannabis smoking polydrug use would show 
that polydrug users would display elevated levels of impairment to learning and memory 
when compared to users of either substance separately or controls. 
 
Working Memory 
 A different domain that impaired in both HSD and cannabis smokers is that of Working 
Memory (WM). Unlike verbal learning and memory, however, WM is a field of research 
where primary studies have been unable to establish a consensus with regards to substance 
misuse and task performance. Generally speaking, this is because WM covers a broad 
range of domains such as visual or auditory memory information processing (Murphy et 
al. 2018). This particular cognitive construct also involves aspects of executive control 
(which will be described later on in this review) in the form of decision making (Baddley, 
2000, Miyakee, 1999). Indeed, Murphy et al. (2018) note that through Latent Variable 
Analysis, it is clear that the Visuo-Spatial aspect of WM is relying heavily upon executive 
functions. This processing is not contingent upon any higher order level of processing 
beyond the acquisition and storage of the information (Miyake et al., 2001). 
 
Consequently, given the range of executive processes concerning WM and the plethora 
of potential stimuli available (Fisk & Sharp 2004, Miyakee et al., 2000). A point of 
particular concern within the field of substance misuse, was the variety of 
neuropsychological measures employed by research teams is one of the primary factors 
implicated in the contradictory sets of results often observed when discussing WM 
impairment concerning both HSD and cannabis consumption (Broyd et al. 2016). The 
lack of consistency across research studies about the WM tasks employed is in part 
responsible for a general lack of clarity regarding substance misuse and WM impairment. 
Broyd and colleagues note that the one exception to this observation is those studies that 
have investigated WM impairment following exposure to the synthetic cannabinoids. 
 
Despite the methodological issues around accurately assessing WM task performance and 
substance misuse, evidence from within the psychological literature that has been able to 
demonstrate the N-back test is a reliable WM tool for establishing relationships between 
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substance misuse and impairments to WM performance (Jaeggi et al. 2010). In support 
of this argument, Cousjin et al. (2014) study examining the effects of cannabis 
consumption on WM using the N-Back indicated that cannabis users displayed significant 
deficits to WM when assessed on the N-Back test. Harvey et al. (2007) were able to report 
spatial WM deficits in cannabis users when analysing them using the Cambridge 
Neuropsychological Automated Test Battery (CANTAB). Whilst the abstinence period 
of this test, that of twelve hours, is within the accepted limits, the relative age of the 
participants (thirteen to eighteen) is considerably younger than the average for this type 
of research (eighteen to thirty). The two studies by Cousjin also contained neuroimaging 
elements to them. They were able to report observable differences in cortical activation 
patterns in the DLPFC with letters as a stimulus.  Indeed the N-Back has been sown to be 
a consistent measure for the assessment of HSD induced WM impairment, Mahedy et al. 
(2018) was able to demonstrate that HSD displayed more significant impairment to WM 
on a 3 Back condition when compared to controls. Neuroimaging research by Park and 
Kim (2018) has been able to demonstrate that HSD affects attendant neurological 
impairment. The researchers reported that while no significant difference in a 2-Back 
condition was initially present with controls HSD’s displayed greater neurological 
exertion to maintain a relative level of task performance to the control group, which is 
indicative of impaired functioning to WM in the HSD condition.   
 
Whilst investigations into WM and substance misuse has found some level of consistency 
with the use of the N-Back. Contradictory sets of results serve to highlight the fact that 
‘these conclusions are tenuous at best and prevent any firm conclusions. Findings 
presented by Smith et al. (2006), in a longitudinal study assessing Visuo-Spatial Working 
memory consistently failed to find any significant difference between controls and 
cannabis users over twenty years. Veredejo-Garcia et al. (2015) also reported that no 
significant effect for any of the 3 N Back conditions where a visual stimulus (a circle) 
with spatial positions used as the determinant factor. In this study, the washout period 
was seventy-two hours, and medication alleviated any withdrawal effects.  Whilst 
Squeglia et al. (2011) was only able to find a partial relationship between WM impairment 
concerning HSD. Specifically, Squeglia and colleagues found females reported deficits 
to WM, while males were displaying no such impairments to task performance, Verdejo-
Garcia and Herzig failed to account for other drug misuses in any substantive detail. 
Indeed this is as a significant methodological confound,  other studies (Montgomery & 
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Fisk, 2008; Wareing et al., 2004) have failed to demonstrate any relationship between 
spatial memory which also took Ecstasy (MDMA). 
 
Concerning any study considering the misuse of cannabis, Cohen (2017) notes that it is 
worth discussing the reported increase in the use of synthetic cannabinoids. Cohen has 
been able to demonstrate a consistent deficit in WM task performance on the N-Back test, 
precisely the 2 Back condition when digits are a stimulus. When measuring the inhibitory 
aspects of WM  via the Stroop Test results have also yielded significant levels of 
impairment in cannabis smoking populations, (Miyakee et al.,.2006). The potent agonistic 
effects of these cannabinoid strains and their apparent effects on WM performance make 
them an important target for future research looking into substance-induced deficits to 
WM, (CDC & Prevention., 2013; Thomas et al. 2014). 
 
The literature examining the effects of HSD and cannabis consumption on WM 
performance is not consistent in their finding’s when compared to investigations into 
learning and memory. Difficulties in operationalising these investigations and potential 
methodological confounds which are interfering with results. Tests such as the N-Back 
are more robust at providing consistent findings and given the prevalence synthetic 
cannabinoids with high CB1 affinities (as discussed in chapter 1, discussion of WM 
impairment in polydrug research is still of vital importance. 
 
Executive Functioning 
As discussed earlier within this chapter, executive functions (EF) are constructs that load 
heavily onto working memory (Baddley, 2000, Miyakee et al., 2000). However, EF can 
also refer to a much broader set of cognitive tools centred around problem-solving, 
planning and decision making. Within the scientific literature, these are; Task Switching, 
Inhibitory control, and executive updating. As with WM examination of the effects of 
HSD and cannabis, smoking on EF is within the substance misuse literature. As with WM, 
studies within this field often report conflicting results. Broyd et al. (2016) concluded that 
the mixed findings often cited within the literature can be related to methodological 
limitations within individual research studies. Such as not accounting for prior exposure 
to cannabis before testing, the dosage of THC consumed, or for haematological 
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concentrations of THC still present within the body (Lezak et al., 2012, Yuen & Raz., 
2014). 
 
One test of EF that has been able to demonstrate consistent results across studies in both 
HSD and cannabis smoking populations is that of the Iowa Gambling Task (IGT). 
Bechara et al. (1994) summarise the task conditions; participants are required to try and 
make as much money as possible by selecting cards from four decks. In two of the decks, 
there is the possibility of increased gains. However, the possibility of losing all the 
accumulated money is high, in the other two decks of cards, the returns are comparatively 
low, and yet, the chances of losing the capital are equally minor.  Moreno et al. 2012 and 
were able to demonstrate that both cannabis smokers and HSD consistently displayed 
impaired performance on this task when compared to controls when participants had to 
be abstinent form either substance for three days before testing. Gonzalez et al., (2012, 
2015) and Parks et al. (2018) were able to report that in instances where substance misuse 
did not appear to play a role in task performance. When the IGT was the measure of EF, 
a more detailed analysis of the results concerning relevant demographic variables was 
indeed able to produce statistically significant differences between HDS and cannabis 
smokers when compared to controls. Gonzales and colleagues were able to identify lower 
task performance on the IGT related to substance dependency symptoms and personal 
issues arising from substance misuse. Maurage and colleagues reported no difference 
between HSD and controls on the IGT. There was a significant difference when the test 
included a real-world monetary risk, and in those instances, HSD reported significant 
deficits to decision making when compared to controls. 
 
As with Working Memory, whilst a pattern of disruption to Executive Functioning 
performance in both populations is evident, these conclusions are again tenuous as studies 
have also reported no relationship. Research conducted by Veredejo-Garcia et al. (2015) 
reported an inverse correlation between THC levels and cognitive flexibility. No 
significant differences in comparison to controls were observed in the assessment of task 
inhibition whilst using the Stroop Task. Whilst Gill-Hernandez et al. (2017) found that in 
a study of three hundred and twenty-two students aged between thirteen and twenty-two 
when compared in terms of EF performance, the researchers did not find a difference 
between the two groups. Additionally. The researchers were unable to find a correlational 
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relationship between the average number of units consumed and alterations to EF 
performance. However, the researchers do admit that that maturational development may 
serve as a neuroprotective agent.     
 
One significant limitation of the investigations into EF performance and substance misuse 
is the issue of ecological validity of the task employed, so that the contradictory set of 
results may be the result of the tests used (Wallisch et al. 2018). Montgomery et al. (2012) 
attempted to address this issue by requiring participants to engage in a Virtual Reality 
(VR) task which loaded onto EF processes. The test required participants to engage in 
tests in a simulation of an office environment.  Results indicated that cannabis users 
displayed significant impairment in planning performance, yet no difference to adaptive 
or creative thinking.   
 
It is logical to conclude therefore that as with WM, the broad range of cognitive skills 
that can are EF and the comparatively broad array of tests that can be employed to this 
domain make it difficult to draw any conclusions. At the same time, researches such as 
Boyd et al. (2016) and Gill-Hernandez (2017) note that the length of substance misuse in 
both HSD and cannabis smoking populations is a significant confounding variable. Issue 
of age-related decline in mental functioning is a further issue that has to be taken into 
account when interoperating these results. 
 
Psychobiological implications for behavioural deficits. 
The cognitive impairment observed in both HSD and cannabis smoking populations does 
not sit within a vacuum, independent from behavioural phenomena. Instead, the deficits 
to both WM and EF may actively contribute to the development and maintenance of 
maladaptive behavioural traits and, therefore, suggest some tentative conclusions about 
the possible behavioural deficits in HDS cannabis smoking polydrug users (Cohen et al. 
2017). 
 
In addition to WM and EF, the pharmacological consequence of HSD and Cannabis 
consumption contribute to behavioural issues (Goudriaan et al ., 2005; Le Berre et al ., 
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2012; Noël et al .,  2007).  Behavioural research has shown that binge drinkers and 
cannabis smokers both favour the instant gratification of using either substance. They will 
tend to ignore its long-term negative consequences; this supports the argument that both 
populations share a disability within their decision making capability (Goudriaan et al .,  
2005). 
 
Neuro-anatomical research around the concept of the somatic marker theory suggests that 
decision making involves an extended brain network, controlled through a dual neural 
circuitry pathway: the impulsive and reflective systems. The model suggests that during 
the development of a substance misuse pattern of behaviour, the impulsivity system, via 
the amygdala, triggers a somatic state from stimuli (emotion, alcohol and cannabis) 
present in the immediate environment. The behaviours of those binge drinkers and 
cannabis smokers become increasingly influenced by alcohol and cannabis-related 
stimuli. These stimuli develop the ability to elicit both cravings for and motivation to 
engage in binge drinking and cannabis smoking behaviours. Persistent engagement in 
these behaviours leads to a strengthening of implicit desire. Relevant associative 
memories can, therefore, generate automatic approach tendencies (Stacy and Wiers, 
2010). The impulsive system, in turn, is linked to the reflective system this allows for a 
more flexible pursuit of long-term goals ). Anatomically speaking the reflective system is 
networked through two neural networks referred to as both “hot and cold” executive 
functioning system. The terms hot and cold with executive functions notes a movement 
away from a purely cognitive conceptualisation of executive functioning to one which 
emphasises the motivational significance of the situation the executive functions are 
related. “Cold” executive functions (those evoked under abstract non-affective 
conditions) in the the “Fronto-cerebellar circuit (Zahr et al., 2010). Hot cognitive  
(motivationally significant) networked in the paralimbic and otbitomedial structures 
(Bechara et al. 2005). Thus, the neurological pathway employed is a function of the 
emotional significance the individual places upon the situation in which the executive 
functions are used (Zelazo and Muller 2002). Arguably, everyday decision-making 
requires the integration of “hot and cold” systems and the ability to consider short- and 




Research indicates that the somatic marker brain network that is susceptible to the 
neurotoxic effects of alcohol and cannabis.  The frontal cortices, amygdala, hippocampus, 
striatum and cerebellum are particularly vulnerable to the neurotoxic effects of alcohol 
and cannabis. Le Berre et al. ( 2012 ) reported that reductions in both white and grey 
matter volume in specific frontal lobe regions result in decision making deficits. Hanlon 
(2016) and Veredejo-García, (2008)  noted a volumetric decrease in the frontal and 
parietal lobes, and reductions in the grey matter fibres are associated with a decrease in 
information encoding during visual decision-making tasks. These results suggest that 
decision-making deficits in the substance misuse group may result from impairment of 
frontal lobe networks. Behaviourally these deficits could lead polydrug users to a more 
significant “myopia” for the future, this would then motivate them to choose instant 
gratification to a greater extent than single drug users (i.e., the immediate advantages of 
their alcohol and cannabis consumption). This “myopia” may inhibit the polydrug users’ 
ability to fully comprehend the long term consequences of this form of substance misuse. 
It would, therefore, hinder their ability to seek treatment for their behaviours (Verdejo-
García 2015). 
 
Both HSD and cannabis smoking populations display addiction and dependency 
personality traits that have attributed to the abuse of both substances (Blum 2012 & 
Hathaway 2004). According to Segal (2010), the categories of cannabis misuse are; 
Cannabis Use Disorder (CUD), Cannabis Intoxication (CI), Cannabis Withdrawal (CW) 
(CID) and (UCRD), with these traits related to the activation of the dopaminergic neurons 
within the Ventral Tegmental Area (VTA).  The Substantia Nigra, is also implicated in 
the behavioural reward pathways within the brain (Clapp et al. 2008). The VTA has strong 
connections to the Nucleus Acumbens, activation of which has reinforcements substance 
misuse behaviours (Filbey et al. 2009). This neurological foundation helps to elucidate 
the biomechanical mechanisms by which perpetuate substance misuse. In short, the 
release of dopamine following these substance taking behaviours acts as positive 
reinforcement, so that individuals repeatedly engage in these behaviours (Murphy et al. 
2018). 
 
Both HSD and cannabis consumption can also encourage the engagement in drug-seeking 
behaviour through serving as a negative reinforce as a means of avoiding the negative 
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physiological consequences of substance withdrawal (Barker et al. 2004). According to 
the Diagnostic Statistical Manual, Version Five (DSM V), three or more of the following 
behavioural criteria need to meet the conditions for a diagnosis of substance withdrawal. 
Behavioural changes, following the cessation of prolonged substance misuse (this 
includes but is not mutually exclusive to HSD and cannabis smoking). Irritability, anger, 
anxiety, sleep deficits, decrease in appetite, weight loss, restlessness, depressed mood 
(APA 2013, p518). These characteristics occur in research settings, with Kerridge et al. 
(2018) being able to elicit the DSM V characteristics of Cannabis withdrawal syndrome 
in participants two days after the onset of abstinence.  
 
The DSM V is the first iteration of the manual to include Cannabis Withdrawal Syndrome 
as a diagnosable condition. Murphy (2018) attributes this change to wider recognition by 
clinicians and politicians to the threat to public wellbeing posed by the newer strains of 
cannabis with increased levels to THC and the increased prevalence of artificial 
Cannabinoids with a higher affinity to CB1 receptors as discussed in chapter 1. Given the 
synergistic effect of cannabis and alcohol and neural communication, cortical structural 
abnormalities, and attendant learning, WM, EF and behavioural characteristics. HSD 
cannabis smoking polydrug use is a crucial area of research as the alterations to cannabis, 
and the artificial strains could cause increased damage to these areas compared to 
traditional types. 
The relevance of other baselines in polydrug research 
One salient issue with regards to polydrug use is the correct identification of control group 
selection criteria.  It is the nature of the control group, which constitutes the baseline 
against which research will use to compare the effects in drug-using groups in polydrug 
use. Consequently, the nature of the control group is of fundamental importance in the 
interpretation of results obtained. To date, there is no consensus on the appropriate 
inclusion criteria for control groups in polydrug research. The failure to establish an 
agreement on proper inclusion protocols is likely to contribute to the indeterminate nature 
of WM and EF findings in polydrug research (Singh et al., 2020). Control groups tend 
towards one of two different types, the drug naïve control (Taylor, 2020. ) and a single 
drug using control group (Toegel et al., 2020.). Research has used both of these group 




Taurah et al. (2014) investigated the effects of ecstasy polydrug on WM and compared 
scores with four control groups, one a drug naïve, the other alcohol and nicotine, alcohol, 
cannabis and nicotine and a non-ecstasy polydrug group. However, operationalising such 
a study would present methodological problems, notably, to have statistical significance, 
such tasks required inflated population samples. The current research the total population 
size was (N = 997) Similarly, Kelly et al. (2017) investigated the effects of cocaine and 
amphetamine polydrug use against a drug naïve control group. Results indicated that the 
polydrug use results in significantly more impairment on measures of WM. However, the 
author did concede that the failure to include amphetamine and cocaine only controls 
limited the scope of the conclusions. Specifically, there was no way to know to what 
extent each substance contributed to the impairment.   
 
Given the potential for greater clarity of results, it would be logical to conclude that the 
use of single substance controls should be the standard for all polydrug research. 
However, Kataja et al. (2017) note that it is often challenging to recruit individuals who 
use only one type of drug.  The attendant psychological variables that help to determine 
drug-taking behaviour predisposition, namely impulsivity, actively contributes to the use 
of multiple drug types. Therefore, while the use of single drug using controls would 
represent a gold standard in this type of research, methodological difficulties around 
participant recruitment require a degree of flexibility in this regard.   
 
Issues around the interpretation of results and methodological limitations 
As in any investigation into substance misuse, analysis of the effects of HSD and cannabis 
require recruitment from populations of individuals regularly engage in these behaviours. 
It is difficult to develop adequate washout periods owing to THC’s presence in the 
systems of heavy users, its action upon dopaminergic systems, and the effects of 
withdrawal (Bundy et al., 2004). Furthermore, the aetiology of withdrawal of either of 
these substances includes sleep disturbances. A potential methodological confound as 
sleep deprivation impact upon EF and WM task performance.  Lowe et al. (2009) who 
notes that as urinary analysis has suggested that while alcohol metabolises after several 
hours even in individuals who engage in extreme binge drinking   THC is present in the 




Given that the majority of studies employ a washout period a month, this means results 
from these studies are susceptible to the detection of neurological impairment as a 
function of exogenous cannabinoid toxicity rather than the detection of any latent long 
terms effects. Addressing this issue, therefore, requires a degree of pragmatism on the 
part of the researcher. Murphy (2018) offers a solution to this issue by applying a 
standardised twenty-four-hour washout level with mean abstinence levels also being 
reported. 
 
A further issue with regards to testing of participants within HSD and cannabis misuse 
research is that of the adequate identification and control for known confounding 
variables. Traditionally within the scientific literature, relationships between variables are 
analysed through random allocation to either an experimental or control condition, to 
assess the correlational relationship between the identified independent and dependent 
variables. Participants wishing to take part in studies examining either HSD or cannabis 
consumption and cognitive processes would have to be assigned randomly to either 
condition. The experimental group, exposed to HSD drinking levels of alcohol and 
cannabis, would impracticable and violates the ethical codes of conduct for human 
testing. Therefore substance misuse research takes an a priori approach to screen and 
control for all known confounding variables that can impact upon cognitive performance 
(Valls-Serrano et al., 2016). Therefore, the prescriptive nature of substance misuse 
research means that experiments into HSD and cannabis smoking are correlational so that 
relationships can be demonstrable when a difference in task performance between the 
groups. However causal relationships remain a significant issue, raising issues around the 
utility of research in this field  
 
Conclusion 
From the evidence presented, there is a significant degree of overlap in the 
psychobiological consequences of both HSD and cannabis consumption. Their effects, 
with regards to WM, EF, and attendant behavioural impairments, provide a basis for 
understanding the possible consequences of HSD cannabis smoking polydrug use. 
However, it is evident from the research already within the academic literature that 
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existing issues around the ethical and methodological limitations of research with human 
participants preclude any confirm cause and effect conclusions from being drawn. The 
results from these studies do still provide a basis for concern regarding the impact of 
polydrug use on cognitive and behavioural performance. This concern is enhanced when 
considering the increasing prevalence of strains of cannabis with artificially elevated 
levels of THC and the emergence of synthetic cannabinoids shown to have a higher 
affinity to the CB1 receptor. The issue of understanding the consequences of HSD 
cannabis polydrug use, therefore, can be seen as one of addressing an ever-increasing 
public health concern. Research into this field can potentially serve as a basis for the 
formulation of effective substance misuse interventions. It is worth noting, however, that 
those arguments made in this, and chapter one is based on the reading of work from other 
research teams and drawing conclusions from what they report. Therefore, the next step 
in addressing this issue is to calculate results around working memory impairment with 
alcohol and cannabis consumption. Thus, the thesis will identify weather a precedent for 
























Chapter 2 discusses the effects of binge drinking and cannabis smoking combinations on 
executive functioning task performance more broadly. However, a scoping search of the 
academic literature (as described in the Methods section of this chapter) notes that one of 
the most widely researched EF domains with regards to binge drinking, and cannabis 
smoking research is that of Visuospatial working memory task performance. 
 
The Visual and spatial aspects of working memory, more broadly referred to as 
Visuospatial working memory, is assumed to hold and process information related to 
visual stimuli. The temporary storage and manipulation of spatial and visual information, 
such as remembering shapes and colours, or the location or speed of objects in space. It 
is also involved in tasks which include planning of spatial movements, like planning one’s 
way through a complex building (Baddley 2003) 
 
Visuospatial working memory is divided into separate visual, spatial and possibly 
kinaesthetic (movement) components. Specifically, Logie (1995) proposed that a multi-
component perspective suggests that modality-specific subsystems control the different 
aspects of Visuospatial processing. Logie (2003) indicated that the Visuospatial 
subsystem is two distinct components: An optical storage component (the inner Scribe) 
and a more dynamic spatial rehearsal component were both proposed to exist (Visual 
Cache). Whereas the visual element is sensitive to decay and interference, the spatial 
rehearsal mechanism actively refreshes the contents of the store and helps to retain spatial, 
sequential information. It also rehearses stimuli in the visual cache and transfers data to 
the central executive (Logie 1995). 
 
As discussed in chapter two, research within the academic literature has found that 
consumption of binging levels of alcohol has resulted in visuospatial working memory 
deficits, for example. Kokavec & Crowe (1999) identified observable differences in task 
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performance. In conjunction with these Working Memory tasks, the study investigated 
executive functioning results for both groups, and binge drinkers displayed more 
significant dysfunction than non-binge drinkers on memory tasks.   
  
Research has also reported deficits to visuospatial working memory in cannabis smoking 
populations. For example, Meyerhoff et al. (2004) reported a causal relationship between 
levels of cannabis consumed and VSWM task scores. Correlation analysis indicated that 
as THC units increased cognitive performance decreased, with lowest scores on executive 
functioning and VSWM, reductions in grey and white matter were also observed in the 
frontal lobe associated with impaired executive functioning and processing speed. The 
results imply that cannabis smoking results in a reduction in parietal neurons when 
compared to non-smoking controls and that THC exposure may result in relatively 
specific neural deficits. 
  
However, there is no consensus on this issue within the academic literature, with a 
significant body of research also indicating no significant effect for visuospatial working 
memory impairment for either binge drinking or cannabis smoking populations. For 
example, in a meta-analysis conducted by Calabria et al. (2018), the author reported that 
the current consensus with regards to binge drinking induced working memory defects is 
that this form of substance misuse has no negative impact upon Working Memory task 
performance.  In cannabis consumption research, meta-analytic results reported by Crean 
et al., (2011) said that although the studies conducted into cannabis and working memory 
are limited, the available evidence emphasises the indeterminate nature of the research in 
the field today. The author notes that out of the four studies that investigated this aspect 
of working memory, three found no significant difference between cannabis users and 
controls.   
 
 Animal model studies may provide one potential explanation for the indeterminate nature 
of the results presented in the literature. However, there is a consensus within the 
academic literature about the requirement for rat and primate studies into both binge 
drinking and cannabis smoking to provide long-term (over months) exposure to begin to 
elicit a behavioural effect (Wezeman, Juknelis, Himes, & Callaci, 2007). Given that most 
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of the human studies reported are on undergraduate populations, the authors conclude that 
animal studies have not provided sufficiently long exposure to substances for an 
observable behavioural effect to become detectable. Advances in the field of imaging 
technology have afforded researchers access to a broader array of techniques that could 
potentially account for the indeterminate nature of results found thus far (Casey et al., 
2005). Introduction of these approaches to the field of substance misuse has been able to 
provide researchers with evidence of physiological damage caused by both THC and 
ethanol, even when no apparent behavioural impairment is evident (Dickerson et al., 
2007). 
  
Using imaging techniques such as Magnetic Resonance Imaging (MRI) research has been 
able to demonstrate that THC and ethanol also cause physiological damage to the cortical 
structures in VSWM in humans. For example, Meyerhoff et al., (2004) measured cortical 
white and grey matter regional volumes to quantify N-acetylaspartate (NAA) 
concentrations (a metabolite biomarker of neural integrity). For bingers (> 100/80 alcohol 
drinks/month on <21 days in the past three years) compared with non-bingers, results 
indicated a significant reduction in NAA concentrations, which, in turn, increased the 
metabolic rate and frontal white matter density reduction, with higher parietal grey matter 
NAA.  Studies state that both THC and ethanol exposure both lead to neurodegeneration 
in corticolimbic areas (Haberly, 1998). The research found that ethanol and THC 
exposure results in neurodegeneration that produced learning deficits (Obernier, White, 
Swartzwelder, & Crews, 2002). Neuroimaging technology has implicated cannabis 
consumption to prefrontal cortex damage during visuospatial task performance. For 
example, Jagger et al. (2006) reported that the binge drinkers displayed comparable task 
performance scores to the control group during the working memory task and the selective 
attention task. At the same time, preliminary neuroimaging results indicated that binge 
drinkers did not differ from controls in terms of overall patterns of brain activity in the 
regions involved in these cognitive functions. A more detailed analysis of prefrontal 
cortex structures indicted that the binge drinkers displayed a significant alteration in brain 
activity in the left superior parietal cortex.     
 
It is logical to conclude from the evidence presented thus far that binge drinking, and 
cannabis consumption combinations have the potential to affect behavioural task 
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performance for executive functions such as visuospatial working memory networked 
within DLPFC cortical structures. Consequently, binge drinking and cannabis smoking 
could theoretically impair VSWM task performance in several ways involving a range of 
neural locations within the prefrontal cortex and DLPFC for the processing of different 
aspects of VSWM (Weise et al., 2019).   
 
This present study uses systematic review and meta-analytic methodology in a 
preliminary investigation of the respective relationships between combined cannabis and 
alcohol consumption, and visuospatial working memory task performance. 
Methods 
Identification of studies 
A preliminary search of literature covering the period up to June 2019 identified 
publications relating to the effects of binge drinking and cannabis consumption on 
visuospatial performance in humans. The analysis searched the  PsycInfo, Pubmed, cinall 
and Web of Science databases. Searching criteria used eight terms in which the search 
parameters paired either 'binge drinking', cannabis, and polydrug with 'spatial', 'visual', 
'Visuospatial' or 'visuospatial'.  All databases avoided duplication. The search employed 
the following keywords and their corresponding synonyms: Binge drinking, cannabis, 
visual, visuospatial or Visuospatial, spatial and performance. In this second search, it was 
possible to explore these terms utilising the relevant database thesaurus to ensure 
completeness of data. Inclusion criteria included English language publications with 
human participants. Other measures were that studies had to be in peer-reviewed journals 
and to be reporting new findings (including attempted replications) regarding visuospatial 
memory performance in the context of binge drinking and cannabis use. Participants 
needed to have been abstinent from cannabis, alcohol and other drugs of misuse at the 
time of testing. By implication, therefore, this review excluded studies that tested 
participants under the influence of alcohol, cannabis or other drug, animal studies and 
studies published in a language other than English, as well as dissertations, conference 
presentations, reviews or meta-analyses. Inclusion in the review sample did not 
automatically imply inclusion in meta-analyses, as additional criteria regarding study 
design, tasks employed and the reporting of data were relevant to these decisions and are 




Figure 1 outlines the search process and corresponding inclusion and exclusion criteria 
for this study. The term 'publication' emphasised the diversity of items initially identified. 
Level 1 examination against the inclusion/exclusion criteria excluded papers where, for 
example, the search terms' binge drinking' and 'spatial', resulted in the identification of 
publications from the realms of the creative arts and engineering. The study also removed 
duplications of research papers at this stage. The study identified two levels of 
examination against the inclusion/exclusion criteria for the remaining 190 reviews. These 
two levels may differentiate the extent of analysis required. For example, in some cases, 
it was possible to identify animal studies and reviews from their abstracts and a 
preliminary examination of the main text. A Level 2 examination against the 
inclusion/exclusion criteria. The studies examined the 70 studies identified as receiving a 
Level 3 examination against the inclusion/exclusion criteria in detail to assess their 
compatibility with these criteria. Table 2 summarises the points of the studies included in 
the review  
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For each research paper included in the review, the study recorded the details for each 
subgroup of participants regarding estimated cannabis and alcohol consumption for the 
last three months, and the number of participants included in each analysis and subgroup. 
The study also reported the types of visuospatial task employed and corresponding means 
and standard deviations. These variables in their published form took the forms of means 
and standard deviations. Where Papers did not record average, the mean alcoholic units 
and cannabis joints smoked in the last three months; calculations were made of an implied 
estimate, if possible, from the available data. Where researchers had explicitly intended 
to compare the performance of cannabis and binge drinkers with the control group, the 
study regarded the former as the experimental groups unless the study did expressly stated 
otherwise. However, the study detailed the use of cannabis and alcohol enough to indicate 
either binging or non-binging behaviours so that it was possible to identify the participants 
as belonging to either a control or an experimental group. The study did not require that 
the use of any other illicit substance, other than cannabis, had resulted in the exclusion of 
participants in the primary studies constituting the present sample. Minor infringements 
of the inclusion criteria were permitted by the author, for example, in the case of Smith 
et al. (2010).  The researchers enabled participants with a low level of lifetime cannabis 
exposure into the drug-naive control groups. In this sample of studies; there was a general 
trend of allowing individuals inclusion into a drug-naive control group who displayed 
long term exposure to legally available substances such as tobacco, i.e. Grant et al. (2012). 
However, all participants had been abstinent from cannabis and other illegal drugs at the 
time of testing, and the study did not include groups designated as former users. Given 
the evidence that compromised brain functioning may return to levels consistent with that 
of controls in former users (Buchert et al.,2004; Selvaraj et al., 2009), the inclusion of 
comparisons of both current and former users to Controls in the same analysis would 
potentially confound its interpretation.   
 
Analytic Strategy 
A criterion agreement established by the author of this thesis (KD) and his Director of 
Studies (PM) for the initial categorisation of a task, with other supervisors, asked to 
challenge any classifications they considered inappropriate. In the interests of consistency 
within the meta-analyses, all comparisons of Cannabis/alcohol use performance were 
with the performance of non-drug using controls.  In this way, all inter-group comparisons 
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included in meta-analyses had some degree of matching for the use of other drugs to 
diminish the potentially confounding effect of their use on the measures of task 
performance. As indicated previously, the study coded inter-group performance 
differences as “negative” if they were consistent with Cannabis and Binge users' 
performance impairment in comparison with the scores of the controls and as positive 
where users performed at a higher level than the control group.  
 
Meta-analyses using the means, standard deviations, and group sizes (N) for all DVs from 
tasks in the respective categories. Within each analysis, each study was represented by 
mean effect sizes for all appropriate comparisons, which in turn represented all of the 
DVs compared. In this way, our meta-analyses avoided the distorting effects of using 
multiple effect sizes where outcomes are not independent because of the same sub-
samples of participants having in various comparisons. The effect size statistic chosen 
was Hedges g, as this controls for distortions arising from small samples in the more 
commonly used Cohen's d statistic (Borenstein et al., 2009). Rosenthal's Fail-safe N is 
reported for each meta-analysis, indicating the minimum number of studies that would be 
required to render the result non-significant. The researchers included only studies in 
peer-reviewed journals in this review. This statistic is important in the interpretation of 
meta-analytic results. Given the possibility that studies reporting significant performance 
differences between binge drinking/ cannabis smoking users and controls may be more 
likely to be published than those reporting no difference. The analysis could not make 
assumptions for fixed-effects models given the variety of visuospatial tasks employed. 
The examiners mad an a priori decision to only examine results for random-effects 
models. The choice of random-effects models in this way, rather than upon the 
consequences for heterogeneity in a fixed-effects model, is currently recommended 
practice in a meta-analysis (Borenstein et al., 2009). In addition to these performance 
comparisons between binge drinkers/ cannabis smokers and controls, meta-regression 
(method of moments) using estimated lifetime alcohol consumption (in units) and 
cannabis (in cigarettes) as a predictor of effect sizes, where estimates were available in 
this form. The analysis coded effect sizes consistent with a binge/cannabis-related effect 
as “negative”, a relationship between these and increasing alcohol and cannabis 
consumption would yield a negative coefficient. Borenstein et al. Recommend at least ten 
studies (or independent subgroups within studies) per predictor in a meta-regression for 
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adequate statistical power. Meta-analyses used COMPREHENSIVE META-ANALYSIS 
(CMA 2.0™ Biostat, Englewood, New Jersey) software 
 
Results 
Table 1 outlines the three levels of the exclusion criteria; the removal of papers at each 
stage and how the articles met specific corresponding inclusion and exclusion criteria. 
For Level 1 papers were excluded that while related to the research question where 
conducted on animals and as such, not suitable for inclusion, for example, Cha (2007). 
Following this, the next most relevant determinant of exclusion was papers that were not 
related to the field of study, in that they were from disciplines not related to the task.  Such 
articles belonged to disciplines such as criminology and law and is a notable case that 
was generated by the scoping search. One study crossed over from the law to dentistry 
(Underwood et al. 2000). The exclusion criteria removed an additional paper, that of a 
review article, which while related to the field was a literature review and as such, offered 
up no new research. (Solowij, 2008). 
 
At level 2,  the study removed papers because the analysis regarded participants as 
polydrug users (other than cannabis or alcohol).  There was a degree of flexibility in this 
stage where individuals reported using drugs other than cannabis and alcohol. However, 
researchers would include a paper if results indicated that the use of other drug use was 
low and was not considered a habitual drug-taking behaviour. The second-largest 
exclusion criteria at this level were that the studies where medical neuroimaging studies 
and whilst carried out the relevant neurocognitive tests did not report the mean or 
standard. Instead, they tended to report exclusively on neuroimaging data such as specific 
brain activation sites in the two groups. Tapert et al. (2004) focused in on binge drinking, 
and visuospatial working memory is concerned with cortical brain activation and the use 
of BOLD imaging, with no mean or standard deviations recorded.  At this stage, three 
papers also reported on cognitive findings of individuals who were not abstinent at the 
time of testing. Specifically, the researchers administered synthetic variants of the drugs 
taken to participants and reported on neurocognitive functioning whilst under the 
influence of drugs (Hunault et al. 2009, Dumont et al. 2011 and Weinstein et al. 2008).  
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The last exclusion criteria at this level identified three longitudinal papers which reported 
on individual's neurocognitive performance at different times during a treatment 
intervention, as such, there was no control group to compare to (Payne et al. 2000, 
Teichner et al. 2001 and Zammit et al. 2002).  The Final level of the examination was 
able to identify three papers that were suitable for exclusion. In all three cases the authors 
of the articles, whilst reporting on relevant neurocognitive tests failed to report any means 
and the analysis converted standard deviations into z scores and the analysis could extract 
no relevant data, (Medina et al. 20071, Medina et al. 20072 and Padula et al. 2007). 
 
Table 1: Summary of exclusion criteria and umber of papers removed at each level 
Level 1 Level 2  Level 3 
Not related to the field of study 
(N =101) 
Cognitive Scores not reported 
(N = 18) 
Failed to Report Means and 
Standard Deviations 
(N = 61) 
 
Animal Study 
(N = 108) 
 
No Control Group 




(N = 1) 
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11 1.0 13.5 Positive  
Negative 





0.47 0.04 10 8.82 4.77 0.50 0.03 14 1.12 2.00 Negative 
Fisk et al. (2011) Alphabetic and 
random 
2.05 1.41  3009.15 18.30 2.83 1.34  145.44 9.58 Negative 
Schweinburg et 
al. (2005) 
Trail Making Test 91.00 9.0 19 12.80 42.27 86 5.0 15 5.0 0.11 Negative 
Caldwell et al. 
(2005)  




















Hanson (2010) Spatial Delayed 
Response 
Task 
-0.18 1.08 29 2396 5.3 0.32 0.75 52 2.1 1.2 Negative 





2.5 7.1 18 7 6 2.30  0.88 10 5 16 Negative 
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Fox (2002) CANTAB 
(ID/ED) 
32.7 5.3 10 275 8.7 32.0 4.1 10 450 10.7 Negative 
Scholes et  
al (2010) 
Wechsler 






















Means and Standard deviations for alcohol and cannabis consumption across the nine 
papers included in this study found in Table 2, as can details of the VSWM task employed 
and the direction of the study's findings. The statistical findings for the systematic review 
utilising a random-effects model in Figure 2. To summarise the main statistical findings, 
the 9 comparisons included in the meta-analysis yielded a non-significant mean weighted 
effect size, failing to show poorer task performance by the cannabis Polydrug users 
(Hedges g = -0.154; 95% confidence interval (CI) -1.027 (Lower) to -0.737 (Upper); z = 
- 0.322, p = .0747, two-tailed). However, given the closeness of the p-value to 
significance, Rosenthal's Fail-Safe N was calculated and indicated that the study would 
require 60 studies to render the observed p non-significant.  
 
Discussion 
The results from the Meta-Analysis reported that there was no significant observable 
effect for Visuospatial working memory and polydrug use. Given the prevalence of Binge 
Drinking and Cannabis Smoking within the general population of not just the UK but 
multiple countries worldwide (Anderson et al. 2006) the findings suggest that this paper 
may be relevant to the policies and practices of governments and health agencies both 
nationally and internationally.       
 
The finding that binge drinking cannabis smokers did not appear to show impaired 
visuospatial memory performance when compared to controls is reflective of the 
indeterminate nature of results from within the academic literature, with papers reporting 
both significant and non-significant results (Gamito et al.,2014 and Hadjiefthyvoulou et 
al.,2012). Indeed, it is a salient argument to make that these results could be reflective of 
the diffuse nature of VSWM networking within the prefrontal cortex (Zimmer, 2008). 
Indeed, compromised functioning in one or more of the network of brain areas recruited 
in the processing of Visuospatial information could still be taking place, but not being 
detected by the results from this analysis.  Tres (2014) reported that traditional VSWM 
tests tend to focus upon aspects of VSWM networked through the PFC, which in itself is 
limiting as VSWM networks through the parietal, temporal and occipital lobes. This 
widespread dispersal of brain areas, therefore, makes it challenging to interoperate the 
results of this study. 
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In conclusion, the study failed to demonstrate those binge drinkers who smoked cannabis 
performed worse on visuospatial tasks when compared to non-cannabis smoking, non-
binge drinking controls. The paper does acknowledge that there are limitations to the 
study, such as limiting the paper inclusion to English Language only. Though the fail-
safe N statistic suggests that the limitations identified, do not preclude the review from 
offering insight into drug use and visuospatial impairment. It is therefore worth noting 
that research in this field is vital for public health as visual and spatial working memory 
are essential for successful navigation through many daily activities such as driving, 
operating machinery and for social wellbeings such as in sports and recreation.  Whilst 
neural structures return to a baseline position after three months abstinence. However, 
this does not necessarily equate to a return to baseline for neurocognitive functions. It is 
challenging to assess neurocognitive functioning in the natural environment however as 
everyday visual and spatial tasks also require the recruitment of different working 
memory and executive functions for successful completion, which in turn recruits other 
neurological structures to facilitate this activity. Despite the limitations, the use of 
laboratory-based experimentation represents a "gold standard" Visuospatial assessment. 
Future investigations into visuospatial working memory would benefit from employing 


















Verbal Memory Performance in Binge Drinkers Who Smoke Cannabis, Literature 




Chapter 2 discusses the effects of binge drinking and cannabis smoking combinations on 
executive functioning task performance more broadly. However, a scoping search of the 
academic literature (as described in the Methods section of this chapter) notes that verbal 
working memory is as widely researched an EF domain as VSWM, with regards to binge 
drinking and cannabis smoking.  
 
Marvel and Desmond (2016) the authors regard the verbal component of working 
memory as a cognitive process facilitating the storage of speech-related information. 
Baddeley (1992) provides a framework with the conceptualisation on the process. 
Maintenance of verbal communication occurs via a cognitive process known as the 
phonological loop. The loop contains two components: (1) a passive storage process, 
relatively quick speech-based information that lasts 1–2 s, and (2) an active articulatory 
control process. Baddley described the process by which verbal communication proceeds 
via this two-stage mechanism. At stage one, stimuli with a visual aspect such as printed 
words translated into a "phonological representation.". Aurally presented information 
requires no such translation. The maintenance of information occurs via subvocal 
repetition, a process referred to as the phonological loop. 
 
As with the research from chapter 3, the academic literature has also found that 
consumption of binging levels of alcohol results in verbal working memory deficits. For 
example. In a meta-analysis conducted by Lannoy et al. (2019), the author reported that 
binge drinking is associated with impairments to verbal working memory. Specifically, 
the author noted that those individuals who meet the DSM-V criteria for binge drinking 
recorded significantly lower test scores on multiple verbal working memory paradigms, 
including the California Oral Word Test (COWAT). In conjunction with these findings, 
the Lannoy argued that previous meta-analyses into this issue have been insufficient due 
to search hits. The traditional belief was that there was no association between verbal 
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working memory and binge drinking. However, Lannoy questioned this, based on the 
assumption of flawed scoping searches. With this addressed, Lannoy argues that a more 
detailed analysis of the literature provides evidence of significant verbal working memory 
impairments in binge drinkers compared to controls.  
 
Research has also reported deficits to verbal working memory task impairment in 
cannabis smoking populations. For example, Radomann et al. (2019) reported a causal 
relationship between cannabis consumption and verbal working memory. Specifically, 
the author noted that in the analysis of “verbal” task score of 141 current cannabis 
smokers, reported lower verbal task performance scores on the California Verbal 
Learning Test (CVLT II) task scores.  
 
However, there is no consensus on this issue within the academic literature, with a 
significant body of research also indicating that there is no significant effect for verbal 
working memory from either binge drinking or cannabis smoking populations. For 
example in a meta-analysis conducted by Cabria et al. (2018), the author reported that the 
current consensus with regards to binge drinking induced working memory defects is that 
this form of substance misuse has no negative impact upon verbal working memory task 
performance.  Meta-analytic results reported by Crean et al., (2011) said that the studies 
conducted into Cannabis and verbal working memory are limited, however, and the 
reviews only serve to emphasise the indeterminate nature of the research in the field 
today. The author notes that out of the four studies that investigated this aspect of working 
memory, three found no significant difference between cannabis users and controls.  
 
However advances in the field of imaging technology has afforded researchers access to 
a broader array of techniques that could potentially account for the indeterminate nature 
of results found thus far (Casey et al., 2005). Introduction of these approaches to the field 
of substance misuse has been able to provide researchers with evidence of physiological 
damage caused by both THC and ethanol, even when no apparent behavioural impairment 
is evident (Dickerson et al., 2007). For example, Cservenka et al. (2012) conducted a 
study on binge drinking and verbal working memory via a variant of the word fluency 
test. Results indicated that while the binge drinkers reported a slower response times. The 
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study could observe no other significant difference. However, through the use of MRI, 
results indicated that the binge drinkers reported a statistically significant reduction in 
prefrontal cortex activity during the task. The authors concluded that not only was verbal 
working memory networked through the PFC. But continued binge drinking could 
potentially result in a progressive degradation of Verbal Working Memory task 
performance, as activations levels continually decrease to a point where task demands 
fail.    
 
Neuroimaging technology has also implicated cannabis consumption to prefrontal cortex 
damage during verbal working memory task performance. For example, Jagger et al. 
(2006) conducted a study in which the study compared ten active cannabis smokers to ten 
non-smoking controls on a battery of verbal working memory tasks. Results indicated 
that the cannabis users displayed comparable task performance scores to the control group 
during the Working Memory task and the selective attention task. At the same time, 
preliminary neuroimaging results indicated that cannabis users did not differ from 
controls in terms of overall patterns of brain activity in the regions involved in these 
cognitive functions. A more detailed analysis of prefrontal cortex structures indicted that 
cannabis users displayed a significant alteration in brain activity in the left superior 
parietal cortex.  
 
The evidence presented thus far suggests that both cannabis and alcohol cause 
impairments to verbal working memory task performance. The neurocognitive data 
presented in this chapter raises the issue of alcohol metabolites and neurotoxicity. Toosi 
et al. (2019) and Chowdury et al. (2019) 
 
This present study uses systematic review and meta-analytic methodology in a 
preliminary investigation of the respective relationships between combined Cannabis and 








The study searched all abstracting databases comprising the United Kingdom National 
Health Service, Evidence Health Information Resource, Academic based research 
databases, specifically: PsycInfo, Pubmed, Cinall and Web of Science database using the 
following key terms: Cannabis, Verbal, Verbal-Memory and Verbal-Memory 
performance. These terms were also 'exploded' using the relevant database thesaurus to 
ensure completeness of data. The analysis restricted the search to English language 
publications with human participants. Other inclusion criteria were that studies had to be 
in peer-reviewed journals and to be reporting new findings (including attempted 
replications) regarding verbal memory performance in the context of cannabis use. 
Participants needed to have been abstinent from Cannabis and other drugs of misuse at 
the time of testing for approximately one month, to remove the potential methodological 
confound of THC intoxication. The study excluded participants under the influence of or 
another drug, animal studies and studies published in a language other than English. The 
review also excluded if they were in the form of dissertations, conference presentations, 
reviews or meta-analyses. The analysis included all relevant studies published before June 
2014 (the time of the search). Inclusion in the review sample did not automatically imply 
inclusion in the meta-analysis, as the need to produce a meaningful summary effect size 
required some degree of design similarity between the primary studies. Inclusion in the 
meta-analysis needed the analysis to compare the performance of cannabis users to that 
of control participants. Inclusion in the review sample did not automatically imply 
inclusion in meta-analyses, as additional criteria regarding study design, tasks employed, 




For each study included in the review, the study recorded the analysis details for each 
subgroup of Participants regarding, number of participants, alcohol and cannabis 
consumption, types of verbal-memory task employed and corresponding means and 
standard deviations, table 4 reports upon the data. The study solely based allocation to 
either the control or experimental upon the level of alcohol drinking in units and cannabis 
cigarettes smoked where research papers intended to compare binge drinkers/ cannabis 
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smokers with a control group of non-bingers/ cannabis smokers, as consistent with the 
study based group allocation on the allocation within the original documents. Where 
intention was not clear, for instance (Hadjiefthyvoulou 2011) mean scores for alcohol use 
that did not meet the criteria for Binge Drinking and no record of cannabis smoking 
resulted in automatic inclusion into the "control" group. The converse automatically 
resulted in inclusion into the "Experimental Group". Where papers failed to report the 
average number of alcohol units drunk, and amount cannabis smoked over the three 
months, (Dougherty 2013). The study then used the calculated means for group allocation 
in terms of polydrug use. The research permitted minor infringements to the inclusion 
criteria. Cunah (2010) allowed low levels of cannabis exposure (having tried it once in 
their lifetime, but still within the one-month washout timeframe) to into the control group. 
There appears to be a trend of laxity towards drug-taking behaviour by the authors. The 
study extended this pattern to participants who had experimented with other drugs, where 
the use of illicit substance did not represent a pattern of behaviour. The study developed 
this approach to persistent legal drug-taking in instances of long term exposure to legally 
available substances of abuse such as tobacco. 
 
Although all participants had been abstinent from Cannabis and other illegal drugs at the 
time of testing, the results did not make performance comparisons with groups designated 
as former users. Given the evidence that compromised brain functioning may return to 
levels consistent with that of controls in former users (Buchert et al.,2004; Selvaraj et al., 
2009). The inclusion of comparisons of both current and former users to Controls in the 
same analysis would potentially confound its interpretation such as in the paper by Pope 
(2001) where the study reported the data from existing users and controls.  
 
Meta-analytic strategy 
The analysis adopted a consistent strategy within the meta-analysis, whereby the study 
compared all cannabis/ binge drinkers task performance to that of non-binge drinking/ 
non-cannabis smoking controls. This approach ensures more power for the matching of 
the intergroup comparisons. As well as the use of additional legal and illicit drugs (so that 
we did not include chaotic polydrug users, who regularly take other substances), and thus 




The meta-analysis used the means, standard deviations, and group sizes (n) for all DVs 
from the verbal-memory tasks. Outcomes coded the information so that worse task 
performance by cannabis users appeared as an adverse effect size whilst in instances 
where the experimental group performed better than the control group the study encoded 
a  positive effect size into the meta-analysis. This approach benefited the meta-analysis 
as it can avoid the distortion inherent in analysing multiple effect sizes where outcomes 
are not independent because of the same sub-samples of participants in various 
comparisons. Given the variety of verbal-memory tasks employed, and the heterogeneous 
nature of the participant samples and their drug use, results could not make the 
assumptions for fixed-effects models.  The researchers decided upon an "a priori" 
decision only to examine outcomes for random-effects models. The researchers chose 
Hedges g effect size statistic, to be able to control for any distortions that may arise within 
the data, a phenomenon common in papers such as this. That use small samples, as 
opposed to the more commonly used Cohen's d statistic (Borenstein et al., 2009). The 
meta-analysis also utilised Rosenthal's Fail-safe N statistic, which indicates the minimum 
number of studies that would be required to render the result of this analysis non-
significant. This statistic is vital in this review as it focused solely upon studies from peer-
reviewed journals, given the propensity for journals to publish studies that report 
significant performance differences between binge drinking/ cannabis smoking users and 
controls. In this instance, the choice of random effects model is currently recommended 
practice in a meta-analysis (Borenstein et al., 2009). The meta-analysis used 





Figure 3, outlines the search process and corresponding inclusion and exclusion levels, for this 
study, the term 'publication' is used to emphasise the diversity of items initially identified. Level 
1 examination against the inclusion/exclusion criteria excluded papers where, for example, the 
search terms' binge drinking' or "Cannabis', resulted in the identification of publications from 
the realms of Criminology or Law. The study removed duplications in papers. The study 
identified two levels of examination against the inclusion/exclusion criteria for the remaining 
231 articles. These two levels differentiated by the extent of the analysis required. For example, 
in some cases, it was possible to identify animal studies and reviews from their abstracts and a 
preliminary examination of the main text. These findings would constitute a Level 2 
examination against the inclusion/exclusion criteria. The study examined the 29 studies 
identified as receiving a Level 3 examination against the inclusion/exclusion criteria in detail 
to assess their compatibility with these criteria. Details of the nine studies included in the 
review are in Table 2. In table 1 can be found a detailed summary of the three levels of 
examination and subsequent exclusion criteria. 













1Examination by title and source 
2Examination by an abstract and preliminary reading of the text 
3Examination by a detailed reading of the text 
 
  
519 publications Identified from 
searches 
 288removeddue to 
duplication and level 1 
exclusion 
231 identified for level 2 examination 
202 excluded after level 2 
20 excluded after level 3 
9 identified as suitable for inclusion 




Figure 3 describes the search process for the systematic review. Papers were either retained or 
deleted from the study based upon a 3-level suitability analysis. At level 1 papers removed 
were from outside the discipline, Markowitz (2005), was concerned with the relationship 
between the taxation of alcohol, availability of illegal drugs such as Cannabis and the level of 
criminal behaviour. The second-largest trigger for exclusion at this level were papers translated 
into English; indeed, upon appraisal of this, it appears that the majority were from Scandinavian 
such as Ringen et al. (2013). The third most common exclusion criteria were that of animal 
studies. The study of rats limits their relevance to human behaviour and deemed inappropriate 
for inclusion, such as the paper by Fehr (1976) into learning impairment in rats exposed to 
alcohol and THC. Three Meta-analyses were also uncovered at this stage and subsequently 
removed (Verbaten 2003, Yücel et al. 2012, Potvin et al. 2008) and finally, the appearance of 
a non-peer-reviewed paper (Argenter, 1996).  Studies removed at At level 2, we're concerned 
with reporting on neuroimaging data.  They did concern themselves with verbal memory 
performance and failed to record any mean scores. Desmond et al. (2003) noted exclusion for 
papers looking at polydrug use, e.g. Rosselli (1996). The study also excluded if participants 
were not abstinent at the time of testing (Parker 1980). The study also excluded papers if they 
were longitudinal and in some instances, a control group was absent entirely. Schott et al. 
(2003) describe the individual case study of a 68-year-old man. At level 3, fewer papers were 
removed level (N=20) owing to inappropriate reporting strategies, or based on a failure to 
convey pertinent information. Squeglia et al. (2009) transformed the means and standard 
deviations into z scores which would distort the overall result if included. As these represent a 
different metric and as such are no longer measures of performance. Whilst Schweinsburg et 
al. (2010) failed to report any means and standard deviation; consequently, the study could not 










Table 3: Mapping of the literature search process 
Level 1 Level 2 Level 3 
Paper did not relate to the field 
of study (N=207) 
No means and standard deviations 
Reported Neuroimaging data only 
 (N= 105) 
Transformation of means into z 
scores (N=2) 
 Animal study (N=28) Control and Experimental group 
were polydrug users (N=52) 
No means or Standard Deviations 
reported (N=18) 
Paper not translated from a 
foreign language to English  
(N=49) 
groups weres intoxicated at the 
time of testing 
(N=36) 
 









Table 4 summarises the alcohol and cannabis consumption mean scores as well as the mean scores for 
the VWM task performance measures. Figure 4 reports upon the main statistical findings; results 
indicated that there was a large and statistically significant mean weighted effect size. Results  
showed lower task performance by the poly-drug users (Hedges g = -0.535; 95% confidence 
interval (CI) -0.806 (Lower) to -0.264 (Upper); z = - 3.871, p < 0.000, two-tailed). Calculation 
of Rosenthal's Fail-Safe N indicated that studies would require 135 papers to render the 












Group 2 (controls) 
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Trial 1 recall 
 


















































As with Visuospatial working memory, the results from this meta-analysis demonstrated a 
reduction in verbal memory performance by the experimental group, when compared to non-
binge drinking/ cannabis smoking controls. Again, as with the previous study into visuospatial 
working memory, this suggests that given the prevalence of binge drinking and cannabis 
smoking within the general population of most major western countries (Anderson et al. 2006) 
that these results would have profound implications for governments and health agencies both 
nationally and internationally. Indeed, these findings are consistent with observations made in 
the academic literature which have noted that alcohol and Cannabis can induce neurological 
damage to cortical structures associated with the processing of verbal memory specifically: the 
prefrontal, parietal, temporal and occipital lobes (Roberts & Montgomery, 2015; Montgomery 
& Fisk, 2012). Thus, it is reasonable to assume that that the act of polydrug use in this fashion 
may result in compromised functioning in one or more of these network of brain areas (Kelley 
et al. 1997). However, the widespread dispersal of these structures represents a significant 
obstacle in the association of deficits in task performance to a specific cortical system. 
 
Upon initial consideration of the data gathered the findings in the review suggests lower verbal 
working memory task performance in polydrug users. However, the neurological capability 
would also depend upon various specific potential confounds that can distort the relationship 
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such as the age of onset of drug-taking behaviour, premorbid IQ, Polydrug history, as well as 
genetic variables. Zakhari and Li (2007) were able to demonstrate a relationship between the 
variability of BAC in heavy alcohol drinkers and genetic variants. Cytochrome P450 2E1 
(CYP2E1) isoform affects the absorption rate of ethanol; this has been implicated in 
predisposing individuals to alcohol dependence and susceptibility to alcohol-induced liver 
damage and neurocognitive impairment. Watanabe et al. (2007)  suggested that Cytochrome 
P450 enzymes metabolise THC and cannabinol. Therefore genetic variation would 
undoubtedly affect absorption rates of THC and affect cannabis-induced neurocognition. Thus, 
future research would benefit from considering genetic variation in the population sample. 
 
In conclusion, the study demonstrated a relationship between cannabis smoking, binge drinking 
and decreased verbal memory performance, when compared to a control group on non-binging/ 
cannabis smoking controls. However, the paper does suffer from some specific limitations that 
future researchers need to address regarding this relationship—potential confounding influence 
of additional substances in the population sample. Additionally, the paper by Cunah et al., 
(2010) appears to have a comparatively strong Hedges g, and as such, it may be exerting an 
undue influence on the meta-analytic results. The review also limited itself to the inclusion of 
English Language only papers the report also failed to account for information within "grey 
literature" such as unpublished conference papers, internal research reports within institutions 
(NHS). Despite the limitations that were identified the results from the study demonstrate a 
Mean weighted effect size that was both large and statistically significant with a robust Fail-
Safe N statistic. Therefore, though the paper has its limitations, they do not preclude the study 
from offering up insight into polydrug use and verbal memory impairment. Indeed, research in 
this area must continue since issues surrounding drug use are a critical public health concern. 
Since verbal working memory is an essential cognitive tool for successful navigation through 
many daily activities such as following instructions and for social wellbeing, any issues that 
affect the functionality of this are of importance for public health. Whilst neural structures have 
returned to a baseline position after three months abstinence (Montgomery et al., 2012) this 
does not necessarily equate to a return to baseline for neurocognitive functions. However, it is 
challenging to assess neurocognitive functioning in the natural environment. Everyday Verbal 
working memory tasks also require the recruitment of different working memory and executive 
functions for successful completion, which in turn recruits other neurological structures to 
facilitate this activity. Despite the limitations, the use of laboratory-based experimentation 
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represents a "gold standard" verbal memory assessment, and as such future investigation must 








Research from within the substance misuse literature has developed theoretical frameworks 
that have served to highlight demographic indices. These psychological and behavioural traits 
serve as risk factors for both heavy social drinking (HSD) and cannabis consumption (Gonzales 
et al., 2017). In developing a deeper understanding of the consequences of HSD cannabis 
smoking polydrug use, it is essential first to consider how polydrug users compare to single 
drug users and controls with regards to these identified indices. Within the scientific literature 
that there are significant age and gender biases within both HSD and cannabis smoking 
populations. In a study conducted by Tu and Ratner (2009) on relative age and gender 
differences concerning substance misuse, of those individuals who reported drinking alcohol, 
a disproportionate number of males reported excessive levels of consumption. Results 
indicated that 63% of males and 42% of females drank more than sensible weekly limits (above 
six units for females and 7 for males) with 56% of males classified as 'binge drinking'. Analysis 
of illicit drug misuse in this population indicated that 55% of the male students also reported 
cannabis use at least once since starting university. 
Further investigation revealed that 8% of males reported current regular use at least once a 
week. These findings are similar to those of Webb (2007) who in an earlier cross-sectional 
nationwide study said that of those questioned, 23% of young males reportedly drank to levels 
regarded as Binge drinking compared with 10% for females. Prevalence of cannabis use was 
highest in males, of whom 27% reported regular weekly use compared with 9% for females. 
Also, males said experience with other illicit drugs, with 64–71% reporting experience ecstasy 
at least once.  
 
 Analysis of substance misuse indices for both alcohol and cannabis misuse in the UK and USA 
indicate that young adult males (between the ages of 18 to 21) tend to report statistically 
significant higher rates of both cannabis consumption and instances of heavy episodic drinking. 
Both cannabis consumption and heavy social drinking are severe threats to the intellectual, 
psychological and physical development of young adults (Boden et al., 2011).  For example, 
73 
 
problems of psychosocial adjustment (Falk et al., 2006), reduced hippocampal volumes (De 
Bellis et al., 2013) and disruptions to the development of neural circuitry (Nguyen-Louie et al., 
2018; Weissman et al., 2015). These are associated with the onset of early alcohol 
consumption, whilst enhanced impairments in cognitive functioning correlate with earlier onset 
of cannabis consumption (Broyd et al., 2016; Schweinsburg et al., 2008). 
 
It is logical, therefore, to consider the demographic statistics of HSD Cannabis smoking 
polydrug users to fully appreciate the impact of this form of substance misuse (Wechsler et al., 
1994, 2000). In addition to demographic issues such as age and gender, studies examining both 
HSD and cannabis consumption have identified psychological and behavioural differences 
when compared to drug naïve controls. Specifically, research has indicated that statistically 
significant differences exist concerning relative levels of anxiety, depression and 
impulsiveness (Askénazy et al., 2003). Evidence from within the substance misuse literature 
has suggested that feelings of anxiety are causally related to both cannabis and alcohol misuse 
(Breese et al., 2011; Haass-Koffler et al., 2014; Spanagel et al., 2014), as well as to the 
development and maintenance of substance use disorders (SUD). Etiological explanations have 
stated that both substances reduce tension/dampen stress responses (Donovan & Marlatt, 1980; 
Sher & Levenson, 1982). Both used for self-medication (Brady & Lydiard, 1993; Khantzian, 
1985; Mueser et al., 1998). Both alcohol and cannabis reduce the unpleasant physiological and 
cognitive symptoms of stress and anxiety, thereby negatively reinforcing, or increasing, 
substance misuse behaviour.  
 
One of the most widely used measures for the examination of anxiety levels in both HSD and 
cannabis smoking populations is that of the Hospital Anxiety and Depression Scale (HADS). 
Crippa et al. (2009) reported that frequent cannabis users consistently displayed higher 
prevalence levels of anxiety and anxiety disorders when analysed via the HADS. However, it 
is unclear if cannabis use increases the risk of developing long-lasting anxiety disorders. 
Similarly, McCaul et al. (2017) have also noted that individuals identified as HSD reported 
statistically higher scores for anxiety on the Hospital Anxiety Scale (HADS) when compared 
to controls. Many hypotheses have attempted to explain these relationships, including 
neurobiological, environmental and social influences. However, numerous preclinical and 
human studies examining effects of stress or anxiety on alcohol use and alcohol-related 
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problems (McCreary & Sadava, 2000; O'Grady et al., 2011; Sayette, 1999; Wand et al., 1998; 
Young et al., 1990) have been equivocal, showing positive, negative, or no relationship. 
 
Balodis et al. (2009) reported that a comparative difference in levels of impulsiveness also 
exists in both HSD and cannabis smoking misuse populations. Indeed, findings from within 
the literature highlight the variability of results from both the HSD and cannabis smoking 
studies. Trull et al. (2016) reported that cannabis misuse increased levels of trait impulsivity 
using a real-time self-report measure. Zuckermann and Kuhlmann (2000) report higher 
impulsivity related to HSD when analysed using the Zuckermann-Kuhlmann personality 
questionnaire (ZKPQ). However, Lejuez et al. (2009) failed to find a statistically significant 
effect with regards to substance misuse related differences in impulsivity with regards to either 
alcohol or cannabis misuse. 
 
In an attempt to explain the contradictory findings regarding impulsivity, Gonzalez et al., 
(2012) have suggested that individual differences with regards to neurological impairment may 
play a key role. The author noted that neurocognitive deficits could affect impulsivity levels. 
Indeed, Cho et al. (2010) have suggested that both alcohol and cannabis impair functioning 
within the right DLPFC, a region of the brain implicated in the processing of impulsive decision 
making. Individual differences with regards to the severity of impairment in this region could 
arguably contribute to the comparative differences in impulsiveness levels currently being 
observed. Stanford (2009) argues that impulsivity measures are insensitive to subtle alterations 
in younger HSD's and cannabis smokers. The Barratt impulsivity measure is more reliable in 
both HSD and cannabis smoking populations. It is, therefore, logical to conclude that an 
analysis of the comparative differences in levels of, anxiety, depression and impulsivity in 
polydrug users would be of benefit to understanding the demographic similarities and 
differences between the two substance misuse groups.  
 
Whilst differences in the psychological characteristics are an essential subject of study in their 
own right, it is also vital to examine the potential influence of such differences on cognitive 
task performance. Consequently, the results presented in this chapter, with regards to 
demographics, psychological variables and substance misuse indices are relevant to all the 
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chapters within this thesis which present new empirical findings. Future chapters will refer 
back to this chapter concerning the reporting of these variables.  
Method 
Design 
A 3-participant group design with a control group consisting of non-binging alcohol users (CO) 
and two experimental groups of binge drinkers (HSD) and binge drinking-cannabis smoking 
polydrug users (HSDCC) for gathering the data reported in this and subsequent chapters of this 
thesis. Drug behaviour type served as the independent variable at three levels (i.e. binge 
drinker, binge drinking cannabis using polydrug user and light social drinking-illicit drug-naive 
controls). The results of the demographic, psychological and substance misuse indices served 
as the dependent variables for this chapter. Cognitive test scores and task-related changes in 
regional cerebral blood flow (rCBF) served as the dependent variables for subsequent chapters. 
 
Participants 
Recruitment resulted in Seventy participants from the campus of Edge Hill University. 
Participants were chosen by opportunity sampling through advertisements placed around the 
University campus, on the Department of Psychology electronic participation recruitment 
system (SONA), and by word of mouth. For inclusion, participants had to demonstrate 
engagement in relevant alcohol and cannabis consumption behaviours for more than three 
months without any detoxification intervention or long period of abstinence within this time. 
Controls were those participants who did not meet the American Psychiatric Association's 
(2013) Diagnostic Statistical Manual-V (DSM-V) criteria for alcohol/substance abuse or 
dependence.  No lifetime exposure to cannabis use or any other illicit drug. Binge drinkers 
were those participants who met the DSM-V criteria for alcohol abuse, report drinking ≥ 5 and 
≥ 4 (for Males and females respectively) units of alcohol in a single drinking session and who 
have engaged in this behaviour ≥ten days/ month in the past three months (Raffo et al., 2019). 
Whilst the binge drinking-cannabis smoking polydrug users also met these criteria as well as 
the DSM-V criteria for substance abuse and ≥ 100-lifetime experiences with marijuana and had 




Exclusion criteria were a positive result on urine toxicological screening and the identification 
of conditions that could render their participation inappropriate. These included Obsessive-
Compulsive Disorder (OCD), Attention Deficit Hyperactivity Disorder (ADHD), and dyslexia. 
In terms of exclusion criteria, a diagnosis of OCD and ADHD predisposes those individuals to 
deficits in sustained attention, which is a crucial component to the successful completion of the 
proposed neurocognitive test battery (Montgomery et al., 2010). In addition to this, individuals 
with either OCD or ADHD, are clinical populations referred to as neuro-atypical, meaning that 
in terms of neurological architecture and functioning they differ from the general population. 
Thus, cognitive performance and cerebral blood flow scores might not be generalisable (Oner 
et al., 2010). Concerning courses of treatment, these disorders frequently lead to the use of 
medications impact on neurocognitive performance. Dyslexia was an exclusion criterion for 
the study as one of the critical tests (Semantic associations) requires a participant to be able to 
read words. 
Consequently, a dyslexia diagnosis would create a statistical confound inhibiting the ability to 
successfully navigate such tasks (Stoodly & Stein, 2013). Application of these inclusion and 
exclusion criteria apply to all new empirical findings reported throughout subsequent chapters 
of this thesis. Furthermore, the researcher made an 'a Priori' decision to include a cut off of 
three exposures to any other drug for all three groups (Voluse et al., 2012). For statistical power, 
an initial “a priori” calculation indicated that 66 participants were required for a power level 
at 0.85 for large effects (f2 = 0.40), with three independent variables (predictors) and a 
conventional alpha level of P < .05 (Faul & Erdfelder, 1992). 
 
Data Collection Instruments and Protocols 
        Background  Measures 
       Drug use questionnaire  
Background drug use questionnaires provided the researcher with indices of drug use patterns 
and other lifestyle variables. In this questionnaire, comprehensive details of alcohol and 
cannabis use, as well as other illicit drug use, are requested, such as first and last drug use, 
patterns of drug use, frequencies and doses over time. Total lifetime drug and drug use for the 
past thirty days used calculations used a method employed by (Montgomery, Fisk, Newcombe 
& Murphy, 2005).    
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 Epworth sleepiness scale (ESS, Johns 1991) 
The Epworth Sleepiness Scale (ESS, Johns, 1991), explores the chances of dozing or falling 
asleep in various situations. A high total score on this scale is indicative of increased subjective 
daytime sleepiness. 
    
   Barrat Behavioural impulsivity scale  
The Barrat Behavioural impulsivity scale (Barrat & Patton, 1983) is a widely used measure of 
impulsiveness. The test measure included  first-order factors; attention, motor, self-control, 
cognitive complexity, perseverance, and mental instability impulsiveness, and second-order 
factors; attentional, motor, and non-planning impulsiveness 
 
   The Hospital Anxiety and Depression Scale 
The Hospital Anxiety and Depression Scale (HADS: Snaith, 2003) measures the levels of 
anxiety and depression that a person is experiencing. The HADS is a fourteen item scale that 
generates ordinal data. Seven of the items relate to anxiety and seven relate to depression, with 
respective dependent variables consequently being generated. Higher scores indicate higher 
levels of anxiety and depression, respectively. 
     
  National Adult Reading Test 
The National Adult Reading Test (NART: Nelson & Willison, 2011) is a widely accepted and 
commonly used method in clinical settings for estimating premorbid intelligence. The test 
comprises 50 written words in British English which all have irregular spellings (e.g. "aisle"), 
to test the participant's vocabulary rather than their ability to apply regular pronunciation rules. 
    
 Ravens Progressive Matrices (Raven, Raven, & Court, 2004)  
This measure is as an indicator of fluid intelligence; it involves a series of problems (5 sets of 
12, 60 in total), presented as a symbolic sequence. Participants are required to select an 
appropriate response to complete the series from a choice of six options. Successful completion 
of the task requires an understanding of the sequence stimuli and their interaction with one 
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another. Each block of twelve problems begins with an intuitively simple issue, and the 
questions become progressively more difficult as the task continues. 
Urine sampling protocol 
Participants provided a urine sample at the end of the experimental session, in a nearby toilet 
facility within the Psychology department. The toxicological test screened for the presence of 
metabolites of both alcohol and cannabis. Participants collected their sample by urinating into 
a plastic specimen tube, secured by a screw cap. A watertight sealable plastic wallet stored the 
urine. For the collection of urine, the research operated following the Human Tissue Act (HTA 
regulations and EHU Quality Manual version 2.0 4.4.3 and 4.8.3) for handling urine.  
 
Standard urine analysis test card sensitive to the presence of metabolites of; Alcohol, Heroin, 
Opiates, Cannabis, Cocaine, ecstasy (Home Health UK Ltd, Bushey, Herefordshire, UK). If 
alcohol and or cannabis were present, a red bar appeared in the corresponding box on the probe.  
Procedure 
Participants completed the Montgomery et al. (2005) drug questionnaire and returned the 
information to the researcher via e-mail. Once the researcher was able to assess initial 
suitability for participation, the study required eligible participants to attend one laboratory 
session. Administration of tests was in the order in which they appear in chapters six and seven. 
Participants responses determined group allocation; control or either of the experimental 
groups. 
 
Urine samples were collected and stored for analysis following participant testing. Participants 
sat in front of a PC loaded with the inquisit programme and related neurocognitive 
programmes. The researcher fitted the participants with the fNIRS cap; they then watched a 2-
minute nature documentary to provided a haematological baseline for the tests. Following this, 
participants completed the neurocognitive test battery. Results form the basis of the subsequent 
chapters of the thesis are not discussed further in this chapter. During the performance of the 
task,  fNIRS measured cortical activity. More specifically, the regions of interest for NIRS 
involved the placement of channels over areas of the left and right dorsolateral/medial 
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prefrontal cortex. At the same time, participants completed the battery of neuropsychological 
tests outlined previously. Chapter seven covered the use of fNIRS. 
 
Participants then provided a hair sample for toxicological screening beyond the scope of the 
current thesis. Hair samples offered a more detailed toxicological history of each participant. 
Hair analysis would provide information related to the levels of alcohol, THC and CBD present 
in the body over one month per 1 cm of hair. However, owing to resource and licencing issues 
related to the legal storage of THC and CBD samples to serve as a comparative marker, such 
analyses might not be available for inclusion in the present thesis. As this proved to be the case, 
it is not possible to report further about these samples. The samples will still be able to provide 
a basis for further analyses beyond the scope of the thesis.   
 
Ethical considerations 
The study followed the British Psychological Society's (BPS) Code of Ethics and Conduct (The 
British Psychological Society [BPS], 2009). Code of Human Research Ethics (BPS, 2014) and 
the National Institute for Alcohol and Addiction (NIAAA) (2018) and data protection act 
(2019) guidelines for data storage. A filing cabinet inside a research office held all the data 
(which is locked when not in use) or on a password protected computers, laptops and USB 
drives. Before testing all participants were made aware of the fact that they will provide a hair 
and urine sample. That the testing will take place on an individual basis (i.e. no other 
participants in the room) and that the assessment involved the use of the NIRS device. 
Participants were made aware that they were free to withdraw at any point; they did not need 
to continue. For the time that they have participated in, the researcher awarded a monetary or 
course credit. 
Furthermore, participants were able to withdraw any of their data for up to two weeks following 
participations.  Since the study involved the procurement, and processing of human urine, and 
saliva, it falls within the remit of the Human Tissue Act 2004. To comply with the relevant 
guidelines, the primary researcher undertook all appropriate HTA training before the start of 
the study and followed all guidelines for obtaining consent, handling, transfer and disposal of 
relevant biological material.  
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The issue of informed and valid consent from research participants is central to the human 
tissue act. To comply with the requirements outlined within the EHU Quality Manual Version 
20: 4.3.3- Consent Requirements, the present research took into account the following. Before 
the administration of tests, the participants gave written and valid permission through a 
standardised consent form. In line with principles of good practice, the consent form was 
generic (i.e. it refers to the provision and analysis of tissues in a non-specific way that does not 
necessitate seeking future consent).  Participants have the right to withdraw their samples from 
the study at any time. 
 
The study gave ethical consideration to the fact that participants may construe the results as a 
justification for taking specific strains of cannabis, consent and information forms accounted 
for this. They stated that the researcher and the associated agencies in the study do not condone 
the use of cannabis or the abuse of alcohol, and this research should not be considered an 
endorsement of substance abuse. 
 
Given that the target population may have some form of cognitive dysfunction, there was a 
possible discrepancy between the skills needed for adequate consent to the research and the 
information literature provided by the research team. It was essential to produce participant 
consent, research information and health literature that was comprehensible at low literacy 
levels. The researcher proposes that the readability of any literature provided is to be 
determined by systematic formulae. Readability formulae assigned a numeric value to the 
readability of written information. The Gunning FOG (Frequency of Gobbledygook) index, 
Flesch-Kincaid Grade Level (FK), SMOG (Simple Measure of Gobbledygook) formula and 
Flesch Reading Ease (FRE) scale are functions of the number of characters, syllables, words 
or sentences in a text sample and extensively to measure the readability of health information. 
The notion of being able to calculate the readability of the text is so widely accepted that word-
processing software packages, such as Microsoft Word, include readability tests. The FOG, 
SMOG and F-K tests provide estimates of the number of years of education required to 
understand a passage of text. Thus, all written information given to the participants had to be 
processed by one of these readability measures before dissemination. In this instance, the 
SMOG test to ascertained the readability of the participant information sheet and consent form. 
A minimum score of 6 and a maximum score of 240 required, the current documents recorded 
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a score of 18.77 which indicates the documents were suitable to be read by individuals of 13 
years of age and above, and as such well within acceptable parameters of readability for the 
target population. 
 
It was made clear to the participant that the cognitive functioning scores obtained did not in 
any way constitute a clinical diagnosis, and that if they did have concerns about their cognitive 
functioning, they should contact a medical professional.  The researcher followed the data 
protection act 1998 guidelines for electronic data was storage following the requirements of 
the Data Protection Act 1998. The ultimate responsibility of the disposal of the hard copy 
records belonged with EHU, and specifically with the principal researcher. 
 
Analytic Strategy 
Preliminary data analysis began with the calculation of means and standard deviations for 
demographic, psychological and substance misuse variables, the removal of outliers was 
achieved through calculation of Skewness and Kurtosis values and deletion of Z-scores more 
than ± 3.29. The normalisation of remaining scores required Square, square roots, natural log 
(logn), and inverse transformations.  Homogeneity of variance and covariance assessed the 
robustness of the data for MANOVA through Levene's F and Box's M (Tabachnick and Fidell. 
2014). Nonparametric ANOVA (Kruskal-Wallis H test) and subsequent Mann-Whitney U tests 
were conducted, with spearman's Rho correlations where appropriate. The homogeneity of 
variance demonstrated in the ANOVAs was assessed through the Fmax procedure as described 
by Tabachnick and Fidell. ANOVA's with subsequent post hoc pairwise comparisons which 
were two-tailed against Bonferroni adjusted alpha levels of α' = 0.17. The relationships 
between the background variables and variables recording the consumption of alcohol and 
cannabis using bivariate correlations. Once again, these analyses comprised either parametric 









Preliminary analysis of demographic variables indicates a bias towards male participation in 
the study, making up 72% (N = 51) of the total sample, whilst subsequently, females made up 
27% (N = 19). In terms of the group, allocation results indicate that there is a numerical bias 
towards males engaging in substance misuse (N = 14) for males in the HSD and (N = 21) for 
the HSDCC group, compared with (N = 6) and (N = 1) for, females respectively). Control group 
allocation, while still biased towards males (N = 16) was more balanced with regards to the 
number of females (N = 12). Chi-Square analysis indicated that there is indeed a statistically 
significant association between group membership and gender (χ2 [2, N = 70] = 9.26, P = .010).  
 
The analysis of background data also indicated that there was no significant difference in age 
between male participants (M = 21.18 years, SD = 4.2 years) and female participants (M = 
22.49 years, SD = 2.58 years) in this study (U = 453.5, ns). In terms of group allocation and 
age, HSD'S were older on average (M = 22.55 years, SD = 5.57 years) than participants in the 
control (M = 21.32 years, SD = 4.43 years) and Poly Drug using groups (M = 21.53 years, SD 
= 4.68 years).   Kruskal Wallis analysis indicated that this difference was not significant (H [2, 
N = 70] =1.530, ns.). 
 
Table 5 summarises the psychological and background measures, ANOVA revealed a 
statistically significant between group's effect for levels of Depression, Premorbid IQ and fluid 
intelligence. Post hoc pairwise comparisons found that higher levels of depression observed in 
the HSDCC group were statistically significant when compared to both HSD and Controls. 
However, the differences between controls and HSD were not Significant. HSDCC participants 
also reported significantly higher premorbid IQ when compared to both HSD and control 
participants, as well as significantly higher fluid IQ scores compared to the HSD group, but not 
the controls.  
 
Nonparametric ANOVA (Kruskal Wallis) yielded statistically significant between group's 
comparisons on impulsivity concerning all six of the Barratt sub-scales. Post hoc Mann 
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Whitney U tests showed that none of the HSD versus HSDCC comparisons was significant. 
However, the HSDCC group were significantly higher than the CO group on all of the 
impulsivity sub-scales except for cognitive complexity. The HSD group had significantly 
higher scores than the CO group on the cognitive complexity and perseverance sub-scales. 
 
Table 5: Mean and Standard deviations for Demographic Variables 
Variable Controls 
(CO) 



















(1) Controls vs 
HSD 
(2) Controls vs 
HSDCC 

















F (2,67)=12.30, P 
<.000, ƞp2=.269 
1. n.s 
2. P <.000 
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11.479, P = .003 
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F (2, 67) = 4.267, 














F (2,67) = 3.932, P 






1 All Post-Hoc analyses were evaluated as two-tailed against a Bonferroni adjusted alpha level of P < .017 
84 
 
Alcohol and Cannabis Consumption 
Table 6 reports upon means and standard deviations for alcohol and cannabis indices, inter-
group comparisons are, of course, not appropriate for the cannabis consumption variables. The 
range for the number of hours since the last reported use of cannabis was from 10 hours to 70 
hours. Onset age for alcohol use did not differ between the groups. The CO group drank alcohol 
less frequently than the other two groups for all the timeframes reported. However, CO 
participants had used alcohol more recently before testing than participants in the other two 
groups. Concerning estimated units of alcohol consumption, the CO group consumed less than 
both other groups over the previous six months. However, the number of reported units 
consumed within a drinking session did not differ significantly between groups.  
 














N = 22 
Significance Post-hoc1 
(1)Controls vs HSD 
(2)Controls vs HSDCC 
(3)HSD vs HSDCC 
Alcohol use 
frequency in 






4.00 H [2, N = 70] = 
54.466,  
P <.000 
1. P <.000 
2. P  <.000 
3. n.s. 










H [2, N = 70] = 4.69, 
ns. 










F (2,67) = 17.943, P 
= .001, ƞp2=.349 
1.  P <.000 












F (2,67) = 16.554, P 
<.000, ƞp2=.331 
1. P .001 





















F (2, 66) = 26.364, P 
<.000, ƞp2=.444 
1. P < .000 











F (2,67) = 28.192, P 
<.000, ƞp2=.457 
1. P <.000 












H [2, N = 70] = 
25.951, P <.000 
1. P <.000 















F (2,67) = 13.359, P 
< .000, ƞp2=.258 
1. P < .000 
2. P = .001 
3. n.s 















































1 All post-hoc analyses were evaluated as two-tailed against a Bonferroni adjusted alpha level of P < .017 
2 Rating scale data: 1 = Never, 2 = occasionally, 3 = Frequently, 4 = Always. 
 
Bivariate correlations with covariates representing alcohol consumption showed that the 
depression scores were on the borderline of a significant negative correlation with the estimated 
number of alcohol units consumed in the previous six months (rs (70) = -.234, P = .051, two-
tailed). Still, they showed a stronger positive correlation with the number of hours since last 
alcohol use (rs (70) = .398, P = .001, two-tailed). Onset age for alcohol use had a positive 
correlation with the anxiety scores, which, whilst significant, was not strong (rs (70) = .237, P 
= .048, two-tailed). Cannabis consumption in the previous 6 months showed a very strong 
correlation with depression scores (rs (70) = .538, P < .000, two-tailed). Within the HSDCC 
group, there was no correlation between the number of hours since last cannabis use and 
depression scores. Table 7 shows the correlations between the impulsivity sub-scales and 
measures of alcohol consumption. The estimated alcohol use in the past six months (measured 
in units of alcohol) and hours since last alcohol consumption showed universally positive 
correlations with the impulsivity sub-scales. Impulsivity and longer periods of abstinence were 
correlated to higher consumption as were to impulsivity. The scores for onset age for alcohol 
use correlated with the “cognitive instability” sub-scale, with this relationship being negative, 




Within the HSDCC group (N = 22), no correlation with the age of first cannabis with their 
scores for depression, anxiety, any of the impulsivity sub-scales, premorbid IQ, or Raven's 
Matrices scores. However, the number of hours since the last use of cannabis had a relatively 
strong positive correlation with anxiety scores (rs (22) = .585, P = .004, two-tailed), indicating 
that anxiety was higher with longer periods of abstinence. There was no correlation between 
the duration of cannabis abstinence and any of the other background variables or substance 
consumption variables. The statistical power of the correlations with these two measures of 
cannabis is affected by the relatively small number of data points. However, taking values of 
‘0' for cannabis consumption in the CO and HSD groups, estimated cannabis consumed in the 
previous 6 months did show significant positive correlations with the impulsivity sub-scales 
for attention (rs (70) = .362, P = .002, two-tailed), motor performance (rs (70) = .346, P = .003, 
two-tailed), self-control (rs (70) = .349, P = .003, two-tailed), and cognitive instability (rs (70) 
= .389, P = .001, two-tailed). Consequently, for both alcohol, cannabis and impulsivity were 
correlated with higher consumption levels. 
Table 7: Spearman correlations between the impulsivity sub-scales and measures of alcohol 
use1 
Impulsivity Sub-Scale Alcohol units 
consumed in the 
past six months  
(N = 70) 
Onset age for 
alcohol use (years)  
(N = 69) 
Hours since last 
alcohol use  
(N = 70) 
Barratts Impulsivity:  
Attention Subscale 
rs = .322,  
P = .007 
rs = -.138,  
ns. 
rs= .340,  
P = .004 
Barratts Impulsivity: 
Motor Subscale 
rs = .299,  
P = .012 
rs = -.116,  
ns. 
rs = .398,  
P = .001 
Barratts Impulsivity: 
Self-control 
rs = .315,  
P = .008 
rs = -.124,  
ns. 
rs = .379,  
P = .001 
Barratts Impulsivity: 
Cognitive Complexity 
rs = .364,  
P = .002 
rs = -.014,  
ns. 
rs = .419,  
P < .000 
Barratts Impulsivity: 
Perseverance 
rs = .375,  
P = .001 
rs = -.058,  
ns. 
rs = .421,  
P < .000 
Barratts Impulsivity: 
Cognitive Instability 
rs = .296,  
P = .013 
rs = -.265,  
P = .027 
rs = .374,  
P = .001 
1 All probability values are two-tailed. 
 
Discussion 
This chapter aimed to analyse the background measures for the sample of participants used in 
this thesis concerning demographic and other background variables, and also the consumption 
of alcohol and cannabis.  The results indicated the variables which are potential covariates with 
the ability to confound the results for performance on tests of psychological functioning. 
Although an opportunity sample reported upon here, the predominance of males in the sample 
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does reflect the findings of more extensive population studies of problematic alcohol use and 
cannabis use (Tu & Ratner, 2009; Webb, 2007). Nevertheless, some conclusions of the current 
literature do suggest that parity between genders concerning HSD (Balodis et al., 2009) and 
cannabis consumption (Hamilton et al., 2019).  
 
Concerning the psychometric measures reported, the HSDCC group showed higher scores for 
depression than both of the other two groups, whilst depression showed a positive correlation 
with the level of cannabis consumption in the previous six months. The results are consistent 
with the existing literature concerning depression related to alcohol use and cannabis 
consumption (Boden & Fergusson, 2011; Green & Ritter, 2000). The present results also 
indicate that levels of impulsivity were more considerable in both substance misuse groups, 
although these were not significantly different from each other. These findings are not 
surprising when considered with the gender distribution within the sample.  
 
The role of impulsivity in explaining Polydrug use is far from a simple one. Impulsivity is not 
a homogenous construct but instead consists of several dimensions (Meda et al., 2009). Table 
6 notes that the sub-scales for impulsivity show the CO group are significantly lower than either 
one or both of the other two groups, the distribution of these differences does vary across the 
sub-scales. These dimensions are a vital feature in the development of some psychiatric 
conditions, including substance misuse (Makillop & Mattson, 2007). 
 
Impulsivity is related to maintenance of substance misuse (Dawe & Loxton, 2004; Kollins, 
2003; Miller et al., 2003). With reward sensitivity resulting in greater attentional impulsivity 
to alcohol and cannabis-related cues. Chapter 6 of this thesis will examine differences in 
executive inhibition between the three participant groups, and the relationship between 
impulsivity and executive inhibition will be a question to be explored.  
 
In terms of Alcohol consumption, the present results indicate that the CO group consumed 
alcohol less frequently on average than participants in the other two groups. However, within 
any particular drinking episode, the level of self-reported consumption of units of alcohol does 
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not seem to differ. Whilst the onset age for alcohol use did not differ significantly between the 
participant groups; it did show a positive correlation with anxiety which might seem to 
contradict earlier findings of a relationship with psychosocial adjustment difficulties (Falk et 
al., 2014). However, results may see the negative correlation in the current data between onset 
age and the “cognitive instability” sub-scale for as more consistent with such problems, and 
with the potential disruption to the development of some neural circuitry (Nguyen-Louie et al., 
2018; Weissman et al., 2015). Cannabis may require up to 95 days to leave the body, with its 
lipophilic nature facilitating its retention in bodily tissues (Verstraete, 2004). Thus, making the 
imposition of a sufficient washout period for cannabis highly problematic, particularly in the 
context of rising levels of Δ9-THC in black market supplies since the year 2000, which have 
contributed to making the drug more dependence producing (Freeman et al., 2014; Hardwick 
& King, 2008; Murphy, 2018). In response to the potentially confounding effect of recent 
cannabis use on the results throughout this thesis, the study will look at the relationship between 
time since last cannabis use to other variables which have shown significant inter-group effects. 
The choice of these variables is explained further in the Analytic Strategy sub-section of 
Chapter 6. Also, the lack of reported nicotine use by participants is conspicuous and warrants 
discussion. One interpretation of nicotines absence is the possible confusion shown by 
participants over the nicotine questions in the drugs questionnaire. Specifically, it is reasonable 
to assume that the participants may have accepted that the study included estimates of nicotine 
use is the measure of cannabis cigarette consumption as they also include tobacco as a base 






Executive Functions and Working Memory: Tasks Used in this Thesis 
 
Introduction 
Executive functioning (EF) is a generic term encompassing a series of cognitive processes that 
exert top-down regulation of working memory (WM) functions to support flexible and adaptive 
goal-directed behaviour (Alvarez and Emory, 2006). Miyake et al.'s (2000) latent variable 
analysis revealed three distinct, yet related executive functions: "updating," "inhibition" and 
"shifting." The updating is part of WM and relates to the ability to maintain information within 
memory for quick retrieval, along with the ability to shield this information from distraction. 
Inhibition refers to the ability to deliberately inhibit or override dominant, automatic, or pre-
potent responses. Shifting is the ability to switch between multiple tasks, operations, or mental 
sets. Hofmann et al. (2012) argue that self-regulatory processes are sub-served by executive 
functions and enable effective goal-directed behaviour. Research from within the 
psychological literature has argued the EF serves as top-down control mechanisms for the 
control of WM, which in turn is a cognitive system with a limited capacity that is responsible 
for temporarily holding information available for processing. WM is essential for reasoning 
and the guidance of decision-making and behaviour and includes two distinct domains, these 
being visuospatial working memory (VSWM) and verbal working memory (VWM) (Diamond 
et al. 2013). VSWM is essential for the manipulation of visual and spatial information, while 
VWM is responsible for the manipulation of oral and written sound and language processing 
(Malenka et al. 2009).  
 
It has been reported in the broader academic literature that the application of WM and EF tasks 
in the assessment of substance misuse has established a pattern of inconsistent results (Cubillo 
et al., 2014). For example, Waring et al. (2000) reported a highly significant correlation 
between ecstasy misuse and deficits to WM and EF. However, Nulsen et al. (2010) noted a 
contradictory pattern with a similar substance misuse group. In an attempt to explain the 
indeterminate results reported, Mehler et al., (2012) highlighted that inconsistency within the 
methodologies constituted a significant cause. Specifically, the author argued that this pattern 
of results was in part due to inconsistencies in the selection of appropriate neurocognitive test 
measures. The paper concluded that not all tests available to researchers were sufficiently 




This line of argument has been supported by Possin (2010), who noted that traditional 
neurocognitive batteries such as the PASSAT are insufficient for the accurate recording of 
impairment in the field of substance misuse. An analysis of the PASSAT found that there was 
an average of 12% overlap between cognitive domains tested. In particular, the author noted 
how aspects of the IC task overlapped with VSWM. In addition to this, Polderman et al., (2009) 
indicated that other test batteries such as the Stroop task required access to semantic long term 
memory.  As a consequence, the tests were deemed inappropriate for assessment of 
neurocognitive impairments for people with an IQ above 100.  Gauvin et al. (2016) suggested 
that in the future researchers must identify as a battery of tests that are sufficiently sensitive to 
meet the needs of substance misuse research.  
 
While test sensitivity is a salient issue in the field of substance misuse, the need for a robust 
battery of tests become all the more critical in matters of polydrug use (Parrot et al.,  2000). 
Issues arise from the pharmacological effects that psychoactive agents have on each other and 
upon attendant neurological structures so that the combined use of multiple substances adds to 
the complexity of the research. These issues also represent a methodological confound that less 
robust tests may not be adequate to address (Snyder et al., 2017).  
 
There is as of yet no established battery of tests designed specifically for the assessment of 
substance misuse. However, the notion that they need to be sufficiently sensitive to detect 
subtle alterations to and mitigate the potential access to additional cognitive resources has led 
to a series of tests identified as best suited to this task. Specifically, van Holst et al., (2011) 
noted that computerised versions of the following functions are the most eligible candidates 
for a battery of tests suitable for the accurate analysis of substance misuse: Go/No-Go Task, 
Number Series Task, N-Back Task, Controlled Oral Word Association Test (COWAT), Corsi-








Evidence from within the academic literature has demonstrated executive updating (EU) is 
particularly vulnerable to the neurotoxic effects of HSD and cannabis consumption. The most 
frequently used task to assess EU in both HSD and cannabis smoking populations in the N-
Back Task. Conventional N-Back measures involve subjects observing a sequence of stimuli. 
The test consists of indicating when the current letter matches the one from “n” steps earlier in 
the series Gazzaniga et al. (2009). 
 
 
The N-Back task has been well cited in the academic literature and has been able to demonstrate 
EU task impairment in HSD populations. For example, Courtney and Polich (2009) reported a 
statistically significant difference between HSD and control populations with regards to EU 
performance, with results indicating that the HSD group showed significant reductions in all 
indices of task performance when analysed via the N-Back paradigm. The N-Back task has 
also demonstrated impairment to EU in cannabis smoking populations. For example, Cousjin 
et al. (2014) reported that when comparing the N-Back task performance of heavy cannabis 
smokers (N = 32) to non-smoking controls (N = 41), the cannabis smokers reported 
significantly lower outcomes on all N-back conditions in comparison to the control group. The 
authors concluded from these results that heavy cannabis users require more significant effort 
to complete the N-Back task, which is indicative of impairment to this executive domain 
 
Inhibitory Control 
Substance misuse research has also demonstrated that inhibitory control (IC) is vulnerable to 
the neurotoxic effects of HSD and Cannabis consumption. The most frequently used task to 
assess inhibitory control (IC) in both HSD and cannabis smoking populations in the Go/ No-
Go test (Schmidt et al., 2017). The Go/No-Go test requires participants to inhibit their 
responses to stimuli actively. Participants respond to “go” (Green box) stimuli by clicking 
button or space bar on computerised versions and actively inhibit this by making no response 
for “no-go”(Blue box stimuli). The Go/No Go has been well cited in the academic literature 
and has been able to demonstrate IC task impairment in HSD populations. For example, Mullan 
et al. (2011) compared IC task performance via the Go/No-Go test in (N = 40) HSD participants 
aged between 30 and 45 years who engaged in HSD behaviours for more than twenty years, to 
that of (N = 50) moderate drinkers and (N = 74) alcohol abstinence controls matched by age. 
One way ANOVA indicated a significant difference between HSD and control participants, 
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with the HSD participants performing worse on all measures of the test. The authors concluded 
that inhibitory control plays a significant role in the translation of intent to engage in HSD into 
active engagement in the act.  
 
 
The Go/No-Go task has also demonstrated impairment to IC in cannabis smoking populations. 
For example, Battisti et al. (2010) found that upon a comparison of 21 cannabis users with a 
mean 16.4 years of daily use to 19 non using controls, cannabis users performed worse on the 
Stroop task. Expressly, once controlling for potentially confounding influences arising from 
the use of additional substances such as alcohol and MDMA, the results indicated that cannabis 
smokers reported more significant numbers of errors. Age of onset of cannabis use is a crucial 
predictor for task performance, with early-onset with enhanced task impairment.  
 
Executive Set Shifting 
The Wisconsin Card Sorting Test (WCST) cited within the academic literature on executive 
functioning regarded as being one of the most robust and frequently used measures of executive 
set-shifting (ESS) within the substance misuse literature (Reynolds, 2015). In particular, 
Diamond et al. (2013) have noted that the most frequently used test in investigations of ESS in 
both HSD and cannabis consumption studies is the WCST. The WCST requires people to 
classify cards according to different criteria. There are four different ways to categorise each 
card, and the only feedback is whether the classification is correct or not, card organisation is 
through colour, number or the shape of the symbols. The classification rule changes every ten 
cards, and this implies that once the participant has figured out the criteria, the participant will 
start making one or more mistakes when the rule changes. The task measures how well people 
can adapt to the changing rules using, for example, measures of errors and reaction times 
(Faustino et al., 2019). 
 
 
Studies which have used the WCST have demonstrated ESS impairment in HSD populations.  
Such results support the notion that consumption of alcohol consistent with binge drinking 
criteria is positively associated with impaired cognitive switching tasks in young adults 
(Montgomery et al. 2012; Bensman et al. 2014). Jurk et al. (2018) reported that in measures 
that require cognitive control, undergraduate HSD (18-21 years of age) display a tendency to 
make significantly more errors and display reduced reaction times (RT) when compared to 
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adults. Furthermore, conflict costs (i.e. RT/error differences between high and low conflict 
trials) are more pronounced (Crone et al. 2006). These results are indicative of a reduction in 
the efficiency of the cognitive control system as it pertains to ESS in HSD's. 
 
Deficits to executive switching (ESS) in cannabis consumption studies, were researched by 
Roberts et al. (2013). Results indicated a significant between groups effect with the cannabis 
polydrug users displaying greater impairment to ESS comparative to the control group. The 
study concluded that there was evidence of atypical processing of attentional shifting in the 
cannabis users. More specifically, research conducted by McHale et al. (2008) was able to 
demonstrate cannabis consumption resulted in increased error rates and reduced reaction times 




An additional component of EF, although not included in Myake et al.’s., (2000) original 
conceptualisation of WM, is inductive reasoning (IR). IR is a method of reasoning in which 
the premises supply some evidence for the solution to a problem. As discussed below, previous 
research has identified that both HSD and cannabis consumption impair IR. One of the most 
frequently used task to assess IR in both HSD and cannabis smoking populations is the Number 
Series Task (NST). Conventional NST measures involve participants to observe a series of 
number strings. Participants then identify the pattern that dictates the numbers in the sequence, 
i.e. increasing in increments of 2 or multiples of 5 etc. (Zhong et al., 2011). 
 
The NST has been well cited in the academic literature and has been able to demonstrate IR 
task impairment in HSD populations. For example, Weissenborn and Duka. (2003) compared 
HSD participants (N = 95) to non-HSD controls (N = 90) on measures of decision making and 
IR. Results indicated that the HSD group performed significantly worse on all measured indices 
of the NST. The authors concluded that IR measured through the NST was a suitable 
assessment measure for the assessment of reasoning and decision making in HSD populations 
and should inform the development of the effective intervention in HSD populations.  
 
The NST has also been used to demonstrate impairment to IR in cannabis smoking populations. 
For example, in a recent literature review on cannabis consumption and cognitive impairment 
Crean et al. (2012) noted that there is a severe lack of research within the field of cannabis 
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consumption and IR. Those studies carried out so far reporting performance impairments in 
those tasks that load heavily onto pattern recognition such as the NST. Crean and colleagues 
were able to demonstrate that studies utilising the NST have consistently identified cognitive 
impairment in moderate, chronic and heavy cannabis users. Their review also notes that these 
effects are persistent after a period of abstinence.  
 
 
Visuospatial Working Memory 
Research has also highlighted Visuospatial working memory (VSWM) as being particularly 
vulnerable to both of these substances, and as such, is a suitable candidate for inclusion in this 
thesis. VSWM draws upon the organisational resources of WM (Miyake et al., 2001), with 
performance decrements reported which were related to the use of ecstasy (MDMA) (Murphy 
et al., 2012; Wareing et al., 2004, 2005). However, the role of cannabis concerning these 
performance decrements was unclear.  VSWM is, therefore, a suitable area for the investigation 
of effects related to heavy social drinking and cannabis. The most frequently used task to assess 
VSWM in both HSD and cannabis smoking populations is the Corsi Block Tapping Test 
(CBTT), with computerised variations of this task also having devised. Concerning 'physical' 
versions of the CBTT, the test involves mimicking a researcher as he/she taps a sequence of up 
to nine identical spatially separated blocks. The series starts simple, usually using two blocks, 
but becomes more complex until the subject's performance suffers. This number is known as 
the Corsi Span, and the average is about 5-6 for participants (Kessells et al., 2000). 
Computerised adaptations generally involve remembering the sequence with which the 
constituent cells of a visual matrix light up. By varying the length of the series task difficulty 
can be controlled (see Wareing et al., 2004, 2005). 
 
A relationship has reported between VSWM impairment in both HSD and cannabis 
consumption populations. In particular, Calbaria et al. (2017) compared 155 undergraduate 
students over six years concerning an HSD group and controls. Over the six years, the HSD 
group consistently committed more errors and showed a lower VSWM span in the difficult 
blocks than non-drinking controls. Although decrements in VSWM span showed some 
improvement, perseveration errors remained constant throughout the follow-ups in stable HSD 
participants. Concerning cannabis consumption, Makella et al. (2006) demonstrated that 
administration of doses of THC to non-cannabis smoking volunteers resulted in statistically 
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significant differences to VSWM during the CBBT, with participants showing more intrusion 
errors during task performance. 
Verbal Working Memory 
In addition to VSWM, verbal working memory is a component of working memory that is 
particularly vulnerable to the neurotoxic effects of both HSD and cannabis consumption. The 
most frequently used task to assess VWM  measure access to semantic long term memory 
(Access). Access memory tasks have demonstrated a particular vulnerability to substance 
misuse neurotoxicity in both HSD and cannabis smoking populations. The most widely used 
measure to assess access is the Controlled Oral Word Association Task (COWAT). The test 
asks the subject to write as many words as possible beginning with the letter 'S' within a 5-
minute limit, then as many words as possible beginning with letter 'C' within the 4-minute limit. 
The total number of 'S' and 'C' words produced, minus the number of rule-breaking and 
perseverative responses, yield the patients' measure of verbal fluency (Stuss, 1998). The 
COWAT has been having been able to demonstrate Access task impairment in HSD 
populations. For example, Parada et al. (2011) compared (N = 62) HSD to (N = 60) non-
drinking controls on a battery of neurocognitive test measures including a measure of Access 
to LTM, through the use of the COWAT. Results indicated that the HSD reported a statistically 
significant reduction in the Total number of correct words produced across all three test 
conditions. The authors concluded that the HSD group was demonstrating impairment to 
Access to LTM. The COWAT has also been used to illustrate impairment to Access task 
performance in cannabis smoking populations. For example, Murphy et al. (2011) examined 
the relationship between the consumption of cannabis and performance on the random letter 
generation task (RLGT). Performance measures compared ecstasy and cannabis polydrug 
users, (N = 15), to cannabis only users, (N = 13), with both groups compared to controls with 
no exposure to either drug, (N = 12). Results from a regression model comprising intelligence 
measures and estimates of ecstasy and cannabis consumption indicated that cannabis 
consumption contributed to the predicted redundancy scores on the RLGT.  
 
Identified Covariates and Executive Functioning 
The covariates identified in chapter five have also demonstrated a correlational relationship 
with EF task performance in cannabis smoking populations. For example, Moreno et al. (2012) 
evaluated impulsivity depression and IQ scores in cannabis smokers engaged in EF and WM 
task performance. Results indicated that the cannabis users (N=26) reported elevated scores for 
impulsivity and depression, while also displaying demised premorbid and fluid IQ scores. 
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Evidence from within substance misuse research has also been able to demonstrate a 
correlational relationship between units of THC and increasing deficits to IC (Murphy et al. 
2018). Herzig et al. (2014) were able to identify a significant correlational relationship between 
the amount of THC consumed and an increase in impairment to EF and WM  performance on 
the Go/No-Go condition and Corsi Block Tapping Test for cannabis users. 
 
Aral et al. (2013) reported that HSD and cannabis smokers recorded elevated levels of 
depression, diminished premorbid and fluid IQ scores, all of which were associated with 
deficits to EF task performance in an HSD group. A meta-analysis conducted by Stephan et al. 
(2017) reported that increased levels of impulsivity resulted in deficiencies in WM an EF. 
HSD's report greater levels of impulsivity across all six measures of the BIS compared to 
controls.  Increases in impulsivity resulted in decreases in EF task performance. Indices of 
alcohol use have also correlated with reductions in EF task performance Easdon et al., (2005) 
reported a positive correlation between units consumed in the past six months, age of onset 
drinking and an increase in errors reported in HSD's compared to controls.      
 
The measures described in this chapter provided an account of the conceptualisation of both 
Working Memory and Executive functioning in this study. The chapter provided a 
conceptualisation of the justification for the selection of measures. The next chapter reports on 







HSD and cannabis use: implications for Executive Functions and Working memory 
 
Introduction 
Following on from the discussion outlined in chapter six, concerning the selection of 
appropriate cognitive functions tests for polydrug research. This chapter will report upon the 
administration and analysis of those WM and EF tasks identified as being potentially the most 
robust with regards to both HSD and cannabis consumption. This analysis aims to ascertain 




This study utilised a 3-participant group design with a control group consisting of non-binging 
alcohol users (CO) and two experimental groups of binge drinkers (HSD) and binge drinking-
cannabis smoking polydrug users (HSDCC). These drug-taking behaviour types served as the 
independent variable (IV) at three levels (i.e. binge drinker, binge drinking cannabis using 
polydrug user and light social drinking-illicit drug-naive controls). The results of the cognitive 
test scores served as the dependant variables (DV). The experiment was a natural using pre-
existing groups rather than random allocation of participants to conditions. 
 
Participants 
Participant recruitment, inclusion and exclusion criteria are in the Participants sub-section in 
chapter 5. 
 
Cognitive task Performance Measures. 
The Go/ No- Go task. 
The cued Go/ No-Go task (Fillmore, 2003) is a measure of executive inhibition, to assess this 
elicits responses through the presentation of an initial 'Go' or 'No-Go' cue before the presence 
of the 'Go' or 'No-Go' target. Cues provide information concerning the probability of a Go target 
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appearing. Manipulation of the cue-target relationship so that the cues have a high probability 
of correctly signalling a 'Go' or 'No-Go' target (valid cues), and a low probability of incorrectly 
signalling a target (invalid clues) (see Figure 5). Correct stimuli tend to facilitate response 
inhibition and speed response execution, whereas incorrect cue cues tend to impair response 
inhibition and slow response execution (Fillmore & Weafer, 2013). 
 
Figure 6 presents the sequence of stimulus events for a valid 'Go' cue trial: the 'Go' cue is shown 
at one of the five SOAs, signalling the subject to prepare to respond to the expected 'Go' target. 
When presented with the 'Go' target, the participant responds by pressing a computer key, and 
the computer provides feedback regarding the accuracy and speed of the response (Fillmore & 
Weafer, 2013). In this condition, the valid 'Go' cue allows the subject to prepare to respond to 
the 'Go' target, so that reaction time to the 'Go' target increases. Figure 7 illustrates the sequence 
of stimulus events for an invalid 'Go' cue trial: presentation of the 'Go' cue prepares the subject 
to respond to the expected 'Go' target. When the 'No-Go' mark appears, the participant often 
fails to inhibit the response, and incorrectly responds to the 'No-Go' target. Poor inhibitory 
control is evident by more failures to inhibit responses in this condition. A test presents 250 
trials and requires 15 minutes to complete. The dependent variables generated by this task 
which will be analysed here will be Task Completion Time (ms), Error Rate for Vertical Cues, 
and Error Rate for Horizontal Cues. Analysis of the Psychometric properties of the test 
indicated that it has strong reliability (r =.098, P<.001) and validity (.070) measures (Filmore 
et al., 2003). 
Figure 5: Cued Go/No-Go Task 
 
Figure 5 describes the Cue-target combination probabilities on the cued go/no go task. Left panel: go cue precede 
go target (green box) on 80% of trials (valid go cue condition) and no-go targets (blue boxes) on 20% of trials 
(invalid go cue condition). Inhibitory failures are most common in the invalid go cue condition. Right panel: no- 




Figure 6: Schematic representation of the trial procedure in the valid 'Go' cue condition 
 
Figure 6. The sequence of stimulus events presented to a participant accompanied by the display duration in 
milliseconds and a corresponding correct response (Screenshot taken from the EPBL, 2019 
 
Figure 7: Schematic representation of the trial procedure in the invalid go cue condition. 
 
Figure 7. identical to figure 2 concerning the stimulus presentation sequence and duration in milliseconds, this 
time is displaying the incorrect cue (Screenshot taken from the EPBL, 2019). 
 
Inductive reasoning measure: Number Series Test 
In each condition, the participant identifies the pattern that determines the distribution of 
number scores presented. Participants are then required to use this information to identify the 
next number in the sequence from a series of options. Once the participant has made their 
choice via mouse-click, the selection gets briefly highlighted before the subsequent trial starts. 
Before the start of the test, five practice problems are presented that explain the logic behind 
the pattern determining the number sequences to ensure that the participants understand the 
rules of the study. Participants have 4.5 min to complete the test with a clock on the screen that 
counts down the minutes for the participants. The inductive reasoning test has two dependent 
variables, these being completion time (ms) and the number of correctly recognised patterns 
Psychometric analysis has indicated that this measure has robust reliability r = 0.92 ( P <.005) 
and validity (0.88) scores (Preston & Coleman, 2000). 
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The N-Back Test 
The letter N-Back task (Figure 8) displays sequences of uppercase consonants with a stimulus 
duration of 500 milliseconds and interstimulus levels of 2500 milliseconds. Uppercase 
consonants maximise readability of stimuli. In the 0 back condition participants responded if 
the target consonant was identical to the one preceding it. During the one back condition, 
participants responded if the target consonant was similar to the one presented one trial ago. In 
the two back condition participants responded if the target consonant was identical to the one-
two trials back, in the three back condition participants responded if the target was the same as 
the letter presented three tests ago. Each condition was repeated three times in a pseudo-random 
order, for a total of 135 stimuli. A target foul ratio of 2:1 (33%) of all marks is maintained 
throughout. Participants are informed about an upcoming condition during a nine-second delay 
between each test. This delay allows the participant to rest and permitted the recovery of 
haemodynamic response from the previous situation. Total task time was 495 seconds. 
Psychometric analysis has reported the reliability of the measures as, r = .094 (P <.001), while 
validity was .80  (De De, 2013). 
 
Figure 8: A trial sequence of the N Back Test 
 
Figure 8 describes the target letter presentation and the N back (1-4) target, the and milliseconds between 
numbers within the sequence Screenshot taken from the EPBL, 2019.   
 
 
Semantic Long Term Memory measure 
Controlled Oral Word Association Test, abbreviated COWA or COWAT, is a verbal 
fluency test that measures spontaneous production of words belonging to the same 
category or beginning with some designated letter. The participant names a word that starts 
with a letter, excluding proper nouns, for one minute and this procedure repeats three 
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times. The most commons letters used are FAS because of their frequency in the English 
language. Task administration requires between 5 and 10 minutes. The Dependent 
Variables (DV) for this task are completion time (ms), and the total number of words 
correctly produced Psychometric analysis reported that the COWAT scored r = .084 (P 
<.001) for reliability and .087 for validity (Ross et al., 2007). 
 
The Wisconsin Card Sorting Test (WCST)  
The WCST (Figure 9) is a neuropsychological test of "set-shifting", i.e. the ability to 
display flexibility in the face of changing schedules of reinforcement. Participants analyse 
stimulus cards. The participant is told to match the cards, but not how to compare; 
however, they know whether a particular match is right or wrong. Psychometric analysis 
indicated that the measure reported a reliability score of r = .88 (P < .001) and validity of 
.90 (Strauss, 2006). 
 
Figure 9: Condition Layout of the computerised WCST 
 
Figure 9 Descries the layout of the computerised WCST; participants use the mouse to click on one of the piles 
labelled 1 to 4 indicating where the card in the bottom left corner belongs  (EPBL, 2019).  
 
 
Visuospatial Computerised Grid Task. 
Based on the traditional (Corsi) block tapping task (Figure 10), the computerised grid task 
measures of visuospatial working memory involved the participant observing the computer 
screen, which presents an image of nine equally spaced blocks. These blocks are "lit up" by the 
computer, turning from blue to yellow. Once the end of the sequence is reached, the squares 
reset, the participant is then required to repeat the series back in order by using the mouse to 
click on the Blocks in the order that they changed colour. The sequence starts simple, 
comprising two blocks, but becomes more complex until the subject's performance suffers. 
This number is known as the visuospatial span and averages about 5 for normal human subjects. 
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The test measures both the number of correct sequences and the most extended sequence 
remembered. Psychometric analysis indicated that the task had a reliability score of r =.89 (P 
<.001) and a validity score of .90 (Robinson & Brewer, 2016). 
 
 
Figure 10: Screenshot example of the VSWM computerised Grid Task 
 
Figure 10 describes the computerised layout of the VSWM Grid Task; participants click on the boxes. In the 
sequence, they turn yellow1. The yellow symbolises the current block in the series (EPBL, 2019). 
 
Procedure 
On arrival at the Human Tissue Laboratory in the Department of Psychology, the researcher 
oversaw the completion of the consent forms and collected samples of urine for toxicology 
measures. The researcher then briefed the participants as to the procedure. The researcher also 
collected hair and saliva samples for analysis which fall outside the scope of the present thesis. 
After this, participants informed about the use of fNIRS. The administration of the cognitive 
tasks scores preceded this. The researchers administered the tasks in the order that they appear 
in the methods section of this chapter. The administration order was determined automatically 
by the “inquisit” programme. The researchers decided not to alter the test order, as participants 
were given an unlimited amount of time to complete the tests, and could have breaks between 
measures or pause tests at any time. In this way, the study intended to negate any risk of mental 
fatigue influencing the results. Upon completion of the cognitive functions measures,  
Analytic Strategy 
The data analysis began with the calculation of means and standard deviations, with the 
removal of outliers achieved through analysis of skewness and kurtosis values and the deletion 
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of z-scores exceeding ± 3.29, for all cognitive tasks. The calculation of Z-scores was part of 
the preparation for MANOVA, which accommodated the multiple DVs for tests without 
compromising alpha levels and inflating the probability of a Type 1 error (Tabachnick & Fidell. 
2014). The analysis than employed square, square root, natural log (logn), and inverse 
transformations as appropriate to normalise the distribution of scores to satisfy the 
requirements for MANOVA.  Homogeneity of variance and covariance assessed the robustness 
of the data for MANOVA through Levene’s F, and Box’s M.   
 
Data analysis evaluated the univariate results against a revised alpha level calculated by the 
procedure described by Tabachnick and Fidell (2014 P.312). Where MANOVA was not 
appropriate due to its assumptions not being met by the data, non-parametric Kruskal-Wallis 
H test and subsequent Mann-Whitney U tests were conducted, with correlations where 
applicable. The analysis evaluated the results of any such tests against Bonferroni adjusted 
alpha levels of α' = 0.17. The relationships between the background variables, consumption of 
alcohol and cannabis and Behavioural Task performance using bivariate correlations. Once 
again, these analyses comprised either parametric or non-parametric correlations, subject to the 




Go/No-Go Task Performance 
The Go/No-Go task generated nine dependent variables (DVs). These were task completion 
time; error rate vertical “cues”. Error rate horizontal “cues”; error rate for trials in which “cue” 
the is Vertical, and the target is a go response (EVTG). Reaction time for “trials” in which the 
“cue” is Vertical, and the target is a no go (EVTN).  Reaction time for No Go response; error 
rate for trials in which the cue was horizontal was a go response (EHTG); overall mean rt (in 
ms) for target = go, and reaction time for “trials” in which the “cue” was horizontal, and the 
target was a no go response (EHTN).  
 
Preliminary analysis of the data indicated issues of skewness and kurtosis across all DV's. 
Subsequent analysis of Z-Scores for the DVs had a cut-off score of Z = ± 3.29. These scores 
indicated no outliers for the following DV's; completion Time, overall means reaction time for 
the target “go”, reaction time for trial in which the cue is vertical, and the target is a go response. 
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Reaction time for the “trial” in which the “cue” is horizontal and, the target is a go response. 
However, two outliers with a score of Z = 4.04 were identified and removed for the DV Error 
rate for vertical cues. The error rate for horizontal “cues” also identified two outliers with scores 
of Z = 3.32 and Z = 4.11. The error rate for trials in which the “cue” is vertical and the target is 
a go response highlighted two outliers, with scores of Z = 3.78 and Z = 5.80. The error rate for 
trials in which the cue is vertical, and the target is a no go response reported two outliers, with 
scores of Z = 3.56 and Z = 5.09. The error rate for No Go Response reported one outlier with a 
score of Z = 5.9. Scores for trials in which the cue was horizontal and the target was a go 
response had two outliers with scores of Z = 3.5 and Z = 4.8. While error rate for trials in which 
the cue was horizontal and the target was a no go response identified two outliers with scores 
of Z = 5.36. 
 
Checks for normality of score distributions for the revised variables following the 
transformation procedures described in the Analytic Strategy indicated that both mean reaction 
time (in ms) for trial in which the cue was vertical. Target was going and mean rt (in ms) for 
trials in which the cue was horizontal, and the target was “go”, were both normally distributed. 
Subsequent Z-Score transformations normalised the distribution of the remaining variables. 
However, this was at the cost of losing data through the number of zero scores, so that these 
methods could not transform the data, as the N values reported here demonstrate. Inverse 
transformations normalised scores for Error rate vertical, (N = 37) and Error rate for horizontal 
cues (N = 15). The error rate for trials in which the cue was vertical, and the target was Go was 
successfully transformed with (N = 21) for Logn and inverse transformations.  Logn and inverse 
transformations normalised error rates for the No Go response (N = 18). Trials in which the 
cue was horizontal, and the target was “go” was also successfully transformed via Logn 
transformations with an (N = 25). Square root transformations of the Error rate for trials in 
which the cue was vertical and the target was no go reported (N = 68), while overall mean 
reaction time (in ms) for the target go (correct responses only) reported (N = 70). Finally, 
normalization failed for task completion time following attempted transformations.  
In summary, the DVs included in the MANOVA were square root transformations of EVTN, 
and Square root transformations of the overall mean rt (in ms) for target = go (correct responses 
only). However, the MANOVA results were not valid due to a lack of homogeneity of variance 
and covariance, as shown by Box’ M statistic. Due to the high number of DVs, the analysis 
used an inspection of the inter-group mean differences to select the five DVs with the inter-
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group differences, for which the research evaluated nonparametric studies against a Bonferroni 
adjusted alpha level of P < .01. Table 8 reports the results for the Go/No Go task. The 
subsequent non-parametric analysis indicated a statistically significant effect between groups 
effect for Error Rate for Horizontal Cues and Overall Mean Reaction Time (in ms) for the go 
responses. Results were evaluated Post-Hoc pairwise comparisons against a Bonferroni 
adjusted alpha level of P < .003, and showed that the HSDCC group displayed significantly 
quicker reaction times for ‘GO’ responses than both the HSD and CO group. There was a 
marginally significant main effect across groups for the error rate for horizontal cues (evaluated 





Table 8: Means and (SD’s) for the Go/ No-Go task response 
Variable Controls 
(CO) 
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Number Series Task Performance 
The NST generated two DV's, specifically completion time and the total of number patters 
correctly recognised. The Z-scores for skewness and kurtosis indicated the normal distribution 
of correct pattern recognition scores while completion time was not. The Z-score analysis 
identified two outliers for completion time for which the cut-off point for scores was Z = ± 
3.29. None of the transformations made NST completion time was “normally” distributed and 
suitable for inclusion in MANOVA. Analysis of these two DVs indicated no correlation. Data 
analysis proceeded with a Univariate analysis without the Bonferroni adjustment for the 
primary effect size due to the lack of correlation between the variables. Post Hoc comparisons 
still required Bonferroni adjustments, of α' = P ≤ .017 two-tailed. 
 
Table 9 reports the results for the NST, the univariate analysis indicated a significant main 
effect across groups for correct pattern recognition, with controls showing better pattern 
recognition in comparison to the HSD group. No other inter-group comparisons were 





Table 9: Means and (SDs) for Number Series Task Performance 
Variable Controls 
(CO) 
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N-Back Task Performance. 
0-Back Task Performance 
The N-Back Task generated 5 DVs; RTs, % correct responses, False alarms, Misses and 
Correct rejections. Owing to the continuous nature of the task, these DV's repeated across each 
of the conditions. For the 0-Back, as with the other tests reported here, the cut-off point for 
outliers is Z = ±3.29. Subsequent Z- Score analysis failed to identify outliers in any of the DVs. 
Therefore, only the RTs were deemed suitable for parametric analysis using univariate 
ANOVA.  No significant inter-group effect was observed (F < 1). None of the subsequent non-
parametric tests performed on the four remaining DVs showed significant inter-group results. 
For all five analyses comparisons of main effects across the groups employed the Bonferroni 






Table 10: Means and (SD’s) for the 0-Back Condition task Performance 
Variable Controls 
(CO) 












































































































F (2,67) = .065, P = 
.937, ƞp2 = .002 
 
 















































1-Back Task Performance 
Preliminary analysis of the scores for the 1-Back condition highlighted the normal distribution 
of the correct rejection of raw scores without the removal of outliers RT’s normalised following 
removal of outliers from line one. Subsequent transformations calculations rendered the three 
remaining DV's normal, with square transformations normalising correct response %, false 
alarms and misses. Analysis subsequently omitted RT’s and scores for misses from the study 
due to excessive correlations. MANOVA was unable to find a significant intergroup effect 
(Pillai’s Trace F < 1), with none of the univariate results approaching significance. Similarly, 
the non-parametric Kruskal Wallis for RTs and misses failed to find a between-group 




Table 11: Means and (SD’s) for the 1-Back Condition task Performance 
Variable Controls 
(CO) 




















































































































F (2, 66) = .545, P = 
.528, ƞp2 = .016 
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2-Back Task Performance 
Scores for the 2-Back condition highlighted that the only normally distributed scores were % 
correct, whilst removal of outliers from line one normalised the RTs scores. There were no 
outliers for the other variables. Square root transformations rendered normal the distributions 
of the false alarms and misses, but not the correct rejections. Further attempts at normalisation 
for the valid rejection scores failed with both natural log and natural log (In) and therefore 
could not be used in the MANOVA or any other parametric analysis. Non-parametric Kruskal-
Wallis analysis of correct rejections did not show a significant inter-group difference. 
Consideration of the correlation scores highlighted those correct responses and SQRT miss 
showing a highly significant negative correlation. The SQRT misses analysis subsequently 
omitted the variable from the MANOVA due to an excessive correlation with at least one of 
the other DVs. 
 
The analysis included the DVs of raw scores for % correct responses, RTs (with outlier 
removed) and square root transformations of false alarms in the MANOVA solution. The 
results indicated that there was a significant Levene's F for the RTs. However, Tabachnick and 
Fidell (2014) recommend the Fmax test as more appropriate to Levene's F for homogeneity of 
variance. Fmax variance calculations indicated that Control group variance = 16,136.7581, HSD 
variance = 36,989.4441, and HSDCC variance = 21,258.2028. As the ratio of smallest group 
size and the largest is less than 1:4, the Fmax test allows a ratio between the smallest variance 
and the largest of up to 1:10 for homogeneity of variance to be claimed (Tabachnick & Fidell, 
2014). The ratio between the smallest and largest variances above is well within this limit. 
Consequently, MANOVA is, therefore, valid with regards to the homogeneity of variance. The 
MANOVA result for inter-group effects was significant with Pillai’s Trace F (6, 130) = 2.309, 
P = .038, ƞp
2 = .096. 
 
Table 12 reports the scores for the 2-Back condition. The results indicated that while there 
appears to be a statistically significant multivariate effect between groups effect for Reaction 
Time, Post Hoc pairwise comparisons failed to find a substantial difference between the 
groups. The data analysed these post hoc comparisons using the following equation, taken from 





EQ1.  α = 1 – (1 – α1)(1 – α2)(1 – α3)   
Where α was the family-wise significance level, α1 was the alpha level for the first dependent 
variable, α2 was the alpha level for the second dependent variable, and α3 was the alpha level 
for the third dependent variable. 
 
This formula is different from that used for Bonferroni adjustments in other contexts. For the 
family-wise α to be P < .05 or less, the revised α level for each univariate result was P < .015, 
which yielded an overall (family-wise) α level of P < .044. None of the univariate results was 
significant against the revised univariate α level of P < .015, although the scores for RTs came 
close  For the RTs, a further adjustment of α = .015/3 for the pairwise intergroup comparisons: 




Table 12: Means and (SD’s) for the 2-Back Condition task Performance 
Variable Controls 
(CO) 











































































































F (2, 66) = 3.617 , P = 
.032, ƞp2 = .099 
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Only three covariates were Normally distributed and offer a full data set; Alcohol consumption 
in prior six months, No. of hours since last alcohol consumed, and alcohol onset age. Valid 
stepdown analyses were not possible because of difficulties posed by the measurement of 
homogeneity of regression in the ANCOVAs with a total of 6 variables to be accommodated 
(1DV and five covariates). However, multiple linear regression analyses using the covariates 
as a block of IVs for each DV in the MANOVA model, respectively (i.e. three analyses) 
showed no significant prediction of the DV. 
3-Back Task Performance 
Analysis of scores for the 3-Back condition highlighted normal distribution for the raw scores 
for RTs, % correct responses, and misses without adjustment. There were no outliers for either 
false alarms or correct rejections. Square root transformations rendered false alarms “normal” 
but not right sacrifices. Correct rejections were subsequently removed from the MANOVA as 
both natural log and inverse transformations did not generate correct rejections normal. 
Nonparametric Kruskal Wallis analysis showed no main intergroup effect for correct 
rejections. Consideration of correlation scores highlighted that a large correlation led to the 
omission of misses from the MANOVA. 
 
Scores for homogeneity of variance indicated a significant score for Levene's F for RTs. As 
with the 2-Back condition, the Fmax solution rectified this issue (Tabachnick & Fidell, 2014). 
Variance scores for each of the conditions were as follows: Control group variance = 
41,815.4648, HSD variance = 105,501.8739, HSDCC variance = 61,740.0542. The ratio 
between the smallest and largest variances above is well within this limit. Consequently, the 
MANOVA results are valid with regards to the homogeneity of variance. The MANAOVA 
result for inter-group effects was non-significant with Pillai's Trace F (6, 132) = 1.719, ns. Data 
analysis evaluated the univariate results against revised alpha levels calculated using EQ1 
above (taken from Tabachnick & Fidell, 2014 P.312). To maintain a family-wise α to be P < 
.05 or less, the revised α level for each univariate result was P < .015, which yielded an overall 
(family-wise) α level of P < .044.  The univariate result for RTs was marginally nonsignificant. 
For the RTs, a further adjustment of α = .015/3 for the pairwise intergroup comparisons: i.e. P 
< .005. The comparison between controls and binge drinkers was marginally non-significant 




MANCOVA solution precluded the inclusion of the covariates; specifically, it would not be 
possible to complete the step-down analysis with this sample size. However, following 
Tabachnick and Fidell (2014) using multiple linear regression (MLR) as a means of 
investigating the relationships between the three covariates as IVs and each DV from the 
MANOVA. Results indicated that none of the scores for the predictive model (of IVs) was 
predictive in any of three analyses conducted. However, alcohol consumption in the last six 
months is worthy of some attention with t (66) = 2.200, P = .031, with a positive B coefficient 
of 2.553 for the prediction of 3-back RTs. The higher the level of alcohol consumption in the 




Table 13: Means and (SD’s)  for the 3-Back Condition task Performance 
Variable Controls 
(CO) 
















































































































F (2, 67) = 4.255, P = 




F (2, 67) = 1.023 , P = 
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1 All Post-Hoc analyses were evaluated as two-tailed against a Bonferroni adjusted alpha level of P ≤  .015 
2 The two-tailed probability for this comparison was P < .006, which was marginally nonsignificant against the 





Semantic Long Term Memory (COWA) 
Analysis of the COWA identified five dependant variables: Letter fluency time (ms), letter 
fluency total, correct total production (A), Correct production (F), and Correct production (S). 
Preliminary checks for normality reported abnormal distribution of letter fluency time. The Z-
scores highlighted four values with scores > ±3.29. The exclusion of these outliers, however, 
did not render this variable “normally” distributed, so that it was analysed using the Kruskal-
Wallis test. Given that the individual letter production scores provide the bases for the 
calculation of letter fluency totals, and also that the three production scores were highly inter-
correlated at r (70) > .87, the researchers decided not to analyse these individual variables. 
Letter fluency total was normally distributed and was analysed using univariate ANOVA. This 
analysis did not show an inter-group effect (F < 1). While Post hoc pairwise comparisons 
indicated, that letter fluency time and letter fluency total were not significantly correlated with 
each other and so were both examined concerning effects with the covariates, letter fluency did 






Table 14: Means and (SDs)  for Semantic Long Term Memory (COWA) task Performance 
Variable Controls 
(CO) 
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F(2,67) = .600, P 

















































Wisconsin Card Sorting Test Task Performance 
Analysis of the WCST generated three potential DVs: completion time (ms), totally correct 
and error rate. Normality scores indicated the only normal distribution was for error rate in its 
raw score form. Frequency Z-scores for the two remaining DV's stated that there were no 
outliers at the cut off of  ± 3.29 for Completion Time while analysis of the scores for Total 
Correct highlighted two, this then rendered the DV normally distributed (N = 68). Subsequent 
square root transformations resolved the issue of normality for completion time. For the 
variables chosen for MANOVA (N = 68), there were no significant inter-correlations between 
square root transformations of completion time, totally correct, and error rate. MANOVA did 
not show a significant main effect between groups with Pillai's trace F (6, 128) = 1.562, ns. 
Analysis of Box's M statistic reported a highly substantial score with analysis of the variances 
between cells suggestive of a violation of the test assumptions. Total correct and transformed 
completion time scores were unsuitable for analysis as Levenes. F identified issues with 
homogeneity of variance. Thus MANOVA was rendered unfit for this analysis.  
 
The problems identified with MANOVA did not, however, automatically invalidate the 
subsequent use of MANCOVA. However, when the covariates of alcohol consumption in the 
prior six months, the number of hours since last alcohol consumed, results included alcohol 
onset age and cannabis consumption in the previous six months. There was again a highly 
significant value for Box's M statistic, combined with a tendency for higher variances in the 
smallest group (i.e. Binge Drinkers). Consequently, the data will not report the  MANCOVA 
results here due to the violations of the assumption of homogeneity of variance and covariance 
matrices. 
 
Total correct and error rates scores were analyses using a Univariate ANOVA, and Kruskal 
Wallis test, with a Bonferroni, adjusted alpha level of P < .025 for main effects and P < .008 
for inter-group comparisons. Results failed to show a between-groups difference for either 
Total Correct (F <1.) or Error Rate (F <1.), nor did the nonparametric ANOVA for Completion 
Time. Post-Hoc pairwise comparisons reported no significant correlations. Table 15 
summarises the results for the WCST. 
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 1 All Post-Hoc analyses were evaluated as two-tailed against a Bonferroni adjusted alpha 
level of P ≤  .015  
Table 15: Means and (SDs)  for The Wisconsin Card Sorting Task Performance 
Variable Controls 
(CO) 
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H [2, N = 70] = 
2.997 P = .223 
 
 
F(2,67) = .801, 
P = .453, ƞp2 = 
.024 
 
F (2,67) = 
0.732, P = 


















Computerised Visuospatial Grid Task   
Analysis of the Grid Task highlighted four dependent variables: completion time, totally 
correct, memory span, and memory total. Scores for total correct and memory span revealed 
that result highlighting the “normal” distribution of these scores, but completion time and 
memory total were not. Following this, frequency Z-score analysis indicated that there were no 
outliers for memory total or for completion time. Normalisation calculations for memory total 
were effective via square root transformations with an N =70.  The square root transformations 
of total scores correlated too highly with the total correct for the analysis (r (70) = .908, P ≤ 
.000, two-tailed). The correlations for the three remaining variables were acceptable. With 
significant correlations identified for memory span and correct total (r (70) = .639, P ≤ .000, 
two-tailed), and logn transformations of completion times and correct total (r (70) = .350, P ≤ 
.001, two-tailed). Correlations between memory span and Logn transformations for completion 
time were non-significant (r (70) = .226, P = .060). The resulting MANOVA did show a 
borderline non-significant result (Pillai's trace F (6, 132) = 2.049, P = .064), with no significant 
inter-group comparisons. However, Box’s M was highly significant (P < .000), and the step-
down analysis failed to show homogeneity of regression for memory span and for the ln 
completion times so that the validity of the MANOVA result is questionable. 
 
The MANCOVA solution included four covariates from the six previously identified; 
precisely, Alcohol consumption in the prior six months, number of hours since last alcohol 
consumed, alcohol onset age, cannabis consumption in the previous six months. However, the 
amount of cannabis used in the last six months was not normally distributed and removed from 
the analysis. However, Homogeneity of regression was not achieved for alcohol onset age, so 
that the investigation did not pursue the MANCOVA further. 
 
In light of the problems with the multivariate results, the dependent variables total correct, and 
results analysed memory span, which met the conditions for ANOVA in that way. At the same 
time, the completion time was suitable for Kruskal Wallis analysis. The revised Bonferroni 
alpha level for main effects was P < .017, and inter-group comparisons used an adjusted alpha 




Table 16: Means and (SD’s) for the Computerised Visuospatial Grid Task. 
Variable Controls 
(CO) 




























































































































Univariate ANCOVAs using reports of alcohol units consumed in the previous six months, 
number of hours since last consumption of alcohol, and alcohol onset age were conducted, with 
their results evaluated against the same revised alpha levels as for the ANOVAs. There was a 
significant intergroup effect for memory span (F (2, 64) = 6.889, P = .002, ƞp
2 = .177), with 
only the post hoc inter-group comparison being that between the controls and the HSDCC 
group, with the control group having a significantly longer span (P < .000 two-tailed). Data 
analysis performed a multiple linear regression to examine the relationships between group 
membership (transformed into a dummy variable) and the covariates identified in Chapter 5 
serving as independent variables (IVs), and VSWM span as the DV. Table 17 shows the order 
of hierarchical entry of IVs into the regression solution. 
 
Table 17: Sequence of IV inclusion for the Regression Model 
Model IV 
1 HSD V Others, 
HSDCC V Others 
2 HSD V Others, 
HSDCC V Others 
Hours since last Alcoholic Drink 
3 HSD V Others, 
HSDCC V Others 
Hours since last Alcoholic Drink 
Alcohol consumed in the last six months (units) 
4 HSD V Others, 
HSDCC V Others 
Hours since last Alcoholic Drink 
Alcohol consumed in the last six months (units) 
Age of first alcohol use (years) 
 
The results indicated that correct pattern recognition with the transformed group variables 
entered alone in model 1 was non-significant. Tables 18 and 19 reports on the hierarchical 
multiple linear regression scores, the regression solution did present significant results at model 
2, where hours since the last alcoholic drink was added to the model and contributed to 11.4% 
of the score. The inclusion of Alcoholic units consumed in the past six months also proved to 
be significant in model 3, contributing to 18.9% of the total variance in span scores. The 
statistics for model 4 were also substantial, where results showed that the inclusion of age at 
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first use of alcohol accounted for 35.1% of the total variance in span scores. Significant Fchange 
values for Models 2, 3, and 4, indicating that each new covariate added significantly improved 
prediction for memory span scores. 
 
Table 18: Summary of regression analysis for VSWM span scores 
Model R2 R2 change F change df1 df2 Sig F change 
1 .020 .020 .668 2 67 n.s 
2 .114 .094 7.204 2 66 P ≤.010. 
3 .189 .075 6.054 2 65 P ≤.017. 
4 .351 .162 15.952 1 64 P ≤.000. 
 
Table 19: ANOVA for VSWM span scores 
Model Component of 
variance 
df MS F Sig. 
1 Regression 2 1.222 .668 .516 
Residual 67 1.830 - - 
Total 69 - - - 
2 Regression 3 4.734 2.827 .045 
Residual 66 1.679 - - 
Total 69 - - - 
3 Regression 4 5.918 3.797 .008 
Residual 65 1.559   
Total 69 - - - 
4 Regression 5 8.777 6.925 .000 
Residual 64 1.268 - - 
Total 69 - - - 
 
Concerning the individual predictors in model 4, the combining of two groups in each of the 
dummy variables renders unclear the interpretation of the t-test results for the HSD versus 
others IV (t (65) = 2.222, P = .030) and the HSDCC versus other IV (t (65) = 3.707, P < .000). 
Both of these IVs showed positive B coefficients of 0.927 and 1.520, respectively. However, 
the result for the HSDCC versus other IV does show that scores significantly associated higher 
VSWM span with not having used cannabis. With regards to the covariates, alcohol units 
consumed in the previous six months showed a significant effect (t (65) = 2.239, P = .029), 
with the positive B coefficient of 0.012 had a positive relationship with VSWM span. The onset 
age for alcohol use also had a significant relationship with VSWM span (t (65) = -3.994, P < 
.000) with the negative B coefficient of -0.092 showing younger-onset ages to be associated 







With regards to measures of IR, the number series task scores indicated that the only 
performance measure to show a significant difference between the groups was the number of 
correctly recognised patterns. Results indicated a significantly higher total for correct 
recognition for the CO group compared to the HSD group, with no other inter-group 
comparisons being significant. This pattern of scores is entirely consistent with findings from 
within the academic literature, serving to highlight the neurotoxic effects of HSD on IR task 
performance (Briere et al. (2019). Crean et al. (2012) noted that there was a lack of studies 
looking at the relationship between cannabis use and IR. The present results did not find any 
significant inter-group comparisons or correlations with covariates identified in chapter 5 limits 
to support an assertion that cannabis use contributes to impairments in this area of EF 
functioning. However, further research is a need in this area, with the potential role discussed 
further below of a neuroprotective effect related to cannabis consumption being part of such 
research (Thayer et al. 2019; Toriño et al., 2010; Rubio et al., 2011)  
 
Results for VSWM task performance demonstrated that the control group showed significantly 
higher visuospatial memory span scores compared to the HSDCC group following the 
introduction of the covariates. This pattern of results is consistent with findings within the 
academic literature related to THC induced impairment to VSWM (Skau et al., 2019), and with 
the findings of Wareing et al. (2004). They reported that cannabis use was a significant 
covariate of VSWM performance in comparisons of ecstasy users to drug naïve controls. 
However, the results from the regression analysis pose a problem in that alcohol consumption 
in the previous six months showed a positive relationship to VSWM span,  while onset age for 
drinking showed a negative relationship to VSWM span. In other words, higher levels of recent 
usage and younger onset were both related to higher span scores.  These scores are contrary to 
other findings concerning VSWM performance in substance users (Barnes et al., 2018), and 
suggests that further research into the relationship between alcohol consumption and VSWM 
performance is necessary. The evidence for a relationship cited here between cannabis 
consumption and VSWM performance highlights the need for poly-substance use accounted 




Concerning the remaining cognitive functions, HSDCC participants showed faster RTs for 
‘GO’ responses in the GO/No-GO task of inhibitory control (IC) than both other groups. 
However, there were no significant differences in other measures of performance, such as those 
concerning errors and correct responses, to suggest whether scores relate this difference to 
better or worse task performance overall. However, result interpretation may see these result 
for RTs as consistent with the generally higher scores for impulsivity reported for HSDCC 
participants in Chapter 5. One further explanation for this pattern is the potential 
neuroprotective effects of cannabinoids. CBD acts against the neurotoxic effects of HSD and 
THC (Toriño et al., 2010; Rubio et al., 2011). To date, there does not appear to have been any 
study of potential neuroprotective effects of cannabis use in the context of human alcohol 
consumption, and it is essential to emphasise that the present study does not test such a 
hypothesis. Nevertheless, the possibility of such an effect being present in the data obtained 
from the participant groups studied is one which should be acknowledged.  
 
Concerning the other cognitive functions examined, the present data set fails to show any 
statistically significant differences between the HSDCC, HSD, and CO groups with regards to 
access to semantic long-term memory and ESS task performance. It is important to note that 
interpretation should see these results in the context of inconsistent findings regarding these 
functions (Blaes et al., 2019) and that further research will inevitably be necessary for a clearer 
picture to emerge. 
 
It is worth noting also that the scores for the N-Back task conditions fail to find any statistically 
significant effects for the 0 and 1 back conditions. These results were in keeping with products 
from the academic literature. Indeed research by Morgan et al. (2016) and Vandrey et al. (2013) 
have noted that the 0-Back and 1-Back are not sufficiently demanding to highlight any 
cognitive impairment in HSD and cannabis smoking populations. At the same time, there was 
a statistically significant multivariate main effect for RTs in the 2-Back condition. The lack of 
substantial univariate effects and post-hoc comparisons, together with there being no 
meaningful relationships between the covariates studied and task performance, limits any 
conclusions. However, the results for the 3-back condition showed that impaired performance 
presented itself through a marginally nonsignificant difference concerning slower RTs for the 
HSD group compared to the CO group. A subsequent multiple linear regression analysis 
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showed a significant positive relationship between RTs and alcohol consumption in the 
previous six months. Chapter 5 reported that this measure of alcohol consumption was 
significantly higher for the HSD group than the CO group, which is consistent with the RT 
difference between the groups. Chapter 5 also showed the HSDCC group to have significantly 
higher alcohol consumption in the previous six months than the control group. The HSD and 
HSDCC groups are not significantly different on this measure of alcohol consumption, which 
would seem to be inconsistent with the lack of any difference between the HSDCC and CO 
groups on task performance. It is clear, therefore, that further investigation into the respective 
relationships of alcohol and cannabis to account at the 3-back level of this task is required. It 
was also highlighted by Hopestaken et al. (2015),  that there tends to be a drop off in task 
performance on all condition post-2-Back as all following conditions elicit a degree of 
cognitive overload. Consequently, the present results from the 3-Back may reflect the influence 
of other factors on task performance which are not necessarily a consequence of substance 
misuse. In this regard, Chapter 5 reported that the HSDCC group scores more highly than both 
other groups on premorbid IQ and, of more relevance to the 3-Back results, more highly on 
fluid intelligence (i.e. Raven’s Matrices) than the HSD group. 
 
The varied nature of these results may reflect the indeterminate nature of scores within the 
current literature (Briere et al., 2019; Calabria et al., 2019; Schult et al., 2019;). A potential 
explanation for this observed patterning is that this is reflective of the relative robustness of 
specific EF and WM domains with regards to HSD and HSDCC induced damage (Robinson et 
al., 2009). Indeed neurocognitive research argues that WM and EF have a diffuse network of 
the neural substrates supporting both WM and EF task performances. These include cortical 
(DLPFC) and sub-cortical structures such as the Thalamus (Tomasi & Chang, 2005; Ullman et 
al., 2014, Zimmer, 2008) therefore HSD and HSDCC induced reductions in cortical 
functionality would not necessarily equate to noticeable decreases in EF task. Fisk and 
Montgomery (2011) note that these inconsistencies are associated with task insensitivity to 
subtle alterations in task performance observed in younger HSD and cannabis smoking 
populations. Montgomery and Fisk (2008) argue that the introduction of supplementary 
imaging technology could address this issue. In this way, research would benefit from 
complementary neuroimaging or neurophysiological data to elucidate on the findings of the 
cognitive functions tests.  
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A limitation of this study is about the failure to report upon nicotine consumption levels as 
introduced in chapter 5. Nicotine affects cognitive task scores. Evans et al., (2009) reported 
that nicotine exerts a neurotoxic effect upon the DLPFC, which in turn reduces functionality 
with regards to both WM and EF. In the study, the author reported that cannabis smokers 
performed worse on all measures of WM and EF compared to controls. It is, therefore, entirely 
plausible that nicotine could be affecting the scores reported in this study. However, the failure 
to report upon the levels of nicotine consumption renders it impossible to explore its potential 
impact here  
 
In conclusion, the present results appear to suggest that the HSDCC participants showed effects 
on their cognitive functionality within the domains of IC and VSWM. At the same time, there 
also exists the potential for the neuroprotective properties of CBD exerting itself upon IC task 
performance. There was evidence for HSD participants showing effects on their IR and EU 
functioning, although the role of alcohol in these effects was unclear due to the lack of impact 
demonstrated by the HSDCC group.  Despite the inconsistent nature of scores, these findings 
represent an advance in our knowledge of EF and WM performance in HSD and HSDCC 
participants, in addition to highlighting a need for further research. Supplementary 
neuroimaging data can highlight possible activity in a wide range of neural substrates to counter 
















HSD and cannabis use: implications for Oxy and De-Oxy Hb concentrations during  EF 
and WM tasks 
 
Introduction 
Marinkovich et al. (2011) attributed the results from EF and WM research in both HSD and 
cannabis consumption to issues in neuropsychological assessment sensitivity. The authors 
suggested that research could address the issues surrounding the detection of subtle alterations 
in task performance constructively through the introduction of supplementary imaging 
technology. Research would benefit from complementary neuroimaging and 
neurophysiological data to elucidate on the findings of the cognitive functions tests. Studies 
conducted by Roberts and Montgomery (2015) noted that functional near-infrared 
spectroscopy (fNIRS) is a reliable measure of regional cerebral blood flow (rCBF) for the 
assessment of cognitive effort during task performance. In particular, increases in Oxy-Hb and 
Deoxy-Hb is indicative of increased resource allocation to meet task demands.  Specifically, 
an increase in the volume of oxygenated blood flow entering a region of interest (ROI), or the 
increased utilisation of Oxy-Hb, which leads to a subsequent rise in Deoxy-Hb concentrations 
would show such a change. 
 
Conversely, decreases in Oxy-Hb and Deoxy-Hb concentrations are indications of decreased 
cognitive engagement. Cerebral blood flow volumes fall in a given ROI as participants struggle 
to engage with a cognitive task or when they actively disengage with a job owing to an overload 
of task demands.  Studies concerned with polydrug use and inhibitory control (IC) mainly focus 
on ecstasy consumption.  
 
Roberts and Montgomery (2015) reported the combined use of an IC task with fNIRS with 
users of ecstasy. The results showed no difference between the users and non-using controls 
on task performance reporting differences between the two groups on rCBF during task 
performance regarding changes from baseline. In particular, results reported changes in Oxy-
Hb levels in the right prefrontal cortex (PFC) and dorsolateral prefrontal cortex (DLPFC) 
between the groups. Although studies did not use fNIRS with either HSD or Cannabis 
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consumption research, the researchers used Go/No Go task, for this present study (see Chapter 
6) was used alongside other neuroimaging and neurophysiological measures. The findings of 
which provided a more in-depth insight into the relationship between brain activity and IC 
performance in participants characterised by HSD and cannabis consumption. For example, 
Lopez-Caneda et al. (2014) used the Go /No Go task to examine neural activation patterns in 
the PFC during IC performance in HSD participants. Event-related potentials (ERPs) track the 
changes in activation patterns over several years, thus providing insight into the aetiological 
progress neurological alterations occurring within HSD participants. Results indicated that the 
study significantly correlated reduced amplitude in activity with an earlier age of onset of 
alcohol consumption than the period stipulated in the DSM V criteria for HSD, as well as with 
greater quantity and speed of alcohol consumption. Regression analysis showed that amplitude 
alterations during response inhibition in the No-Go condition were a significant predictor of 
the rate of alcohol intake and the age of onset of regular drinking. Intergroup comparisons 
demonstrated that engaging in HSD for a minimum of 2 years, resulted in significantly larger 
NoGo-P3 amplitudes than controls. These findings suggest that not only do HSD participants 
display more significant impairment to IC task performance than non-HSD participants but 
also that an early onset of HSD may impair the neural functioning related to inhibitory 
processes.  
 
The Go /No Go task has also been used in conjunction with imaging technology to provide 
deeper insights into the effects of cannabis consumption on IC. In a study conducted by Hester 
and Garavan (2009), the researchers used the Go/No-Go task to conjunction with fMRI. Results 
indicated that the cannabis smoking group performed worse than controls, with a more 
significant number of errors recorded as well as a considerable deficit in awareness of 
commission errors. Results also indicated that cannabis users showed reduced behavioural 
monitoring capacity associated with hypoactivity DLPFC. The observed increase in the 
occurrence of hypoactivity was statistically significant when correlated with error-awareness 
rates.  These findings not only confirm the observations that cannabis consumption is 
associated with reduced IC functioning. But also that the results may highlight the difficulties 
in cognitive control and the monitoring of interoceptive awareness in chronic drug users as a 




As with IC, neuroimaging tools have been successfully implemented in studies investigating 
inductive reasoning (IR). Meintjes et al. (2019) were able to combine IR assessments with 
fMRI data. The authors compared HSD young adults (N = 15)  to controls (N = 18)  with 
regards to IR task performance using a number series task where the analysis required 
participants to recognise the pattern in a numerical sequence and select from options, the next 
number in the series. While results recorded no significant difference between the groups with 
regards to behavioural task performance, fMRI analysis indicated that the HSD group engaged 
in more effortful cognition to maintain baseline scores. Results explicitly demonstrated that the 
HSD group required the recruitment of additional cortical networks, specifically the left and 
right angular gyrus and posterior cingulate cortex and precuneus. During tasks that required 
more in-depth analyses such as the addition of number strings, the HSD group also displayed 
more diffuse and widespread activation of other networks, including the cerebellar vermis.   
  
IR research also used fMRI concerning the effects of cannabis consumption on this aspect of 
functioning. Moeller et al. (2010) reported that while cannabis users did not display any 
behavioural deficits with regards to IR using the Number Series Task, fMRI recordings showed 
significant differences in the HSD group comparative to drug naïve controls. Expressly, results 
indicated that the HSD group reported increase activation of cortical networks in the DLPFC 
compared with non-drug-using controls, during task performance. In another study, 
Campanella et al. (2013) reported results comparing the task performances of (N = 16) cannabis 
smokers and (N = 16) non-smoking controls on a 2-Back condition from a traditional N-Back 
paradigm. While the cannabis smokers performance did not significantly differ from the control 
group, the fMRI analysis indicated that cannabis smokers displayed an increase in PFC activity, 
with an increase in bilateral activation of the pre-supplementary motor area. Analysis of 
behavioural data reported a positive correlation between the estimates of joints consumed per 
episode and activation levels of the dorsomedial prefrontal cortex and increases in the 
cerebellum, thalamus, and insula. Thus the authors concluded that cannabis smoking could lead 
to compensatory actions within the brain that enable smokers to facilitate executive updating 





In contrast to the literature on IC and IR functioning, there appears to be a lack of studies using 
the N-Back paradigm with substance-using populations which have used fNIRS to provide 
measures of task-related rCBF changes. Concerning fMRI data, Pferbaum et al. (2001) 
examined the effects of HSD on executive updating with participants completing a 2-back 
Paradigm. Whilst the results of this study indicated that there appeared to be no significant 
difference between the two groups on relative task performance. Analysis of fMRI data 
suggested that the HSD reported greater activation of the PFC, specifically Brodmann’s area’s 
9, 10 and 45, regions implicated in the processing of executive updating. Therefore Crews et 
al. (2000) has suggested that consideration of cortical activation patterns is a requirement of 
HSD research. These findings offer more in-depth insight and clarity around any potential 
neurocognitive effects and the compensatory actions of cortical structures. Montgomery et al. 
(2012) conducted a meta-analysis on EF task performance in HSD populations. Results 
indicated that the trends within the academic literature are suggestive of no significant 
difference with regards to behavioural task performance in EU when assessed using the N-
Back paradigm, consistent with the findings of Pferbaum et al., (2001). Concerning cannabis 
use, Fisk and Montgomery (2008) failed to find a significant between-group difference with 
regards to EU performance on the N-Back test in cannabis-using participants. Given the 
potential contributions of both alcohol and cannabis to impaired cognitive functioning 
reviewed in chapters 1 to 4 of this thesis. It appears that there is a need for research into the 
respective HSD and cannabis consumption n EU functioning, which incorporates task-related 
changes in brain functioning alongside task performance data. 
 
Fisk and Montgomery (2016) propose that data on brain structure and functioning could 
provide insights concerning the inconsistent results reported for Access tasks, in addition to 
issues of test insensitivity. Again, the introduction of supplementary imaging technology could 
address this. Chanraud et al. (2009) reported that CWFT performance decreased in an HSD 
population (N = 31), compared to drug naïve control (N = 28). Analysis associated these scores 
with decreases in grey matter concentrations in the left and right dorsolateral frontal cortex 
(up to 20% lower). The study saw this reduction to a lesser extent in the temporal cortex, 
insula, thalamus, and cerebellum. Decreases in white matter volume were widespread, being 
up to 10% in the corpus callosum. Data analysis correlated reductions in CWFT with grey 
matter volume decreases in the frontal lobe, insula, hippocampus, thalami and cerebellum, 
and with white matter decrease in the brainstem. 
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Additionally, Churchwell et al. (2010) reported cannabis users (N = 18) displayed no 
behavioural deficits compared to drug naïve controls (N= 17) with regards to Access task 
performances through the use of CWFT. The fMRI analysis did demonstrate significant 
morphological differences between cannabis using and drug naïve controls. Specifically, 
cannabis smokers reported decreased volume in the Right PFC. 
 
A similar pattern of apparent test insensitivity to performance differences between substance 
users and nonusers was also reported by Zehra et al. (2019) for executive set-shifting (ESS) 
performance using the Wisconsin Card Sorting Task (WCST).  In this study, HSD participants 
(N=19) compared to drug naïve controls (N =23), with no differences reported for WCST 
performance. However, fMRI analysis indicted that the HSD group recorded higher activation 
patterns in neurological structures associated with ESS, specifically parietal and prefrontal 
cortices and the occipital cortex. Research has also applied imaging technology to the WCST 
performance of cannabis users. Imaging technology has also been used to significant effect 
elucidate the impact of HSD on visuospatial working memory (VSWM) task performance. For 
example, Squeglia et al. (2011) compared 40 HSD’s to 50 non-drinking controls. Their fMRI 
results indicated that HSD participants engaged in more effortful cognition to maintain VSWM 
task performance than the controls. Specifically result shown that the HSD group reported 
greater bilateral activation of frontal, anterior cingulate, temporal, and cerebellar cortices 
compared to controls. Studies also researched the use of fNIRS in ecstasy/cannabis polydrug 
use task performance. Montgomery and Fisk (2017) compared (N = 20) cannabis/ecstasy, 
polydrug users, too (N = 20) drug-naive controls with results indicating that there was no 
significant difference between the groups concerning VSWM updating performance. However, 
the polydrug users did show a significant between-group difference for VSWM task difficulty. 
Analysis of haemodynamic responses indicated that substantial increases in Oxy-Hb and 
Deoxy-Hb are suggestive of the Polydrug users engaging in more effortful cognition to meet 
task demands. 
 
The present study gathered data on regional cerebral blood flow (rCBF) using fNIRS from 
participants as they completed the tasks reported in Chapter 7 of this thesis. Results predicted 
that results would associate changes from baseline in rCBF during task performance with 





Chapter 5 details the research design in Design sub-section. The task performance-dependent 
variables (DV) are the changes from baseline in Oxy-Hb and Deoxy-Hb blood. 
 
Participants 
Chapter 5 details the participant recruitment, inclusion and exclusion criteria in the design sub-
section. 
 
fNIRS Data Collection Procedure 
Measures of the changes in rCBF accompanying task performance used a continuous-wave 
OxyMon fNIRS system developed by Artinis Medical Systems (Elst, The Netherlands). Table 
20 details the regions of interest (ROIs). Taking recordings from these ROIs involved the 
placement of optodes over areas of the left and right dorsolateral/medial prefrontal cortex. 
These corresponded to locations F3. F4. F7 and F8 of the 10-20 system). The researcher fitted 
the optodes within a standard EEG cap to allow the precise locations for recording. Table 20 
also shows the corresponding Brodmann areas for these ROIs. 
 
Details of the recruitment, screening, and the group allocation process are in the Procedure sub-
section of chapter 5. The researcher debriefed the participants about data collection using 
fNIRS, including the placing of the optodes on their head. The researcher then fitted an EEG 
cap containing the optodes appropriately on their heads, and the baseline readings are taken 
whilst watching the nature video. The administration of cognitive tasks then followed this. 
Upon completion of the tests of cognitive function, the researcher then removed the  EEG cap, 





1 Prefrontal cortex (PFC): dorsolateral prefrontal cortex (DLPFC) 
 
Analytic Strategy 
The rCBF data were analysed for each task in two halves, corresponding to data from the left 
and right hemispheres, respectively. In addition to limiting the number of DVs in each 
multivariate analysis, this distinction also took into account differences in functioning between 
the two cerebral hemispheres. Data on the changes from baseline for Oxy-Hb and Deoxy-Hb 
were examined for deviations from a normal distribution concerning z-scores for skewness and 
kurtosis, as described by Tabachnick and Fidell (2014). Consequently, decisions regarding the 
use of either parametric MANOVA, MANCOVA or a nonparametric Kruskal-Wallis analysis 
for inter-group comparisons for Oxy Hb and De-oxy Hb for each ROI, were made in the light 
of the distribution of the data. Following the guidance of Tabachnick and Fidell, data analysis 
also used multivariate linear regression (MLR) to examine the relationship of covariates to the 
rCBF in cases where scores did not meet the assumptions of MANCOVA.  Data analysis 
evaluated univariate results against adjusted alpha levels calculated using EQ1 reported in 
Chapter 6, taken from Tabachnick and Fidell (2014 P312).  
 
The study conducted pairwise post hoc analyses where results showed a significant main effect 
across participant groups. These comparisons were two-tailed against a Bonferroni adjusted 
alpha level, calculated using the univariate alpha level as the numerator in this calculation, and 
three as the denominator, representing the three participant groups. In the case of variables 
differing significantly from a normal distribution, analysis employed the Mann-Whitney U test 
Table 20: Optode placement used in the 10-20 system and corresponding Brodmann areas 
procedure 
ROI1 10-20 system position Brodmann area 
Right inferior PFC AF8 10 
Right superior PFC AF4 9 
Right inferior DLPFC F6 46 
Right superior DLPFC F4 8 
Left inferior PFC AF7 10 
Left superior PFC AF3 9 
Left inferior DLPFC F5 46 
Left superior DLPFC F3 8 
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for the post hoc intergroup comparisons. As the study recorded levels of Oxy-HB and Deoxy-
Hb deviations from baseline, a verification procedure was used by which a version of these 
variables added a constant to render all values as positive. Although the analysis did not use 
these transformed variables in the final analysis, they did serve to confirm the interpretation of 
the data reported below.  
 
Results 
fNIRS response to the Go/No-Go Task 
The nature of the fNIRSs resulted in the study producing the same 8 DV’s for analysis of both 
left and right hemispheres across all of the EF and WM measures. Specifically, the 8 DVs were: 
Oxy inferior PFC, Deoxy inferior PFC, Oxy superior PFC, Deoxy superior PFC, Oxy inferior 
DLPFC, Deoxy inferior DLPFC, Oxy superior DLPFC, and Deoxy superior DLPFC. 
 
Right hemisphere. Preliminary analysis of skewness and kurtosis scores for the Go/No-Go task 
identified that Oxy-Hb inferior PFC, Oxy-Hb superior PFC, Deoxy-Hb superior PFC, and Oxy-
Hb superior DLPFC, were all normally distributed. The Z-Score analysis identified scores 
which violated z-Score limits of z =  ± 3.29, for Deoxy-Hb inferior PFC, Oxy-Hb inferior 
DLPFC, Deoxy-Hb inferior DLPFC, and Deoxy-Hb superior DLPFC. The removal of one 
participant rendered all variables normally distributed save for Oxy-Hb inferior DLPFC. The 
analysis omitted scores for Deoxy-Hb inferior PFC from MANOVA because of a high positive 
correlation with Oxy-Hb inferior PFC. Multivariate and univariate analysis did not find a 
significant effect between groups (Pillai’s Trace F < 1). None of the nonparametric 
comparisons was substantial either. Table 21 shows the rCBF results for the right hemisphere 




























































































































































H [2, N = 70] = 
3.686 P = .186 
 
 








H [2, N = 70] 




H [2, N = 70] = 
.047 P = . 
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Left hemisphere. Analysis of Oxy-Hb and Deoxy Hb changes in the left hemisphere identified 
the normal distribution of scores Oxy-Hb inferior PFC, Oxy-Hb inferior DLPFC, and Oxy-Hb 
superior DLPFC. The z-score analyses identified outliers for  Deoxy-Hb inferior PFC, Oxy-Hb 
superior DLPFC, Deoxy-Hb superior DLPFC, and Deoxy-Hb superior PFC. Removal of these 
scores failed to normalise the results as did subsequent transformation procedures. Multivariate 
analysis was unable to find a statistically significant intergroup with Pillai’s Trace (F < 1). 
 
Furthermore, there were no significant univariate effects or intergroup comparisons. Nor did 
any of the nonparametric tests identify a substantial impact for any region of interest. Table 22 





































































































































































H [2, N = 70] = 




H [2, N = 70] = 
.633 P = .793 
 
 
H [2, N = 70] = 
.117 P = ..943 
 
 
H [2, N = 70] = 
1.142 P = .565 
 
 























































H [2, N = 70] = 














fNIRS  response to the Number Series Task 
Right hemisphere. The z-score analyses for the right hemisphere identified 3 DVs “normally” 
distributed before the removal of outliers; Oxy-Hb inferior PFC, Oxy-Hb superior PFC, and 
Oxy-Hb superior DLPFC. Scores identified outliers in the dataset for Oxy-Hb inferior DLPFC, 
Deoxy-Hb inferior DLPFC, and Deoxy-Hb superior DLPFC. Results identify no outliers for 
Deoxy-Hb inferior PFC nor Deoxy-Hb superior PFC. Removal of outlier scores was able to 
normalise scores for Oxy-Hb inferior DLPFC, Deoxy-Hb inferior DLPFC and Deoxy-Hb 
superior DLPFC. As discussed previously, the potential for transformations in this data set is 
limited to the use of inverse transformations owing to the mixture of positive and negative raw 
data scores. Inverse transformations did not render the two remaining regions of interest 
normally distributed.  Nonparametric Kruskal Wallis tests on the two areas of interest not 
“normally” distributed did not show significant effects. 
 
Initial correlations showed three high correlations for Oxy-Hb inferior DLPFC, with one of 
these being more than r ± .60 and was consequently, removed from the list of MANOVA DVs. 
There were, therefore, five DVs in the MANOVA solution. The MANOVA showed no 
significant inter-group effects (Pillai’s Trace F (< 1). There no univariate results or post hoc 
comparisons between groups. The analysis attempted a second MANOVA with Deoxy superior 
DLPFC removed due to some high inter-correlations, although these had all been r < ± .60. 
The MANOVA result remained nonsignificant (Pillai’s Trace F < 1). All univariate and post 
hoc results also remained nonsignificant. Table 23 shows the rCBF results for the right 





















































































































































H [2, N = 70] = 
4.516 P = .105 
 
 




H [2, N = 70] = 
3.965,  P = .138 
 
 











































































Left hemisphere. The only region of interest for the left hemisphere “normally” distributed 
before the removal of outliers was the Oxy-Hb inferior PFC. The study identified and removed 
outliers for Oxy-Hb superior DLPFC and Oxy-Hb superior PFC. The analysis also removed 
outliers for Deoxy-Hb superior PFC. After the removal of outliers, only Oxy-Hb inferior PFC 
and Oxy-Hb inferior DLPFC had normal distributions. After inverse transformations, only Oxy 
superior PFC became “normally” distributed. The Kruskal Wallis test on the ROIs excluded 
from the MANOVA showed no significant inter-group effects. Subsequent correlations 
showed that Oxy-Hb sup PFC had to be removed from the model due to a score above r ± .60. 
The MANOVA was not significant with Pillai’s Trace F < 1. Neither of the univariate results 
was substantial, as were none of the post hoc comparisons. Table 24 shows the rCBF results 
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H [2, N = 70] = 
2.492,  P = .288 
 
 




H [2, N = 70] = 
.489,  P = .783 
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fNIRS analysis for the N-Back 
Before presenting results from the N-Back, the researcher made an “a-priori” decision to 
combine the different levels of the task into one analysis due to recording anomalies which 
became apparent in the study of the data. 
 
Right hemisphere. With regards to the analysis of the right hemisphere, the Z-score analyses 
identified outliers on all of the DV’s for one participant, which may have been due to a technical 
fault in recording the data. Subsequent removal of these scores rendered Oxy-Hb inferior PFC, 
Oxy-Hb superior PFC, Oxy-Hb inferior DLPFC, Oxy-Hb superior DLPFC, and Deoxy-Hb 
superior DLPFC normally distributed. Inverse transformations for the three remaining 
variables failed to normalise them. Nonparametric analyses revealed that none of these analyses 
was significant intergroup differences. Due to a high correlation, results removed Oxy-Hb 
superior DLPFC from the MANOVA model. A separate univariate ANOVA did not show a 
significant intergroup effect for this variable. The MANOVA did not show a significant inter-
group impact (Pillai’s Trace F (8, 128) = 1.376, ns.) and none of the univariate analyses showed 
























































































































































H [2, N = 70] = 
.4.083,  P = .091 
 
 




H [2, N = 70] = 









H [2, N = 70] = 
.983,  P = .983 
 
 




































































Left hemisphere. Analysis of the data from the left hemisphere revealed normal score 
distribution for Oxy-Hb inferior PFC, Oxy-Hb inferior DLPFC, and Deoxy-Hb inferior 
DLPFC. The Z-score's indicated outliers for Deoxy-Hb inferior DLPFC, Deoxy-Hb superior 
DLPFC, Oxy-Hb superior PFC, Deoxy-Hb superior PFC, and Oxy-Hb inferior DLPFC. Inverse 
transformations were able to normalise the following variables; Deoxy-Hb superior PFC, Oxy-
Hb superior DLPFC, and Deoxy-Hb superior DLPFC. The analysis used a nonparametric 
alternative for the two variables not “normally” distributed, with neither variable showing a 
significant inter-group difference. 
 
Correlational analysis before the MANOVA indicated that the correlation between Deoxy-Hb 
inferior DLPFC and Oxy-Hb inferior DLPFC was very high, but just below the threshold of r 
>.70 (r (67) = .693 P < .000, two-tailed). The MANOVA solution was therefore tested firstly 
with both of these variables, and then with one of them removed. Results for the six-variable 
MANOVA solution approached significance (Pillai’s Trace F (12, 120) = 1.720, P = .071, ƞp
2 
= .147).  With regards to the five variable MANOVA, this was conducted following the 
removal of the variable Oxy-Hb inferior DLPFC, as this variable tended to have higher 
correlations with the other variables than Deoxy-Hb Inferior DLPFC. The result of the five 
variable  MANOVA solution was now significant (Pillai’s Trace F (10, 122) = 1.996 P = .039, 
ƞp
2 = .141). Although none of the univariate analyses was significant against the revised alpha 
level of P < .01, the Deoxy-Hb Superior PFC came the closest (F (2, 64) = 3.206, P = .047, ƞp
2 
= .091), followed by Oxy-Hb superior DLPFC (F (2, 64) = 2.795, P = .069, ƞp
2 = .080).  The 
family-wise alpha level for the univariate analyses was P < .049. Adjustment of the alpha level 
calculated using EQ1 in Chapter 6 of this thesis, taken from Tabacjnick and Fidell (2014 
P.312). 
 
None of the inter-group comparisons was significant when evaluated against their revised alpha 
level of P<.003. The comparison between the HSD and the HSDCC groups for Deoxy-Hb 
superior PFC came the closest (P = .014, two-tailed), followed by the comparison between 
controls and the HSD group for Oxy-Hb superior DLPFC (P = .021, two-tailed). These are also 
the two variables which had shown the closest results to univariate significance. For the Deoxy-
Hb superior PFC, the HSD group showed the most massive increase above baseline, and the 
HSDCC group the smallest increase. The controls were in the middle and did not significantly 
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differ from either group. For Oxy-Hb superior DLPFC, the control group showed a slight drop 
from baseline whilst the HSD group showed the most significant increase. The HSDCC group 
showed a small addition which did not significantly differ from the other groups. While these 
results are noteworthy, it is essential to reiterate that none of the univariate results or inter-
group comparisons was significant. Table 26 shows the rCBF results for the left hemisphere 























































































































































H [2, N = 70] = 




H [2, N = 70] = 
5.601,  P = .061 
 
 


































































F (2, 64) = 2.795, 


















Given that the five variable MANOVA result had been significant, data analysis conducted a 
stepdown analysis to examine its validity. The results revealed that with Deoxy-Hb superior 
PFC as the dependent variable, Oxy-Hb superior DLPFC significantly interacted with the 
independent variable of the group (F (2, 19) = 3.934, P = .037, ƞp
2 = .293). The analysis 
subsequently dropped Oxy Superior DLPFC from the model as this was the only other variable 
to approach a significant univariate result for intergroup differences. Rather than re-run the 
MANOVA with four DVs, the researchers decided to adopt a different approach. The approach 
would include three of the covariates identified in Chapter 5 as IVs: alcohol consumption in 
prior six months, No. of hours since last alcohol consumed, and alcohol onset age. As the DVs 
in these analyses, Deoxy-Hb superior PFC and Oxy-Hb superior DLPFC (both transformed 
variables) had a relatively small correlation. However, it was significant (r (67) = .270, P = 
.027, two-tailed). A revised alpha level set at P < .025 for each of two multiple linear regression 
(MLR) analyses which used them, respectively, as DVs. Neither of the MLRs was significant 
with F < 1 for Deoxy-Hb as the DV, and F (3,63) = 1,278, ns. for Oxy-Hb superior DLPFC as 
the DV. Curvilinearity in the unstandardised residuals was apparent in a scatterplot for the latter 
analysis so that the analysis performed the natural log transformations of the IVs. The resulting 
regression model remained nonsignificant (F < 1). Finally, estimated cannabis use in the past 
six months, which had not been included as an IV in the MLRs due to not being normally 
distributed, was not correlated with Oxy-Hb superior DLPFC (rs (70) = .042, ns.). Still, a trend 
was apparent for Deoxy-Hb superior PFC (rs (70) = -.217, P = .071, two-tailed).  
 
fNIRS analysis for the COWAT 
Right hemisphere. With regards to distribution scores for Oxy-Hb and Deoxy-Hb changes for 
the right hemisphere, results indicated normally distributed the scores for Oxy-Hb inferior PFC, 
Oxy-Hb superior PFC, Oxy-Hb inferior DLPFC and Oxy-Hb superior DLPFC. Subsequent z-
score analyses showed that there were no outliers for Deoxy-Hb inferior and Deoxy-Hb 
superior PFC. However, the results identified z-scores greater than ± 3.29 for Deoxy-Hb 
inferior DLPFC and Deoxy-Hb superior DLPFC. Subsequent removal of outliers did not render 
any of the four Deoxy-Hb variables “normally” distributed. Besides data removal, inverse 
transformations made no difference to the distribution of these four variables, with or without 
the outliers. Subsequently, these variables were deemed unsuitable for inclusion in the 
MANOVA. Nonparametric Kruskal Wallis tests showed no significant effects on these four 
Deoxy-Hb variables. Correlations indicated that levels Oxy-Hb superior DLPFC had two high 
159 
 
positive correlations which were not more than r = .70. The subsequent MANOVA solution 
was nonsignificant with Pillai’s Trace F < 1. Data analysis performed a further MANOVA with 
Oxy-Hb superior DLPFC omitted from the DVs, but, Pillai’s Trace was once again 
nonsignificant F < 1. All univariate analyses were also nonsignificant. Table 27 shows the right 



















































































































































F (2, 67) = .328, 
P = .721, ƞp2 = 
.010 
 
H [2, N = 70] = 
3.614,  P = .164 
 
 
F (2, 67) = .747, 
P = .478, ƞp2 = 
.022 
 
H [2, N = 70] = 
.749,  P = .688 
 
 
F (2, 67) = 1.234, 
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F (2, 67) = .397, P 
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Left hemisphere. Scores for Oxy-Hb and Deoxy-Hb changes within the left hemisphere found 
that results for Oxy-Hb inferior PFC, Deoxy-Hb inferior PFC, Oxy-Hb superior PFC and Oxy-
Hb inferior DLPFC were all normally distributed. However, the z-score analysis found scores 
of greater than ±3.29 for Oxy-Hb inferior DLPFC, Oxy-Hb superior DLPFC, Deoxy-Hb 
superior DLPFC, and Deoxy-Hb inferior PFC. Deoxy-Hb inferior DLPFC had no outliers. 
Inverse transformations did not make normal any of the four variables above. Subsequent 
nonparametric analyses showed that none of these regions of interest had significant intergroup 
effects. Correlation analysis also indicated that there was no correlation over r = ± .60. The 
subsequent MANOVA solution was nonsignificant, with Pillai’s Trace F (8, 118) = 1.271, ns. 
The univariate result for Oxy inferior PFC did however approach significance, with F (2, 61) 
= 3.616, P = .033, ƞp
2 = .106. The revised alpha level here for each univariate result was P < 
.01, calculated using EQ1 shown in Chapter 7 of this thesis (Tabachnick & Fidell, 2014 P.312). 




















































































































































F (2, 67) = 3.616, 
P = .033, ƞp2 = 
.106 
 
F (2, 67) = 1.182, 
P = .314, ƞp2 = 
.037 
 
F (2, 67) = 1.544, 
P = .222, ƞp2 = 
.048 
 
F (2, 67) = 1.220, 
P = .302, ƞp2 = 
.038 
 
H [2, N = 70] = 
.066,  P = .967 
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With regards to the intergroup comparisons, the revised alpha level for these was P < .003, 
none of the comparisons was significant. However, the comparison between the control group 
and HSD with cannabis for Oxy-Hb inferior PFC approached significance (P = .010, two-
tailed). The means for this fNIRS measure for this ROI in Table 29. 
 
Table 29: Descriptive statistics for Oxy-Hb Change Left Inferior PFC during the VWM task  
 N Mean SD 
Control 2.1739 26 5.26487 
HSD .4610 19 7.20726 
HSDCC -3.0253 19 7.07569 
 
Results indicated that the controls showed an increase in Oxy-Hb change relative to baseline, 
whilst the HSDCC group showed a decrease. To investigate this further multiple linear 
regression analysis was conducted with the Oxy-Hb left inferior PFC. The study entered scores 
as the DV, and the following consumption variables as independent variables; Alcohol 
consumption in the prior six months, number of hours since last alcohol consumed and Alcohol 
onset age. The alcohol-related variables were entered hierarchically, based on their correlation 
with the DV, in Table 30. 
Table 30: Sequence of IV inclusion for the Regression Model 
Model IV 
  
1  Hours since last alcoholic drink 
 
2 Hours since last alcoholic drink: Alcohol consumed 
the previous six months (units) 
 
3 Hours since last alcoholic drink: Alcohol consumed 
the previous six months (units): Age of first alcohol 
use in years 
 
Results for the MLR are in tables 31 and 32 and show that Oxy-Hb changes from baseline in 
the left inferior PFC with the group variables entered in all of the models 1-3 were 
nonsignificant. The residuals showed no evidence of heteroscedasticity or curvilinearity and 
normally distributed. Spearman correlation showed a significant negative correlation between 
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lifetime cannabis use and the Oxy-Hb left inferior PFC change from baseline scores (rs (64) = 
-305, P = .014, two-tailed). Data analysis repeated this correlation after adding a constant to 
the Oxy left inferior PFC change scores to remove the negative values, to clarify our 
interpretation of this result. This correlation result was the same as the original without the use 
of the constant. Therefore, higher estimated use of cannabis was correlated with lower levels 
of Oxy-Hb in the left inferior PFC during the performance of the verbal working memory task 
(the COWAT). Results did not relate alcohol consumption variables to Oxy-Hb changes in this 
ROI. 
 
Regarding task performance data, there were no cannabis-related effects on this task. However, 
the estimated amount of cannabis use in the previous six months is the only variable for which 
a full data set exists because, for non-users, entered a score of 0. Inevitably, this makes the 
variable highly skewed. 
 
Table 31: Summary of regression analysis for Oxy-Hb change in the Left inferior PFC and predictors. 
Model R2 R2 change F change df1 df2 Sig F change 
1 .008 .008 .518 1 62 .474 
2 .016 .008 .483 1 61 .490 
3 .021 .005 .297 1 60 .587 
 
 
Table 32: ANOVA for Oxy-Hb change in the Left Inferior PFC and Predictors 
Model Component of variance df MS F Sig. 
1 Regression 1 23.461 .518 .474b 
Residual 62 45.251   
Total 63    
2 Regression 2 22.752 .499 .610c 
Residual 61 45.631   
Total 63    
3 Regression 3 19.745 .428 .734d 
Residual 60 46.163   
Total 63    
 
 
fNIRS response to the computerised grid task 
Right hemisphere. Analysis of skewness and kurtosis values for the right hemisphere identified 
the Oxy-Hb inferior DLPFC and Oxy-Hb superior DLPFC as being normally distributed. 
Removal of violations to z-score limits was necessary for both Oxy-Hb inferior PFC, Oxy-Hb 
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Superior PFC, and Deoxy-Hb superior DLPFC, and succeeded in rendering these measures 
distribution “normal”.  Concerning transformation procedures, only inverse transformations 
are permissible with fNIRS data due to the negative values. Inverse transformation of Deoxy-
Hb inferior PFC, Deoxy-Hb superior PFC and Deoxy-Hb inferior DLPFC failed to normalise 
the distribution of these variables.  
 
Before the MANOVA solution, results omitted Oxy-Hb superior DLPFC due to high 
correlations. A separate univariate ANOVA on this DV showed no intergroup effect (F < 1). 
Multivariate analysis also failed to find a significant between groups impact using the four 
DV’s retained in the MANOVA model (Pillai’s Trace F < 1). Nonparametric equivalents for 
the remaining dependent variables also showed no significant intergroup effect. Table 33 shows 






Table 33: fNIRS Right Hemisphere Oxy and Deoxy-Hb changes from baseline for the 
Computerised Grid Task 
Variable Controls 
(CO) 







































































































































F (2, 67) = .255, P 
= .775, ƞp2 = .008 
 
 
H [2, N = 70] = 
3.405,  P = .182 
 
 
F (2, 67) = .107, P 
= .898, ƞp2 = .003 
 
 
H [2, N = 70] = 
2.860,  P = .239 
 
 
F (2, 67) = .919, P 




H [2, N = 70] = 




F (2, 67) = .682, P 






















































F (2, 67) = .829, P 













Left hemisphere. Analysis of skewness and kurtosis scores for Oxy-Hb and Deoxy-Hb for the 
left hemisphere indicated that the raw scores for  Oxy-Hb inferior PFC, Deoxy-Hb superior 
PFC and Oxy-Hb inferior DLPFC were all normally distributed. Removal of outliers for 
Deoxy-Hb inferior DLPFC, Deoxy-Hb inferior PFC, Oxy-Hb superior DLPFC, and Deoxy-Hb 
Superior DLPFC failed to normalise these scores. There were no outliers for Oxy-Hb superior 
PFC. None of the inverse transformations rendered any of the variables “normally” distributed. 
MANOVA for the raw scores of the three “normally” distributed variables was nonsignificant 
for an intergroup effect with Pillai’s Trace F < 1. None of the univariate results or intergroup 
comparisons was significant. Nor were the scores for the Kruskal Wallis analyses of the 




Table 34: fNIRS Left Hemisphere Oxy and Deoxy-Hb changes from baseline for the 
Computerised Grid Task 
Variable Controls 
(CO) 











































































































































F (2, 67) = 1.101, 
P = .339, ƞp2 = 
.035 
 
H [2, N = 70] 
=1.559,  P = .459 
 
 
H [2, N = 70] = 
3.267,  P = .195 
 
 
H [2, N = 70] = 
1.014,  P = .602 
 
 
H [2, N = 70] = 
3.672,  P = .159 
 
 
F (2, 67) = .919, P 
= .291, ƞp2 = .040 
 
 
H [2, N = 70] = 















































F (2, 67) = 1.295, 












fNIRS response to the Wisconsin card sorting task 
Right hemisphere. Preliminary analyses indicated the normal distribution of scores for Oxy-Hb 
inferior PFC, Oxy-Hb superior PFC, and Oxy-Hb inferior DLPFC without the removal of 
outliers. Subsequent z-score analysis for the remaining regions failed to find outliers for Deoxy-
Hb inferior PFC, Deoxy-Hb inferior DLPFC and Deoxy-Hb superior PFC. However, the 
research identified outliers for Oxy superior DLPFC and  Deoxy superior DLPFC. Removal of 
the outliers normalised scores for Oxy-Hb superior DLPFC and Deoxy-Hb superior DLPFC. 
Finally, following inverse transformations, scores for Deoxy-Hb inferior DLPFC were 
rendered normally distributed. Neither of the two remaining variables showed significant group 
effects when subjected to a nonparametric Kruskal-Wallis analysis. 
 
With regards to the multivariate analysis for the remaining variables, the correlational study 
indicated that Oxy-Hb superior DLPFC was positively correlated and subsequently removed 
from the analysis. Of the five remaining variables included in the initial MANOVA solution 
results showed that there was no significant inter-group effect with Pillai’s Trace F < 1, and no 
significant univariate effects. Following the initial MANOVA, the correlational analysis 
indicated that Oxy-Hb inferior DLPFC had three positive correlations over r = .50, which 
although within limits set by Tabachnick and Fidell (2014), were nevertheless high. This 
variable was, consequently, removed for a second analysis. Once again, there was no 
significant inter-group effect (Pillai’s Trace F  <1), and no significant univariate results. Results 
also indicated that the DV’s Oxy-Hb superior DLPFC and Oxy-Hb inferior DLPFC were highly 
correlated. As Oxy-Hb inferior DLPFC showed a higher inter-group difference, data analysis 
conducted a univariate ANOVA on this DV. However, there was no significant inter-group 
























































































































































F (2, 67) = .186, P 
= .831, ƞp2 = .006 
 
 
H [2, N = 70] = 
2.274,  P = .321 
 
 
F (2, 67) = 1.549, 
P = .221, ƞp2 = 
.048 
 
H [2, N = 70] = 
2.233,  P = .327 
 
 
F (2, 67) = .662, P 







F (2, 67) = .721, P 


















































F (2, 67) = 721, P 












Left hemisphere. Results found normal distributions of scores without the removal of outliers 
for Oxy-Hb inferior PFC and Deoxy-Hb inferior DLPFC. Preliminary z-score analysis 
indicated that there were no outliers for Oxy-Hb inferior DLPFC and Deoxy-Hb inferior 
DLPFC. Additionally, scores did not “normally” distribute Oxy-Hb inferior PFC, Deoxy-Hb 
inferior PFC, Oxy-Hb superior DLPFC, Deoxy-Hb superior DLPFC, Oxy-Hb superior PFC 
and Deoxy-Hb superior PFC. Subsequent inverse transformations rendered Deoxy-Hb Superior 
DLPFC scores “normal”. Kruskal Wallis nonparametric analyses were conducted on the five 
variables, not having a normal distribution, and showed that none of these variables showed a 
significant inter-group effect. For the MANOVA solution, the preliminary correlational 
analysis revealed no high correlations between the three variables selected. There was no 
significant multivariate inter-group effect (Pillai’s Trace < 1) and no significant univariate 


















































































































































F (2, 67) = 1.217, 
P = .303, ƞp2 = 
.035 
 
H [2, N = 70] = 
2.102,  P = .350 
 
 
H [2, N = 70] = 
1.229,  P = .541 
 
 
H [2, N = 70] = 
.711,  P = .701 
 
 
H [2, N = 70] = 
1.635,  P = .442 
 
 
F (2, 67) = .661, P 
= .520, ƞp2 = .019 
 
 
H [2, N = 70] = 















































F (2, 67) = .537, P 











This chapter aimed to investigate differences in rCBF changes from baseline as they pertain to 
cognitive task performance. Results found a significant multivariate effect between groups in 
the left hemisphere during the performance of the N-Back task (Gazzaniga et al., 2009). Still, 
there were no univariate effects or significant post hoc comparisons. A trend was noted in the 
superior PFC for the HSD group to have a more substantial increase in Deoxy-Hb than the 
HSDCC group during task performance. Similarly, for HSD participants to show the rise in 
Oxy-Hb in the superior DLPFC compared to a decrease from the baseline established by the 
controls, both of these trends could be consistent with more effortful cognition required by the 
HSD group than the other group in these respective comparisons (Roberts & Montgomery, 
2015). These results will not be explored further concerning a potential relationship to 
substance consumption because of their lack of statistical significance. However, it is worth 
noting that as a language-based task using letters, it may not be surprising that the left 
hemisphere showed trends towards rCBF effects related to alcohol use, rather than the right 
hemisphere. There is evidence that computerised WM and EF tasks tend to elicit greater 
activation of structures in the left hemisphere compared to physical or paper tests (Fraser et 
al.,2020). This higher level of evoked activity could have contributed to the absence of inter-
group effects in rCBF in the right hemisphere in the present study.    
 
No significant between-group effects, either multivariate or univariate, were found for Go/No-
Go task measuring inhibitory control (IC). The visuospatial working memory task (VSWM), 
or the Wisconsin Card Sorting Task (WCST) measuring executive set-shifting (ESS). 
Consequently, there was no evidence of more effortful cognition as a result of alcohol and 
cannabis consumption in these areas which draw upon the executive functions (EF) of working 
memory (WM: Baddeley, 2000b; Miyake et al., 2000, 2001). Similarly, the IR task used in this 
study also failed to show any significant inter-group effects concerning rCBF during task 
performance.  
 
Although the Controlled Oral Word Association Task (COWAT: Stuss, 1998) of access to 
semantic long-term memory (Access) also failed to show any significant inter-group effects, 
there was a trend whereby the controls showed an increase in Oxy-Hb in the left inferior PFC 
during task performance, compared to a decrease shown by the HSDCC group. Lifetime 
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cannabis use estimates showed a significant negative correlation with Oxy-Hb changes in this 
ROI, while alcohol consumption showed no relationship to changes in this measure of rCBF. 
Lower levels of Oxy-Hb, therefore occurred with higher cannabis consumption and showing 
less effortful cognition in the performance of this task related to higher levels of cannabis use. 
Although the present data showed no effects in the DLPFC, decreased DLPFC activation on 
this task has previously related this to cannabis consumption (Aloi et al., 2018).  It is important 
to note that there were also no inter-group effects in the present study on the performance 
measures for this task and that cannabis use has related to impaired Access functioning 
(Murphy et al., 2011). However, results could take the present to indicate that the HSDCC 
group maintained an adequate performance level with less effort. It is essential to note the 
robustness of EF and WM to compromised functioning arising from substance use (Briere et 
al., 2019), and the lack of sensitivity of tests of EF and WM to both subtle changes in 
performance ability and their ability to elicit rCBF changes in the neural substrates 
underpinning performance (Calabria et al., 2019). The diverse nature of these results reflects 
the indeterminate nature of results reported in the broader academic literature. (Morgan et al., 
2016; Vandrey et al., 2013). 
 
Concerning cannabis use, previous research has demonstrated that both THC and CBD may 
serve as neuroprotective agents against the effects of HSD (Toriño et al., 2010; Rubio et al., 
2011). To date, there does not appear to have been any study of potential neuroprotective 
effects of cannabis use in the context of human alcohol consumption, and it is essential to 
emphasise that the present study did not test such a hypothesis. Nevertheless, the possibility of 
such an effect being present in the data obtained from the participant groups in the present 
study is one which should be acknowledged.  The possible existence of such a neuroprotective 
effect could have contributed to the general lack of differences between the HSDCC group and 
the other two groups concerning both task performance and rCBF changes. This observation is 
particularly worth considering with the present sample as the HSDCC group had consumed 
more alcohol in the previous six months than the HSD group (see Chapter 5). It is also possible 
that the general lack of inter-group effects in rCBF could be a consequence of behavioural task 
overload, as reported by Robert and Montgomery (2015). This pattern is similar to the findings 
in brain imaging research of instances of cognitive overload where participants display a 
reduction in cortical activity as a result (Yun et al., 2010). This observation implies that testing 
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procedures in studies such as the present one need to spread out cognitive testing over a more 
extended period, despite the standard practice of rest breaks between tests. 
 
The possible insensitivity of the tasks used to subtle changes in EF and WM and the protective 
effects of cannabinoids means the lack of significant inter-group effects could reflect the 
limitations of the use of fNIRS concerning brain activity related to EF and WM tasks. It is 
important to note that WM and EF tasks are not solely dependent upon PFC and  DLPFC areas, 
but rather is a diffuse network of cortical and subcortical structures (Linden, 2007). The 
thalamus, for example, has been implicated in the processing of IC, IR EU and VSWM, with 
fMRI scans showing that the thalamus becomes hyper-stimulated in response to associated 
neurocognitive tests (Kulich et al., 2019). Furthermore, Troster (2019) reported that deep brain 
stimulation (DBS), where an electrical current applied to subcortical regions, including the 
thalamus, resulted in improved performance IC, IR, EU and VSWM. Therefore, before further 
conclusions about the relationship between brain activation in EF and WM tasks and the 
consumption of alcohol and cannabis can be made, more extensive studies of brain functioning 
are necessary for this field. 
 
Finally, it is pertinent to consider the thesis inability to report upon the use of nicotine in this 
analysis. Indeed research has shown that nicotine consumption has an effect on rCBF in the 
DLPFC.  Yuan et al. (2018) reported that cigarette smoking resulted in reduced hippocampal 
cell regeneration by 15% and reduced cortical activation of the DLPFC whilst engaged in WM 
tasks. The lack of data on cigarette consumption as a covariate of HSD and cannabis 
consumption posed a limitation to the analyses possible with the results presented in this 
chapter.  
 
In conclusion, the only significant findings this chapter can report concern a relationship 
between cannabis use and lower Oxy-Hb levels in the left inferior PFC during a task concerning 
access to semantic long-term memory. Nonsignificant trends for the left superior PFC and left 
superior DLPFC, which indicated the presence of more effortful cognition related to alcohol 
use in performing an EU task suggest the need for further investigation. Results may relate to 
the general lack of significant effects reported in this chapter to the limitations of current tests 
182 
 
of EF and WM functioning. The possible protective effect of cannabinoids and the limits of 




























Summary of main findings. 
 
This thesis aimed to investigate differences in executive functioning (EF) and working memory 
(WM) task performance between the CO, HSD and HSDCC groups, together with concurrent 
task-related changes in rCBF measures. Whilst the literature around alcohol misuse has 
traditionally focused upon the cognitive effects of chronic alcohol addiction, research on the 
impact of HSD (binge drinking) is underdeveloped by comparison. Anstey et al. (2009), for 
example, was only able to find 15 publications suitable for inclusion in a meta-analysis on HSD 
induced deficits to WM. Research indicates that some binge drinkers use cannabis, and some 
do not (McKetin et al., 2014). Therefore, whilst the literature on HSD has grown since 
Montgomery et al. (2012), there are many matters unaddressed, and the issue of associated 
cannabis use is one of them. This lack of research serves as the foundation for the new 
contributions to knowledge which this thesis is making. 
 
From the evidence presented in the literature reviews in chapters one and two, there is a 
significant degree of overlap in the psychobiological consequences of both HSD and cannabis 
consumption (Campanella et al ., 2013; Chanraud et al., 2009; Murphy, 2018). Their effects, 
with regards to neurotransmission and LTP, have been shown to impair WM, EF, and attendant 
behavioural impairments. These observations provide a basis for understanding the possible 
consequences of HSD cannabis smoking polydrug use. The meta-analytic studies conducted in 
chapters three and four found a marginally non-significant performance decrement for HSD 
cannabis-using participants in visuospatial functioning. But a more extensive and statistically 
significant decrement in studies of verbal memory. 
Tables 37 and 38 summarise the significant intergroup differences and intergroup correlations 






Table 37: summary of significant intergroup differences from Chapter 5 to Chapter 8. 
Variable Intergroup comparison results Relevant 
chapter 
Gender The predominance of males in 
the sample 
5 
Depression HSDCC > HSD 
HSDCC > CO 
5 
Premorbid IQ HSDCC > HSD 
HSDCC > CO 
5 
Raven’s Matrices IQ HSDCC > HSD 5 
Barratt Impulsivity: Attention Subscale HSDCC > CO 5 
Barratt Impulsivity: Motor Subscale HSDCC > CO 5 
Barratt Impulsivity: Self-control HSDCC > CO 5 
Barratt Impulsivity: Cognitive Complexity HSD > CO 5 
Barratt Impulsivity: Perseverance HSD > CO 
HSDCC > CO 
5 
Barratt Impulsivity: Cognitive Instability HSDCC > CO 5 
Alcohol use frequency in the past three months HSD > CO 
HSDCC > CO 
5 
Age of first use of alcohol (years) CO > HSD 
HSD > HSDCC 
5 
Hours since last alcoholic drink HSD > CO 
HSDCC > CO 
5 
Days since last alcoholic drink HSD > CO 
HSDCC > CO 
5 
Times drinking per week HSD > CO 
HSDCC > CO 
5 
Times drinking per month HSD > CO 
HSDCC > CO 
5 
Times drinking per year 
 
HSD > CO 




Alcohol consumed the last six months (units) 
 
 
Go/No Go Error Rate for Horizontal Cues  
 
 
Go/No-Go Number Overall Mean Reaction Time (in ms) for the 
go responses 
 
Number Series Task Correct Pattern Recognition 
 
2-Back reaction time 
 
 











VSWM Memory span 
 
 
HSD > CO 
HSDCC > CO 
 
Sig. A Main effect, but all inter-
group comparisons ns. 
 
HSDCC <  HSD 
HSDCC < CO 
 
CO > HSD 
 
 
Sig. A multivariate main effect, 
but no significant univariate 
effects or inter-group 
comparisons 
 
CO quicker RTs than HSD, but 
this was marginally ns. 
MLR showed six-month alcohol 
consumption to be significantly 
related to longer RTs 
 
Sig. Multivariate inter-group 
effect for left hemisphere but no 




CO > HSDCC in comparisons 
following univariate ANCOVA. 
MLR showed cannabis use 
associated with smaller span 
scores. However, results related 
to six-month alcohol use and 
earlier onset of alcohol use to 









































Table 38: summary of significant intergroup correlations from Chapter 5 to Chapter 9 
Variables Correlational direction Relevant 
chapter 
Barratts Impulsivity: Attention Subscale and Alcohol 
units consumed in the past six months   
Positive 5 
Barratts Impulsivity: Attention Subscale and Onset 
age for alcohol use (years) 
Negative 5 
Barratts Impulsivity: Attention Subscale and Hours 
since last alcohol use 
Positive 5 
Barratts Impulsivity: Motor Subscale and Alcohol 
units consumed in the past six months   
Positive 5 
Barratts Impulsivity: Motor Subscale and Onset age 
for alcohol use (years) 
Negative 5 
Barratts Impulsivity: Motor Subscale and Hours since 
last alcohol use 
Positive 5 
Barratts Impulsivity: Self-control and Alcohol units 
consumed in the past six months   
Positive 5 
Barratts Impulsivity: Self-control and Onset age for 
alcohol use (years) 
Negative 5 
Barratts Impulsivity: Self-control and Hours since last 
alcohol use 
Positive 5 
Barratts Impulsivity: Cognitive Complexity and Alcohol 
units consumed in the past six months   
Positive 5 
Barratts Impulsivity: Cognitive Complexity and Onset 
age for alcohol use (years) 
Negative 5 
Barratts Impulsivity: Cognitive Complexity and Hours 
since last alcohol use 
Positive 5 
Barratts Impulsivity: Perseverance and Alcohol units 
consumed in the past six months   
Positive 5 
Barratts Impulsivity: Perseverance and Onset age for 
alcohol use (years) 
Negative 5 
Barratts Impulsivity: Perseverance and Hours since 
last alcohol use 
Positive 5 
Barratts Impulsivity: Cognitive Instability and Alcohol 
units consumed in the past six months   
Positive 5 
Barratts Impulsivity: Cognitive Instability and Onset 
age for alcohol use (years) 
Negative 5 
 
Barratts Impulsivity: Cognitive Instability and Hours 
since last alcohol use 
 
HADS-D and alcohol units consumed in the previous 
six months 
 
HADS-D and hours since last alcohol 
Use  
 
HADS-A and onset age for alcohol use 
 
3-Back reaction time and alcohol consumption in the 
last six months 
 
VSWM span and where hours since last alcoholic 
drink 
 
VSWM Span and Alcoholic units consumed in the past 
six months 
 



















































Preliminary analysis of demographic variables from chapter five indicated a bias towards male 
participation in the study, making up 72% of the total sample. In terms of the group allocation, 
results suggest that there was a numerical bias towards males engaging in substance misuse (N 
= 14 for males in the HSD and N = 21) for the HSDCC group. Control group allocation, while 
still biased towards males (N = 16) was more balanced with regards to the number of females 
(N = 12). The analysis of background data also indicated that there was no significant difference 
in age between male and female participants. In terms of group allocation and participant age, 
however, HSD participants were older on average than participants in the CO and HSDCC 
groups. Still, a Kruskal Wallis analysis indicated that this difference was not significant. 
 
The analyses in Chapter Five reported significant differences between the three groups in which 
the HSDCC group demonstrated higher levels of depression, and also higher levels of 
impulsivity compared to the HSD and CO groups. Studies have shown that both HSD and 
cannabis smoking population display more significant levels of depression compared to 
controls  (Paljärvi et al., 2009; Asghar et al., 2019). This pattern of results, therefore, can be 
regarded as consistent with demographic findings from the relevant substance-using 
populations from within existing academic literature. However, results also indicate that the 
HSDCC group demonstrated higher premorbid IQ scores compared to either of the two other 
groups, and higher fluid IQ scores compared to the HSD group. Results from within the 
academic literature tend to report lower IQ scores in both HSD  (Sjölund et al., 2016) and 
cannabis smoking populations (Mokrysz et al., 2016).   
 
In terms of substance misuse indices, Chapter Five reported that while the HSD and HSDCC 
reported a higher rate of alcohol consumption compared to the CO group. The HSD and 
HSDCC do not differ on any alcohol use variable except onset age for which the HSDCC group 
was younger. Bivariate correlations with covariates representing alcohol consumption, showed 
that the depression scores were on the borderline of a significant negative correlation with the 
estimated number of alcohol units consumed in the previous six months. However, results did 











show a stronger positive correlation with the number of hours since the last alcohol. Onset age 
for alcohol use had a positive correlation with the anxiety scores, which, whilst significant, was 
not robust.  Results demonstrated a positive correlation for all indices of impulsivity and 
alcohol units consumed in the past six months and hours since the last alcoholic drink. These 
results are consistent with results from within the literature have reported that heavy social 
drinkers are more impulsive than non-bingers (Banca et al., 2016). The estimated alcohol use 
in the past six months and hours since last alcohol consumption showed universally positive 
correlations with the impulsivity sub-scales. Consequently, there had been long periods of 
abstinence for participants high in impulsivity. These findings would be consistent with the 
observation that binge drinking comprises short periods of excessive consumption, preceded 
and followed by periods of abstinence (McCaul et al., 2017).  
 
Alcohol consumption in the previous six months showed a strong correlation with depression 
scores within the HSDCC group. Scores indicated that no correlation exists between hours 
since the participant last used cannabis and levels of depression. Within the HSDCC group (N 
= 22), there was no correlation reported for the age of first for cannabis use with the scores for 
depression, anxiety, any of the impulsivity sub-scales, premorbid IQ, or Raven's Matrices 
scores. However, the number of hours since the last use of cannabis had a relatively strong 
positive correlation with anxiety scores, indicating that anxiety was higher with more extended 
periods of abstinence. Research by Schuster et al. (2017) suggests this may be symptomatic of 
cannabis withdrawal, which increases anxiety levels. There was also no correlation for 
cannabis abstinence with any of the other background variables or substance consumption 
variables. The statistical power of the correlations with these two measures of cannabis use 
would, of course,  limited by the relatively small number of participants in this group. However, 
taking values of '0' for cannabis consumption in the CO and HSD groups estimated cannabis 
consumed in the previous six months did show significant positive correlations with the 
impulsivity sub-scales for attention, motor performance, self-control, and mental instability. 
Consequently, for both alcohol and cannabis, impulsivity predicted higher consumption levels 
which again is in keeping with findings from the broader academic literature (VanderVeen et 




With regards to the findings of chapters 7 and 8 on WM and EF performance, there were 
relatively few significant effects emerging from the data. The Go/No-Go task of IC did reveal 
quicker RTs for ‘Go’ responses for HSDCC participants compared to the other groups. 
However, the absence of significant effects on other performance measures for this task does 
not permit detailed speculation concerning whether results should interpret this as showing 
better (i.e. quicker) performance, or less attentive understanding. This pattern would be 
consistent with current (see Chapter 5) and previous findings (VanderVeen et al. 2016; Lannoy 
et al., 2017) regarding impulsivity in cannabis users. There was a significant multivariate effect 
for one of the error rate measures on this task. Still, there were no significant univariate effects 
or inter-group comparisons to shed light based on this result. However, the results for this task 
do suggest that IC functioning is an area worthy of further research concerning HSD and 
cannabis polydrug use. The fNIRS data on rCBF reported in Chapter 8 failed to show any 
significant effects for this task. 
 
The number-series task of IR showed a significantly higher total of correct responses for the 
control participants compared to the HSD participants. While this would be consistent with the 
effects of HSD on essential brain areas in cognition (Campanella et al ., 2013; Chanraud et al., 
2009; Weissenborn and Duka, 2003), the lack of any effects related to cannabis is not consistent 
with previous literature (Aloi et al., 2018; Broyd et al., 2016; Murphy, 2018). Given that the 
HSDCC group had higher alcohol consumption in the previous six months compared to the 
control group but not to the HSD group. The absence of any impairment in their performance 
relative to the controls raises the possibility of a neuroprotective effect of cannabinoids (Cabral 
& Jamerson., 2014; Sarne & Mechoulam, 2005) which would be worthy of further 
investigation. There were no significant effects on the fNIRS data on this task. 
 
In terms of performance on the N-Back task, there was a significant multivariate effect across 
groups for the 2-Back condition. Still, there were no significant univariate effects or group 
comparisons. Although there were no inter-group effects for the 3-Back condition, multiple 
linear regression (MLR) showed alcohol consumption in the previous six months to be 
significantly related to longer RTs. The comparison between controls and HSD participants 
narrowly failed to be significant, with the control group showing faster times. The fNIRS data 
for this task showed a significant multivariate effect for the left hemisphere, but there were no 
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significant univariate effects or inter-group comparisons. Regrettably, recording errors had 
necessitated the combining of fNIRS data for this task across all four of its levels, as this may 
have obscured some effects which may have been significant at the respective groups. The 
results reported here are inconclusive, and also lack examination in terms of nicotine use which 
may also have impacted upon performance. Nevertheless, they do indicate that EU functioning 
is an area worthy of further research concerning the potential effects of HSD and cannabis 
polydrug use.  
 
The VSWM task showed longer spans for control participants than the HSDCC group once 
data analysis had controlled covariates related to alcohol consumption. This control would be 
consistent with the findings of (Wareing et al. 2004) of a relationship between cannabis use 
and VSWM performance, and also other existing literature concerning the implications of 
cannabis use for cognitive functioning (Broyd et al., 2016; Murphy, 2018). However, contrary 
to prediction, alcohol consumption in the previous six months and earlier onset ages for alcohol 
use, were both related to longer VSWM span scores. These latter results are difficult to explain 
but may reflect an uneven distribution across the groups of the potentially confounding effects 
of impairments in brain activation and WM and EF performance arising from nicotine 
consumption (Gonzales et al. 2020; Nardone et al., 2020). As noted above, it was not possible 
to examine nicotine consumption as a covariate in this study due to an apparent 
misunderstanding of questions on this matter on the drug use questionnaire administered. The 
fNIRS results for the VSWM task showed no significant effects. 
 
Concerning access to semantic long-term memory (Access), as measured by the COWAT, 
although there were no significant effects related to task performance. There was a significant 
negative correlation between the use of cannabis and Oxy-Hb changes in the left inferior PFC 
related to task performance. Although not significant, results found a trend for the control group 
to show an increase compared to baseline in Oxy-Hb in this ROI during task performance, 
compared to a decrease shown by the HSDCC group. Cannabis use has reported relation to 
impaired access to semantic long-term memory (Murphy et al., 2011). Despite the absence of 
performance differences between the groups in the present study, the finding of this left 
hemisphere effect warrants further investigation of the Access function of WM concerning 




In conclusion, the WCST which failed to show any significant inter-group effects for either 
task performance or rCBF changes measured by fNIRS. Overall, the findings from the other 
areas of EF summarised above in this chapter, concerning inhibitory control, executive 
updating, visuospatial working memory, and access to semantic long-term memory, in addition 
to the results for inductive reasoning, provide grounds for suggesting that further research into 
these areas of functioning concerning the potential implications of HSD and cannabis polydrug 
use, would be justified. Nevertheless, a large majority of the analyses conducted in Chapters 7 
and 8 showed no significant effects. Given the contrast of this absence of impact compared to 
the existing literature for alcohol and HSD (Campanella et al ., 2013; Chanraud et al., 2009; 
Weissenborn and Duka, 2003), and cannabis use (Aloi et al., 2018; Broyd et al., 2016; Murphy, 
2018), the scarcity of significant effects may have been due to the limitations of the present 
study discussed below. 
 
Limitations 
The present study relied upon self-reports of alcohol and cannabis consumption, which are 
inevitably vulnerable to memory distortions, and also to the deliberate falsification of data for 
a variety of personal motives. Reliance upon self-reports in the literature is common practice, 
including the studies reviewed in Chapters 3 and 4 of this thesis. Lifetime estimates of 
consumption, and estimates of consumption in the previous six months, inevitably go beyond 
the ability of toxicological tests to verify, so that self-reports become the only source of data in 
many cases. Reliance upon self-reports also precludes the possibility of controlling for the 
differing strengths of cannabis possibly consumed, given the variability of cannabis potency 
found in black market supplies (Freeman et al., 2014; Hardwick & King, 2008). Its level of 
THC content determines the strength of a collection of cannabis. The lack of information 
regarding the potency of cannabis consumed means that the thesis can not address questions 
around the balance of neuroprotective and toxic effects linked to proportions of CBD and THC 
(Cabral & Jamerson., 2014; Sarne & Mechoulam, 2005).  Once again, however, this limitation 
is shared with the studies reviewed in Chapters 3 and 4 of this thesis. Concerning alcohol 
consumption, the conversion of self-reports into estimated units of alcohol in the present study 




The present study also has the limitation of having recruited participants from a student 
population, so that the thesis cannot consider the results as representative of a broader 
population of HSD and HSDCC consumers. Concerning the possible relationship between 
alcohol and cannabis-related effects on cognition in people who are older than the present 
sample and have differing levels of education, this is a limitation. Episodes of heavy drinking 
occur across all ages (Office for National Statistics, 2017) as does cannabis use (EMCDDA, 
2019; Ganzer et al., 2016) so that the scope of the present study was reasonably limited in 
demographic terms from the outset. 
 
The design of the present study used three groups to identify impaired cognitive functioning 
and differences in rCBF data which were related to alcohol and cannabis, respectively. The 
rationale was that if the HSD and HSDCC groups showed no differences from each other, but 
differed from the controls than the observed effect, researchers could attribute the effect to 
alcohol. Conversely, if the control group and HSD groups did not differ from each other, but 
differed from the HSDCC group, the results would attribute the observed effect to cannabis. It 
is clear from the literature that cannabis poses the possibility of a variety of potential products 
which may include neuroprotection (Cabral & Jamerson., 2014; Sarne & Mechoulam, 2005), 
and toxic damage to brain structures (Broyd et al., 2016; Ganzer et al., 2016; Murphy, 2018). 
The recruitment of the fourth group of cannabis users without HSD might have helped present 
a complete picture of the relationship between EF and WM functioning and cannabis and 
alcohol consumption patterns, respectively? In effect, the recruitment of such a group would 
have established a more explicit baseline against research could then compare the results of 
HSD and cannabis polydrug. The establishment of such baselines is an inherent and recurring 
issue in polydrug use research and has resource implications for the recruitment of adequate 
samples sizes (Taurah et al., 2014). 
 
The present study used a cross-sectional design of pre-existing groups of HSD and HSDCC 
participants, plus controls. Murphy (2018) discusses the use of such methods in substance use 
research generally, which a response to the ethical, practical, and legal barriers to enforcing the 
consumption of alcohol, cannabis, and other drugs on participants before testing. The use of 
cross-sectional designs means that the only conclusion to be drawn is that of correlational 
relationships between substance consumption and cognitive functioning, as opposed to cause 
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and effect relationships. The present study,  therefore, has this limitation, although its 
occurrence in the literature as a whole is not rare. 
 
One significant limitation is the absence of data on nicotine use as the result of an apparent 
misunderstanding of questions on nicotine consumption in the drug use questionnaire 
administered to participants. Nicotine consumption results in lower grey matter density in the 
prefrontal cortex, cingulate gyrus, parietal lobe, cerebellum, thalamus, striatum and medial 
temporal lobe (Yuan et al., 2018). Nicotine has also resulted in impairments to the DLPFC 
liked to sensorimotor, emotional, and cognitive impairments (Levin et al. 2018). Nardone et al. 
(2020) reported nicotine consumption to be positively correlated with deficits to WM and EF 
in cannabis smokers, while Otto et al. (2020) reported that combinations of ethanol and nicotine 
resulted in decreased visuospatial working memory task performance. It is apparent therefore 
that the lack of data on tobacco and nicotine consumption as a covariate in the present study 
limited the analyses conducted into EF and WM functioning in the context of HSD and 
cannabis consumption, respectively. 
 
One final limitation to the present study may is the nature of the measures of  WM and EF 
used, and also of underlying brain activity as measured by fNIRS. It is the case that all of the 
tests used, as described in Chapter 6, were those identified by van Holst et al. (2011) as being 
the most suitable in their computerised form, for measuring these functions in a substance using 
population. Nevertheless, the literature does note the limitations to the sensitivity of existing 
neurocognitive tests to subtle changes in WM and EF in drug-using people (Fisk & 
Montgomery, 2011; Gauvin et al., 2016; Snyder et al., 2017). The present study would suffer 
from whatever limitations may exist to the sensitivity of the tests used. Still, many other tasks 
in the existing literature share these limitations. Concerning fNIRS, this constitutes a recording 
method for rCBF in the cerebral cortex (Roberts & Montgomery, 2015). Still, it is not capable 
of obtaining measures of activation in subcortical structures known to be important in cognitive 
functioning, such as the thalamus, hippocampus, and amygdala. Research has noted changes 
in the construction and functioning of these areas in reviews of the relationship between alcohol 
and cannabis consumption and cognitive functioning (Broyd et al., 2016; Murphy, 2018). 
Consequently, the inability of the present study to measure responses in these structures raises 
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Implications of the present findings 
The primary area of practical implication arising from the findings concerns the development 
and application of diagnostic criteria for polydrug use. The results in Chapter 5 identified the 
HSDCC group as having a significantly higher profile than the other two groups concerning 
impulsivity and depression. Given the limitations of the current sample size, further research 
should seek to elaborate upon these findings for incorporation into revisions of DSM-5 
(American Psychiatric Association, 2013), and guidelines for clinical practice produced for 
practitioners (e.g. Clinical Guidelines on Drug Misuse and Dependence Update, 2017). The 
development of interventions for curbing impulsivity, and for depression, for people with a 
substance use disorder involving HSD and cannabis use might be a possible development from 
the current findings after further research. Such work might include further investigation of IC 
functioning in people with HSD and cannabis use patterns of consumption.  
 
These findings may inform health promotion initiatives by results concerning impulsivity and 
depression in HSD and cannabis use. The present findings come from a cross-sectional study 
and are essentially correlational. It is not possible to say from them if impulsivity and 
depression cause HSD and cannabis use, or if they are the consequence of such a pattern of 
substance use. Although these would be questions for further research, impulsive substance 
misuse, specifically HSD and cannabis smoking, have been described as an attempt at 
regulating negative emotions such as depression (Bo et al., 2016). The practical implications 
of such findings are that they highlight possible warning indicators for educators in schools 
and colleges to identify individuals who may be vulnerable to developing this pattern of 
substance use. In this regard, it is worth noting that Chapter 5 reported that the HSDCC group 
had an earlier onset age for alcohol use. The HSDCC group also had higher premorbid IQ than 
both other groups and higher fluid IQs than the HSD group. The combination of high 
impulsivity, depression, high IQ, and early onset of alcohol use may therefore present a set of 
warning indicators for those who work with young people, and who might be able to bring in, 
appropriate interventions promptly. An extensive literature already exists concerning the 
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harmful effects of early-onset alcohol use (Broyd et al., 2016; Schweinsburg et al., 2010). This 
literature is also present in cannabis use (Solowij & Battisti, 2008; Schweinsburg et al., 2005, 
2008) which present a consistent picture of harm and dysfunction with which the present 
findings are consistent. 
 
The general lack of significant findings for the tests of WM and EF necessarily limits the 
practical implications arising from the results in Chapters 7 and 8. In short, although there are 
indications that further research in some areas of functioning would be appropriate. The present 
results do not show a pattern of impairments suggesting that remedial interventions and the 
consideration of constraints on such things as using machinery and driving, need to be 
considered. The present findings are not however consistent with some other findings 
concerned with HSD and cannabis use (Broyd et al., 2016; Campanella et al ., 2013; Chanraud 
et al., 2009; Murphy, 2018). 
 
Potential future Directions 
In addition to the implications for further research and professional practice discussed in the 
previous section, there were relatively few significant effects in the findings reported in 
Chapters 7 and 8 concerning WM and EF. The results which did emerge do suggest the utility 
of further research in the areas of inhibitory control, inductive reasoning, executive updating, 
visuospatial working memory, and access to semantic long-term memory, concerning the 
potential implications of HSD and cannabis polydrug use on functioning. Future studies will 
require careful and detailed attention to the effects of potential covariates such as tobacco and 
nicotine consumption (Nardone et al., 2020; Otto et al., 2020) as well as other drugs of misuse, 
to control for their potentially confounding effects.  As noted by Murphy er al., (2018), the 
field of cannabis and alcohol consumption research is dominated by animal studies, specifically 
with research conducted on rats. Therefore, there is a  need for future scientific knowledge of 
the effects of cannabis and alcohol on human cognition to be based upon studies with human 





Despite the evidence which exists for toxic effects linked to cannabis consumption (Murphy, 
2018; Rochetti et al., 2013), the potential neuroprotective effects of cannabinoids (Cabral & 
Jamerson., 2014; Sarne & Mechoulam, 2005), including both THC and CBD, needs further 
investigation. Such an inquiry would present a fuller picture of the relationship between 
cannabis use and cognitive functioning. Concerning cannabinoid biomarkers given the high 
lipid solubility of THC, blood plasma estimates would be inappropriate as they would not 
provide an accurate measure of THC consumed. Hair follicle analysis with its ability to cover 
more extended periods would be a logical alternative (Mieczkowski et al. 1993).  
 
The further development of tests which would be maximally appropriate for use in testing WM 
and EF in substance misusing populations is one area requiring further attention (Gauvin et al., 
2016; Snyder et al., 2017). The development of these tests might also link them to conceptual 
products regarding the description and classification of WM and EF processes. Murphy et al. 
(2012) noted such issues concerning VSWM tests administered to users of ecstasy (MDMA). 
Rather than group all VSWM tests together in their meta-analyses, Murphy et al. separated 
trials into four different categories, such as those involved in tracking and locating stimuli, and 
reproducing complex figures, respectively. A further example was the report of Polderman et 
al. (2009) that the Stroop test of cognitive inhibition also drew upon semantic memory so that 
it was unclear what cognitive function the test analysed. The point for the present discussion is 
that more explicit conceptualisations of WM and EF processes will go together with better 
measurement, which will, in turn, enable a better picture of the implications of HSD and 
cannabis consumption for WM and EF to emerge.  
 
A further avenue of research may include the relationship of relevant genetic variants to HSD 
and cannabis use effects on cognitive functioning. For example, the gene for the P450 2E1 liver 
enzyme is polymorphic, with the variant held by a particular individual determining the rate of 
metabolism of both alcohol and cannabis, and thus their bioavailability (Zakhari & Li, 2007; 
Watanabe et al., 2007). It is reasonable to assume that the bioavailability of alcohol and 
cannabis to the brain will be an essential variable mediating their effects on cognition and 
underlying brain activity. The incorporation of appropriate genetic testing into future research 




In conclusion, Chapter 1 of this thesis highlighted the high levels of use across many societies 
of both alcohol and cannabis. The large number of people who may potentially be affected by 
the harmful consequences of HSD and cannabis use makes it essential that research in this field 
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